Table of Contents

 

Delaware Life NY Variable

Account D

Financial Statements as of and for the Year Ended December 31, 2023 and

Report of Registered Public Accounting Firm


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

Index

December 31, 2023

 

 

     Page(s)  

Report of Independent Registered Public Accounting Firm

     1-3  

Financial Statements

  

Statement of Assets and Liabilities

     4-7  

Statements of Operations

     8-30  

Statements of Changes in Net Assets

     31-64  

Notes to the Financial Statements

     65-84  


Table of Contents

Report of Independent Registered Public Accounting Firm

To the Board of Directors of Delaware Life Insurance Company of New York and the Contract Owners of Delaware Life NY Variable Account D:

Opinion on the Financial Statements

We have audited the accompanying statements of assets and liabilities of the Sub-Accounts listed in the Appendix that comprise Delaware Life NY Variable Account D (the Separate Account), as of December 31, 2023, the related statements of operations and changes in net assets for the periods indicated in the Appendix, and the related notes (collectively, the financial statements) and the financial highlights for each of the years or periods in the three-year period then ended. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Sub-Accounts as of December 31, 2023, the results of their operations and changes in their net assets for the periods indicated in the Appendix, and the financial highlights for each of the years or periods in the three-year period then ended, in conformity with U.S. generally accepted accounting principles. The financial highlights for each of the years or periods ended on or prior to December 31, 2020 were audited by other independent registered public accountants whose report, dated April 28, 2021, expressed an unqualified opinion on those financial highlights.

Basis for Opinion

These financial statements and financial highlights are the responsibility of the Sub-Accounts’ management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Sub-Accounts in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Such procedures also included confirmation of securities owned as of December 31, 2023, by correspondence with the transfer agent of the underlying mutual funds; when replies were not received from the transfer agent, we performed other auditing procedures. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ KPMG LLP

We have served as the auditor of Delaware Life Insurance Company of New York’s Separate Accounts since 2021.

Hartford, Connecticut

April 23, 2024


Table of Contents

Appendix

AB VPS Relative Value Portfolio (Class B) Sub-Account (A71) (1) (2)

AB VPS Sustainable Global Thematic Growth (Class B) Sub-Account (A70) (1)

Alger Mid Cap Growth Portfolio I-2 Sub-Account (A54) (1)

American Funds Insurance Series Growth Income Fund Class 2 Sub-Account (302) (1)

BlackRock Global Allocation V.I. Fund (Class III) Sub-Account (B18) (1)

Columbia Variable Portfolio - Large Cap Growth Fund Class 2 Sub-Account (C60) (1)

LVIP Delaware SMID Cap Core Fund - Standard Class Sub-Account (D37) (1)

DWS Small Cap Index VIP Class B Sub-Account (D55) (1)

DWS Small Mid Cap Value VIP Class A Sub-Account (S61) (1)

BNY Mellon Investment Portfolios: MidCap Stock Portfolio, Initial Shares Sub-Account (D18) (1)

Fidelity VIP Balanced Portfolio (Service Class 2) Sub-Account (FD7) (1)

Fidelity VIP Contrafund Portfolio (Service Class 2) Sub-Account (F24) (1)

Fidelity VIP Contrafund Portfolio (Service Class) Sub-Account (F29) (1)

Fidelity VIP Growth Portfolio (Service Class) Sub-Account (F21) (3)

Fidelity VIP Index 500 Portfolio (Service Class 2) Sub-Account (F26) (1)

Fidelity VIP Index 500 Portfolio (Service Class) Sub-Account (FM7) (1)

Fidelity VIP Mid Cap Portfolio (Service Class 2) Sub-Account (F41) (1)

Fidelity VIP Government Money Market Portfolio (Service Class) Sub-Account (FM8) (1)

Fidelity VIP Overseas Portfolio (Service Class) Sub-Account (F23) (1)

First Eagle Overseas Variable Fund Sub-Account (FE3) (1)

Franklin Templeton Foreign VIP Fund Class 2 Sub-Account (T20) (1)

Franklin Templeton Mutual Shares VIP Fund Class 2 Sub-Account (F54) (1)

Franklin Templeton Small Cap Value VIP Fund Class 2 Sub-Account (F53) (1)

Franklin Templeton Strategic Income VIP Fund Class 2 Sub-Account (T28) (1)

Goldman Sachs VIT Mid Cap Value Fund I Sub-Account (G32) (1)

Goldman Sachs VIT U.S Equity Insights Fund I Class Sub-Account (G31) (1)

Invesco V.I. Growth and Income Fund Series I Sub-Account (IB1) (1)

Invesco V.I. EQV International Equity Fund Series I Sub-Account (A21) (1)

M Capital Appreciation Fund Sub-Account (MB0) (1)


Table of Contents

M International Equity Fund Sub-Account (MB1) (1)

M Large Cap Growth Value Fund Sub-Account (MB5) (1)

M Large Cap Value Fund Sub-Account (MA9) (1)

MFS U.S. Government Money Market Portfolio Initial Class Sub-Account (MD8) (1)

MFS VIT Total Return Series Service Class Sub-Account (M35) (1)

MFS VIT I Growth Series Initial Class Sub-Account (M31) (1)

MFS VIT I Mid Cap Growth Series Initial Class Sub-Account (MF1) (1)

MFS VIT I New Discovery Series Initial Class Sub-Account (M05) (1)

MFS VIT I Total Return Bond Series Initial Class Sub-Account (M06) (1)

MFS VIT I Research Series Initial Class Sub-Account (M33) (1)

MFS VIT I Utilities Series Initial Class Sub-Account (M44) (1)

MFS VIT I Utilities Series Service Class Sub-Account (M40) (1)

MFS VIT I Value Series Initial Class Sub-Account (M83) (1)

MFS VIT I Value Series Service Class Sub-Account (M08) (1)

MFS VIT II Blended Research Core Equity Portfolio I Class Sub-Account (MB6) (1)

MFS VIT II Corporate Bond Portfolio S Class Sub-Account (MA0) (1)

MFS VIT II Emerging Markets Equity Portfolio S Class Sub-Account (MA1) (1)

MFS VIT II Government Securities Portfolio I Class Sub-Account (M96) (1)

MFS VIT II High Yield Portfolio I Class Sub-Account (MA6) (1)

MFS VIT II International Growth Portfolio I Class Sub-Account (M97) (1)

MFS VIT II International Growth Portfolio S Class Sub-Account (MD5) (1)

MFS VIT II Research International Portfolio S Class Sub-Account (ME3) (1)

MFS VIT III Blended Research Small Cap Equity Portfolio Initial Class Sub-Account (MB8) (1)

MFS VIT III Global Real Estate Portfolio Initial Class Sub-Account (MF6) (1)

MFS VIT III Growth Allocation Portfolio Initial Class Sub-Account (MF8) (1)

MFS VIT III Inflation Adjusted Bond Portfolio Initial Class Sub-Account (MG0) (3)

MFS VIT III Limited Maturity Portfolio Initial Class Sub-Account (MF2) (1)

MFS VIT III Mid Cap Value Portfolio Initial Class Sub-Account (MG3) (1)

MFS VIT III Moderate Allocation Portfolio Initial Class Sub-Account (MG5) (1)

MFS VIT III New Discovery Value Portfolio Initial Class Sub-Account (ME0) (1)


Table of Contents

Morgan Stanley Variable Insurance Fund, Inc. Discovery Portfolio Class II Sub-Account (V43) (1)

Invesco V.I. Capital Appreciation Fund, Series I Sub-Account (O01) (1)

Invesco V.I. Global Fund, Series II Sub-Account (O20) (1)

PIMCO VIT CommodityRealReturnTM Strategy Portfolio Admin Class Sub-Account (P10) (3)

PIMCO VIT Emerging Markets Bond Portfolio Admin Class Sub-Account (PK8) (1)

PIMCO VIT Real Return Portfolio Admin Class Sub-Account (P06) (1)

PIMCO VIT Total Return Portfolio Admin Class Sub-Account (P07) (1)

T. Rowe Price Blue Chip Growth Portfolio Sub-Account (307) (1)

 

(1)

Statement of assets and liabilities as of December 31, 2023, the related statement of operations for the year then ended, the statements of changes in net assets for each of the years in the two-year period then ended, and the financial highlights for each of the years in the three-year period then ended. Financial highlights for the years or periods ended on or prior to December 31, 2020 were audited by other independent registered public accountants.

 

(2)

Formerly AB VPS Growth and Income Portfolio (Class B).

 

(3)

Statement of operations for the year ended December 31, 2023, and the statements of changes in net assets for each of the years in the two-year period then ended.


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENT OF ASSETS AND LIABILITIES

DECEMBER 31, 2023

 

 

                                                                                                           
          Assets     Liabilities      
       Shares        Cost        Investments  
at fair value
     Total Assets        Payable to  
Sponsor
     Net Assets  
    

 

  

 

  

 

  

 

AB VPS Relative Value Portfolio (Class B) Sub-Account (A71) ¹

     3,140       $ 87,895       $ 90,362       $ 90,362       $ -        $ 90,362  

AB VPS Sustainable Global Thematic Growth (Class B) Sub-Account (A70)

     74        2,200        2,305        2,305        -         2,305  

Alger Mid Cap Growth Portfolio I-2 Sub-Account (A54)

     3,400        56,262        57,282        57,282        -         57,282  

American Funds Insurance Series Growth Income Fund Class 2 Sub-Account (302)

     784        37,368        45,731        45,731        -         45,731  

BlackRock Global Allocation V.I. Fund (Class III) Sub-Account (B18)

     4,539        66,329        59,147        59,147        -         59,147  

Columbia Variable Portfolio - Large Cap Growth Fund Class 2 Sub-Account (C60)

     1,070        16,859        38,548        38,548        -         38,548  

LVIP Delaware SMID Cap Core Fund - Standard Class Sub-Account (D37)

     1,213        29,849        31,005        31,005        -         31,005  

DWS Small Cap Index VIP Class B Sub-Account (D55)

     1,550        22,224        21,111        21,111        -         21,111  

DWS Small Mid Cap Value VIP Class A Sub-Account (S61)

     934        13,123        12,946        12,946        -         12,946  

BNY Mellon Investment Portfolios: MidCap Stock Portfolio, Initial Shares Sub-Account (D18)

     6,883        129,951        128,570        128,570        -         128,570  

Fidelity VIP Balanced Portfolio (Service Class 2) Sub-Account (FD7)

     10,927        192,882        235,370        235,370        1        235,369  

Fidelity VIP Contrafund Portfolio (Service Class 2) Sub-Account (F24)

     1,484        52,737        69,475        69,475        -         69,475  

Fidelity VIP Contrafund Portfolio (Service Class) Sub-Account (F29)

     3,353        121,757        161,950        161,950        -         161,950  

Fidelity VIP Growth Portfolio (Service Class) Sub-Account (F21)4

     -        -        -        -        -         -  

Fidelity VIP Index 500 Portfolio (Service Class 2) Sub-Account (F26)

     262        67,241        119,101        119,101        -         119,101  

Fidelity VIP Index 500 Portfolio (Service Class) Sub-Account (FM7)

     610        159,086        280,497        280,497        -         280,497  

Fidelity VIP Mid Cap Portfolio (Service Class 2) Sub-Account (F41)

     2,426        79,440        84,165        84,165        -         84,165  

Fidelity VIP Government Money Market Portfolio (Service Class) Sub-Account (FM8)

     6,392        6,392        6,392        6,392        -         6,392  

Fidelity VIP Overseas Portfolio (Service Class) Sub-Account (F23)

     4,752        100,609        122,020        122,020        -         122,020  

First Eagle Overseas Variable Fund Sub-Account (FE3)

     751        18,852        16,969        16,969        -         16,969  

Franklin Templeton Foreign VIP Fund Class 2 Sub-Account (T20)

     3,071        40,587        43,725        43,725        -         43,725  

Franklin Templeton Growth VIP Fund Class 2 Sub-Account (F56) ²

     -        -        -        -        -         -  

Franklin Templeton Mutual Shares VIP Fund Class 2 Sub-Account (F54)

     364        5,626        5,579        5,579        -         5,579  

Franklin Templeton Small Cap Value VIP Fund Class 2 Sub-Account (F53)

     3,501        53,626        46,454        46,454        -         46,454  

Franklin Templeton Strategic Income VIP Fund Class 2 Sub-Account (T28)

     844        9,713        7,603        7,603        -         7,603  

Goldman Sachs VIT Mid Cap Value Fund I Sub-Account (G32)

     6        90        91        91        -         91  

Goldman Sachs VIT U.S Equity Insights Fund I Class Sub-Account (G31)

     911        16,476        17,796        17,796        -         17,796  

Invesco V.I. Growth and Income Fund Series I Sub-Account (IB1)

     209        4,020        3,943        3,943        -         3,943  

Invesco V.I. EQV International Equity Fund Series I Sub-Account (A21)

     1,665        51,698        56,746        56,746        -         56,746  

M Capital Appreciation Fund Sub-Account (MB0)

     1,311        33,009        32,016        32,016        -         32,016  

M International Equity Fund Sub-Account (MB1)

     2,039        24,994        27,709        27,709        -         27,709  

M Large Cap Growth Value Fund Sub-Account (MB5)

     2,326        63,041        67,594        67,594        -         67,594  

M Large Cap Value Fund Sub-Account (MA9)

     2,587        32,992        37,958        37,958        -         37,958  

MFS U.S. Government Money Market Portfolio Initial Class Sub-Account (MD8)

     49,082        49,082        49,082        49,082        -         49,082  

MFS VIT Total Return Series Service Class Sub-Account (M35)

     1,152        25,741        26,122        26,122        -         26,122  

MFS VIT I Growth Series Initial Class Sub-Account (M31)

     37        1,911        2,257        2,257        -         2,257  

MFS VIT I Mid Cap Growth Series Initial Class Sub-Account (MF1)

     3,644        28,405        31,231        31,231        -         31,231  

MFS VIT I New Discovery Series Initial Class Sub-Account (M05)

     722        12,252        9,338        9,338        -         9,338  

MFS VIT I Total Return Bond Series Initial Class Sub-Account (M06)

     11,782        151,496        137,852        137,852        -         137,852  

MFS VIT I Research Series Initial Class Sub-Account (M33)

     1,390        40,254        44,434        44,434        -         44,434  

MFS VIT I Utilities Series Initial Class Sub-Account (M44)

     83        2,662        2,663        2,663        -         2,663  

MFS VIT I Utilities Series Service Class Sub-Account (M40)

     600        20,758        18,916        18,916        -         18,916  

MFS VIT I Value Series Initial Class Sub-Account (M83)

     2,279        44,895        48,465        48,465        -         48,465  

MFS VIT I Value Series Service Class Sub-Account (M08)

     6,914        131,958        143,175        143,175        -         143,175  

MFS VIT II Blended Research Core Equity Portfolio I Class Sub-Account (MB6)

     118        5,856        6,529        6,529        -         6,529  

MFS VIT II Corporate Bond Portfolio S Class Sub-Account (MA0)

     4,386        50,776        41,099        41,099        -         41,099  

MFS VIT II Emerging Markets Equity Portfolio S Class Sub-Account (MA1)

     -        2        1        1        -         1  

MFS VIT II Government Securities Portfolio I Class Sub-Account (M96)

     701        7,720        7,620        7,620        -         7,620  

 

The accompanying notes are an integral part of these financial statements.

 

- 4 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF ASSETS AND LIABILITIES (CONTINUED)

DECEMBER 31, 2023

 

 

                                                                                                           
          Assets     Liabilities      
       Shares        Cost        Investments  
at fair value
     Total Assets        Payable to  
Sponsor
     Net Assets  
    

 

  

 

  

 

  

 

MFS VIT II High Yield Portfolio I Class Sub-Account (MA6)

     8,438       $ 41,791       $ 42,191       $ 42,191       $ -        $ 42,191  

MFS VIT II International Growth Portfolio I Class Sub-Account (M97)

     54        721        786        786        -         786  

MFS VIT II International Growth Portfolio S Class Sub-Account (MD5)

     2,617        35,946        37,769        37,769        -         37,769  

MFS VIT II Research International Portfolio S Class Sub-Account (ME3)

     33        468        545        545        -         545  

MFS VIT III Blended Research Small Cap Equity Portfolio Initial Class Sub-Account (MB8)

     1,441        15,334        14,424        14,424        -         14,424  

MFS VIT III Global Real Estate Portfolio Initial Class Sub-Account (MF6)

     3,002        41,954        39,270        39,270        -         39,270  

MFS VIT III Growth Allocation Portfolio Initial Class Sub-Account (MF8)3

     -        -        -        -        -         -  

MFS VIT III Inflation Adjusted Bond Portfolio Initial Class Sub-Account (MG0)4

     -        -        -        -        -         -  

MFS VIT III Limited Maturity Portfolio Initial Class Sub-Account (MF2)

     49,398        498,396        492,501        492,501        1        492,500  

MFS VIT III Mid Cap Value Portfolio Initial Class Sub-Account (MG3)

     7,224        60,642        71,016        71,016        -         71,016  

MFS VIT III Moderate Allocation Portfolio Initial Class Sub-Account (MG5)

     122,186        1,625,068        1,309,834        1,309,834        4        1,309,830  

MFS VIT III New Discovery Value Portfolio Initial Class Sub-Account (ME0)

     110        826        875        875        -         875  

Morgan Stanley Variable Insurance Fund, Inc. Discovery Portfolio Class II Sub-Account (V43)

     3,733        40,942        15,119        15,119        -         15,119  

Invesco V.I. Capital Appreciation Fund, Series I Sub-Account (O01)

     420        20,143        19,753        19,753        -         19,753  

Invesco V.I. Global Fund, Series II Sub-Account (O20)

     1,215        44,361        43,145        43,145        -         43,145  

PIMCO VIT CommodityRealReturnTM Strategy Portfolio Admin Class Sub-Account (P10)4

     -        -        -        -        -         -  

PIMCO VIT Emerging Markets Bond Portfolio Admin Class Sub-Account (PK8)

     8,707        97,566        91,857        91,857        -         91,857  

PIMCO VIT Global Managed Asset Allocation Portfolio Administrative Class Sub-Account (PK9) ²

     -        -        -        -        -         -  

PIMCO VIT Real Return Portfolio Admin Class Sub-Account (P06)

     44        519        509        509        -         509  

PIMCO VIT Total Return Portfolio Admin Class Sub-Account (P07)

     3,201        31,287        29,382        29,382        -         29,382  

T. Rowe Price Blue Chip Growth Portfolio Sub-Account (307)

     5,604        206,508        258,840        258,840        -         258,840  

1This Sub-Account had a name change in 2023. Refer to Note 1 in the Variable Account’s Notes to Financial Statements for more information.

2This sub-account is active but had zero balance as of December 31, 2023, and no activity for the years ended December 31, 2023 and 2022, respectively. Therefore, this sub-account is not disclosed in the Statements of Operations and Statements of Changes in Net Assets.

3This Sub-Account had a fractional share at December 31, 2023 which was reported as zero due to rounding.

4This Sub-Account is active but had zero balance at December 31, 2023.

 

The accompanying notes are an integral part of these financial statements.

 

- 5 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENT OF ASSETS AND LIABILITIES (CONTINUED)

DECEMBER 31, 2023

 

 

 

         Total Units             Net Assets    

A71

     2,132        $ 90,362  

A70

     103        $ 2,305  

A54

     1,153         57,282  

302

     836         45,731  

B18

     2,394         59,147  

C60

     1,305         38,548  

D37

     416         31,005  

D55

     321         21,111  

S61

     285         12,946  

D18

     2,611         128,570  

FD7

     5,322         235,369  

F24

     1,378         69,475  

F29

     2,109         161,950  

F21

     -         -  

F26

     2,868         119,101  

FM7

     5,210         280,497  

F41

     2,418         84,165  

FM8

     463         6,392  

F23

     4,243         122,020  

FE3

     856         16,969  

T20

     1,317         43,725  

F56

     -         -  

F54

     264         5,579  

F53

     1,359         46,454  

T28

     434         7,603  

G32

     2         91  

G31

     370         17,796  

IB1

     82         3,943  

A21

     1,619         56,746  

MB0

     806         32,016  

MB1

     2,287         27,709  

MB5

     1,461         67,594  

 

The accompanying notes are an integral part of these financial statements.

 

- 6 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF ASSETS AND LIABILITIES (CONTINUED)

DECEMBER 31, 2023

 

 

 

         Total Units             Net Assets    

MA9

     1,435        $ 37,958  

MD8

     4,484         49,082  

M35

     1,321         26,122  

M31

     47         2,257  

MF1

     758         31,231  

M05

     297         9,338  

M06

     11,171         137,852  

M33

     1,164         44,434  

M44

     157         2,663  

M40

     1,157         18,916  

M83

     1,523         48,465  

M08

     6,635         143,175  

MB6

     122         6,529  

MA0

     2,129         41,099  

MA1

     -         1  

M96

     388         7,620  

MA6

     1,228         42,191  

M97

     24         786  

MD5

     1,204         37,769  

ME3

     37         545  

MB8

     246         14,424  

MF6

     716         39,270  

MF8

     -         -  

MG0

     -         -  

MF2

     36,779         492,500  

MG3

     1,731         71,016  

MG5

     42,211         1,309,830  

ME0

     18         875  

V43

     275         15,119  

O01

     359         19,753  

O20

     1,145         43,145  

P10

     -         -  

PK8

     2,167         91,857  

PK9

     -         -  

P06

     23         509  

P07

     1,318         29,382  

307

     3,309         258,840  

 

The accompanying notes are an integral part of these financial statements.

 

- 7 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     A71        A70        A54
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 1,498         $ -          $ -   

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (3,849        (1        (3,032

Realized gain distributions

     9,460          -           -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     5,611          (1        (3,032
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     4,986          105          10,950  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     10,597          104          7,918  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      12,095         $      104         $      7,918  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 8 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     302        B18        C60
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 569         $ 1,434         $ -   

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     173          (452        1,497  

Realized gain distributions

     2,134          -           -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     2,307          (452        1,497  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     6,711          5,746          10,330  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     9,018          5,294          11,827  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      9,587         $      6,728         $      11,827  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 9 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     D37        D55        S61
       Sub-Account            Sub-Account          Sub-Account  

Income:

            

Dividend income

    $ 325         $ 213         $ 137  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     356          (962        (29

Realized gain distributions

     1,482          606          459  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     1,838          (356        430  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     730          3,710          1,128  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     2,568          3,354          1,558  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      2,893         $      3,567         $      1,695  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 10 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     D18        FD7        F24
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 1,171          $ 3,383          $ 164   

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     7,874          725          349  

Realized gain distributions

     4,708          7,946          2,305  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     12,582          8,671          2,654  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     10,579          29,633          14,714  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     23,161          38,304          17,368  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      24,332         $      41,687         $      17,532  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 11 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     F29        F21        F26
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 575          $ -          $ 1,400   

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     707          568           6,785  

Realized gain distributions

     5,158          28          1,114  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     5,865          596          7,899  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     34,197          173          16,897  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     40,062          769          24,796  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      40,637         $      769         $      26,196  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 12 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     FM7        F41        FM8
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 4,543         $ 306         $ 517  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     78,891          (71        -   

Realized gain distributions

     3,206          2,292          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     82,097          2,221          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     (12,796        8,451          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     69,301          10,672          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      73,844         $      10,978         $      517  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 13 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     F23        FE3        T20
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 1,167         $ -          $ 1,657  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     8,982          (170        (472

Realized gain distributions

     327          1,243          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     9,309          1,073          (472
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     13,899          453          10,295  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     23,208          1,526          9,823  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      24,375         $      1,526         $      11,480  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 14 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     F54        F53        T28
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 103         $ 224         $ 337  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (353        (354        (43

Realized gain distributions

     475          2,421          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     122          2,067          (43
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     486          2,984          284  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     608          5,051          241  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      711         $      5,275         $      578  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 15 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     G32        G31        IB1
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 1         $ 113         $ 60  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     -           (5        (24

Realized gain distributions

     2          -           475  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     2          (5        451  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     6          3,327          (66
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     8          3,322          385  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      9         $      3,435         $      445  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 16 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     A21        MB0        MB1
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 123         $ 130         $ 791  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     464          (86        (72

Realized gain distributions

     46          1,968          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     510          1,882          (72
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     8,065          4,171          3,084  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     8,575          6,053          3,012  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      8,698         $      6,183         $      3,803  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 17 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     MB5        MA9        MD8
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ -          $ 816         $ 2,381  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     81          69          -   

Realized gain distributions

     3,421          548          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     3,502          617          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     12,976          1,274          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     16,478          1,891          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      16,478         $      2,707         $      2,381  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 18 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     M35        M31        MF1
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 452         $ -          $ -   

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     4          2,699          (10,564

Realized gain distributions

     1,078          950          390  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     1,082          3,649          (10,174
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     896          342          15,952  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     1,978          3,991          5,778  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      2,430         $      3,991         $      5,778  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 19 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     M05        M06        M33
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ -          $ 4,238         $ 208  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (81        (1,044        (11

Realized gain distributions

     -           -           2,193  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     (81        (1,044        2,182  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     1,225          6,421          5,760  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     1,144          5,377          7,942  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      1,144         $      9,615         $      8,150  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 20 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     M44        M40        M83
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 95         $ 630         $ 746  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     10          (5        5,473  

Realized gain distributions

     146          1,057          3,138  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     156          1,052          8,611  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     (310        (2,129        (5,901
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     (154        (1,077        2,710  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      (59       $      (447       $      3,456  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 21 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     M08        MB6        MA0
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 1,917         $ 83         $ 1,452  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     778          61          (482

Realized gain distributions

     9,610          464          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     10,388          525          (482
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     (2,149        850          2,454  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     8,239          1,375          1,972  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      10,156         $      1,458         $      3,424  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 22 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     MA1        M96        MA6
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 12         $ 222         $ 3,321  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (282        (1,330        (3,878

Realized gain distributions

     -           -           -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     (282        (1,330        (3,878
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     328          1,562          6,534  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     46          232          2,656  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      58         $      454         $      5,977  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 23 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     M97        MD5        ME3
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 44         $ 325         $ 4  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     478          (69        10  

Realized gain distributions

     126          1,139          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     604          1,070          10  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     53          3,281          51  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     657          4,351          61  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      701         $      4,676         $      65  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 24 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     MB8        MF6        MF8
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 162         $ 397         $ -   

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (2,581        (1,670        -   

Realized gain distributions

     706          3,229          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     (1,875        1,559          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     4,527          2,593          2  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     2,652          4,152          2  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      2,814         $      4,549         $      2  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 25 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     MG0        MF2        MG3
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 611         $ 7,552         $ 1,172  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (7,421        (2,287        372  

Realized gain distributions

     -           -           2,222  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     (7,421        (2,287        2,594  
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     5,849          23,220          4,337  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     (1,572        20,933          6,931  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      (961       $      28,485         $      8,103  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 26 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     MG5        ME0        V43
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 33,657         $ 57         $ -   

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (4,574        (235        (8,109

Realized gain distributions

     79,487          413          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     74,913          178          (8,109
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     43,550          5          12,936  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     118,463          183          4,827  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $     152,120         $      240         $      4,827  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 27 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     O01        O20        P10
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ -          $ -          $ 2,554  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (44        (137        (3,006

Realized gain distributions

     -           4,614          -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     (44        4,477          (3,006
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     5,241          6,767          (310
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     5,197          11,244          (3,316
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      5,197         $      11,244         $      (762
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 28 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     PK8        P06        P07
       Sub-Account            Sub-Account            Sub-Account  

Income:

            

Dividend income

    $ 5,233         $ 17         $ 1,602  

Net realized and change in unrealized gains (losses):

            

Net realized gains (losses) on sale of investments

     (5,148        (1,924        (5,049

Realized gain distributions

     -           -           -   
  

 

 

 

    

 

 

 

    

 

 

 

Net realized gains (losses)

     (5,148        (1,924        (5,049
  

 

 

 

    

 

 

 

    

 

 

 

Net change in unrealized appreciation (depreciation)

     9,574          1,984          5,670  
  

 

 

 

    

 

 

 

    

 

 

 

Net realized and change in unrealized gains (losses)

     4,426          60          621  
  

 

 

 

    

 

 

 

    

 

 

 

Net increase (decrease) in net assets from operations

    $      9,659         $      77         $      2,223  
  

 

 

 

    

 

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 29 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF OPERATIONS (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 2023

 

 

     307
       Sub-Account  

Income:

  

Dividend income

    $ -   

Net realized and change in unrealized gains (losses):

  

Net realized gains (losses) on sale of investments

     31,889  

Realized gain distributions

     -   
  

 

 

 

Net realized gains (losses)

     31,889  
  

 

 

 

Net change in unrealized appreciation (depreciation)

     67,799  
  

 

 

 

Net realized and change in unrealized gains (losses)

     99,688  
  

 

 

 

Net increase (decrease) in net assets from operations

    $      99,688  
  

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

- 30 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     A71 Sub-Account            A70 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,498     $ 1,287         $ -      $ -   

Net realized gains (losses)

     5,611       19,744          (1     -  

Net change in unrealized appreciation (depreciation)

     4,986       (27,275        105       -  

Increase (decrease) in net assets from operations

     12,095       (6,244        104       -  

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,270       13,278          -        -  

Transfers between Sub-Accounts (including the Fixed Account), net

     (172     127          2,225       -  

Withdrawals, surrenders, annuitizations and contract charges

     (31,233     (489        (3     -  

Mortality and expense risk charges

     -        -           -        -  

Cost of insurance and administrative expense charges

     (14,710     (17,265        (21     -  

Net increase/decrease from Contract Owner Transactions

     (44,845     (4,349        2,201       -  

Total increase (decrease) in net assets

     (32,750     (10,593        2,305       -  

Net assets at beginning of year

     123,112       133,705          -        -  

Net assets at end of year

   $ 90,362     $ 123,112        $ 2,305     $ -  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 31 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     A54 Sub-Account            302 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ -      $ -         $ 569     $ 510   

Net realized gains (losses)

     (3,032     (512 )          2,307       3,920  

Net change in unrealized appreciation (depreciation)

     10,950       (8,286        6,711       (11,958

Increase (decrease) in net assets from operations

     7,918       (8,798        9,587       (7,528

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     90       90          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     40,232       7          -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (96     (68        (1,264     -   

Mortality and expense risk charges

     -        -           (20     (19

Cost of insurance and administrative expense charges

     (3,883     (3,571        (387     (333

Net increase/decrease from Contract Owner Transactions

     36,343       (3,542        (1,671     (352

Total increase (decrease) in net assets

     44,261       (12,340        7,916       (7,880

Net assets at beginning of year

     13,021       25,361          37,815       45,695  

Net assets at end of year

   $ 57,282     $ 13,021        $ 45,731     $ 37,815  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 32 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     B18 Sub-Account            C60 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,434     $ -         $ -      $ -   

Net realized gains (losses)

     (452     766          1,497       3,629  

Net change in unrealized appreciation (depreciation)

     5,746       (12,014        10,330       (16,776

Increase (decrease) in net assets from operations

     6,728       (11,248        11,827       (13,147

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           1,002       1,002  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           (849     899  

Withdrawals, surrenders, annuitizations and contract charges

     (9     (9 )          (16     (5,109 )  

Mortality and expense risk charges

     (25     (27        -        -   

Cost of insurance and administrative expense charges

     (3,556     (3,535        (1,115     (912

Net increase/decrease from Contract Owner Transactions

     (3,590     (3,571        (978     (4,120

Total increase (decrease) in net assets

     3,138       (14,819        10,849       (17,267

Net assets at beginning of year

     56,009       70,828          27,699       44,966  

Net assets at end of year

   $ 59,147     $ 56,009        $ 38,548     $ 27,699  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 33 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     D37 Sub-Account            D55 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 325     $ 51         $ 213     $ 164   

Net realized gains (losses)

     1,838       632          (356     4,527  

Net change in unrealized appreciation (depreciation)

     730       (2,774        3,710       (11,217

Increase (decrease) in net assets from operations

     2,893       (2,091        3,567       (6,526

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           452       452  

Transfers between Sub-Accounts (including the Fixed Account), net

     19,724       (77        (110     -   

Withdrawals, surrenders, annuitizations and contract charges

     (41     (33        (6,431     (137

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (2,230     (2,707        (773     (760

Net increase/decrease from Contract Owner Transactions

     17,453       (2,817        (6,862     (445

Total increase (decrease) in net assets

     20,346       (4,908        (3,295     (6,971

Net assets at beginning of year

     10,659       15,567          24,406       31,377  

Net assets at end of year

   $ 31,005     $ 10,659        $ 21,111     $ 24,406  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 34 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     S61 Sub-Account            D18 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 137     $ 103         $ 1,171     $ 1,066   

Net realized gains (losses)

     430       161          12,582       37,759  

Net change in unrealized appreciation (depreciation)

     1,128       (2,426        10,579       (62,445

Increase (decrease) in net assets from operations

     1,695       (2,162        24,332       (23,620

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     254       254          1,896       1,896  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           (417     (5

Withdrawals, surrenders, annuitizations and contract charges

     (41     (43        (34,230     (578

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (400     (336        (4,705     (4,280

Net increase/decrease from Contract Owner Transactions

     (187     (125        (37,456     (2,967

Total increase (decrease) in net assets

     1,508       (2,287        (13,124     (26,587

Net assets at beginning of year

     11,438       13,725          141,694       168,281  

Net assets at end of year

   $ 12,946     $ 11,438        $ 128,570     $ 141,694  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 35 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     FD7 Sub-Account            F24 Sub-Account  
       December 31,         December 31,              December 31,         December 31,    
     2023     2022          2023     2022  

Operations:

           

Net investment income (loss)

   $ 3,383     $ 2,279         $ 164     $ 160   

Net realized gains (losses)

     8,671       14,156          2,654       3,034  

Net change in unrealized appreciation (depreciation)

     29,633       (61,460        14,714       (22,949

Increase (decrease) in net assets from operations

     41,687       (45,025        17,532       (19,755

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,501       1,501          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     (1     4          -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (106     (107        (1,880     (1

Mortality and expense risk charges

     (103     (102        (33     (30

Cost of insurance and administrative expense charges

     (6,565     (7,024        (582     (504

Net increase/decrease from Contract Owner Transactions

     (5,274     (5,728        (2,495     (535

Total increase (decrease) in net assets

     36,413       (50,753        15,037       (20,290

Net assets at beginning of year

     198,956       249,709          54,438       74,728  

Net assets at end of year

   $ 235,369     $ 198,956        $ 69,475     $ 54,438  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 36 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     F29 Sub-Account            F21 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 575     $ 549         $ -      $ 22   

Net realized gains (losses)

     5,865       7,282          596       384  

Net change in unrealized appreciation (depreciation)

     34,197       (52,069        173       (1,710

Increase (decrease) in net assets from operations

     40,637       (44,238        769       (1,304

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,447       1,447          97       194  

Transfers between Sub-Accounts (including the Fixed Account), net

     245       (459        (1     -   

Withdrawals, surrenders, annuitizations and contract charges

     (351     (337        (4,860     (26

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (2,698     (2,423        (54     (107

Net increase/decrease from Contract Owner Transactions

     (1,357     (1,772        (4,818     61  

Total increase (decrease) in net assets

     39,280       (46,010        (4,049     (1,243

Net assets at beginning of year

     122,670       168,680          4,049       5,292  

Net assets at end of year

   $ 161,950     $ 122,670        $ -      $ 4,049  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 37 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     F26 Sub-Account            FM7 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,400     $ 1,466         $ 4,543     $ 4,672   

Net realized gains (losses)

     7,899       14,343          82,097       10,672  

Net change in unrealized appreciation (depreciation)

     16,897       (42,487        (12,796     (86,520

Increase (decrease) in net assets from operations

     26,196       (26,678        73,844       (71,176

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     3,309       3,309          2,449       8,892  

Transfers between Sub-Accounts (including the Fixed Account), net

     11,963       1,015          (426     9,108  

Withdrawals, surrenders, annuitizations and contract charges

     (22,515     (12,185        (104,149     (1,351

Mortality and expense risk charges

     (6     (7        -        -   

Cost of insurance and administrative expense charges

     (10,792     (12,379        (9,550     (11,847

Net increase/decrease from Contract Owner Transactions

     (18,041     (20,247        (111,676     4,802  

Total increase (decrease) in net assets

     8,155       (46,925        (37,832     (66,374

Net assets at beginning of year

     110,946       157,871          318,329       384,703  

Net assets at end of year

   $ 119,101     $ 110,946        $ 280,497     $ 318,329  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 38 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     F41 Sub-Account            FM8 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 306     $ 226         $ 517     $ 154   

Net realized gains (losses)

     2,221       6,450          -        -   

Net change in unrealized appreciation (depreciation)

     8,451       (21,596        -        -   

Increase (decrease) in net assets from operations

     10,978       (14,920        517       154  

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,025       1,025          231       263  

Transfers between Sub-Accounts (including the Fixed Account), net

     4,630       508          -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (9,056     (2,637        (5,476     (39

Mortality and expense risk charges

     (23     (24        -        -   

Cost of insurance and administrative expense charges

     (4,201     (4,817        (329     (320

Net increase/decrease from Contract Owner Transactions

     (7,625     (5,945        (5,574     (96

Total increase (decrease) in net assets

     3,353       (20,865        (5,057     58  

Net assets at beginning of year

     80,812       101,677          11,449       11,391  

Net assets at end of year

   $ 84,165     $ 80,812        $ 6,392     $ 11,449  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 39 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     F23 Sub-Account            FE3 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,167     $ 1,293         $ -      $ 333   

Net realized gains (losses)

     9,309       2,125          1,073       595  

Net change in unrealized appreciation (depreciation)

     13,899       (44,767        453       (2,333

Increase (decrease) in net assets from operations

     24,375       (41,349        1,526       (1,405

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,974       1,974          745       745  

Transfers between Sub-Accounts (including the Fixed Account), net

     (151     (53        80       (179

Withdrawals, surrenders, annuitizations and contract charges

     (25,334     (559        (5     (1,179

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (3,920     (3,531        (718     (611

Net increase/decrease from Contract Owner Transactions

     (27,431     (2,169        102       (1,224

Total increase (decrease) in net assets

     (3,056     (43,518        1,628       (2,629

Net assets at beginning of year

     125,076       168,594          15,341       17,970  

Net assets at end of year

   $ 122,020     $ 125,076        $ 16,969     $ 15,341  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 40 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     T20 Sub-Account            F54 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,657     $ 2,202         $ 103     $ 113   

Net realized gains (losses)

     (472     (858        122       330  

Net change in unrealized appreciation (depreciation)

     10,295       (7,450        486       (964

Increase (decrease) in net assets from operations

     11,480       (6,106        711       (521

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,127       1,224          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     (223     51          (28     (179

Withdrawals, surrenders, annuitizations and contract charges

     (37,269     (360        (7     (2,946

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (1,691     (4,083        (899     (774

Net increase/decrease from Contract Owner Transactions

     (38,056     (3,168        (934     (3,899

Total increase (decrease) in net assets

     (26,576     (9,274        (223     (4,420

Net assets at beginning of year

     70,301       79,575          5,802       10,222  

Net assets at end of year

   $ 43,725     $ 70,301        $ 5,579     $ 5,802  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 41 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     F53 Sub-Account            T28 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 224     $ 412         $ 337     $ 315   

Net realized gains (losses)

     2,067       7,470          (43     (34

Net change in unrealized appreciation (depreciation)

     2,984       (12,507        284       (1,147

Increase (decrease) in net assets from operations

     5,275       (4,625        578       (866

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,025       1,025          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     45       -           -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (8     (10        (10     (11

Mortality and expense risk charges

     (11     (11        -       -  

Cost of insurance and administrative expense charges

     (858     (944        (89     (78

Net increase/decrease from Contract Owner Transactions

     193       60          (99     (89

Total increase (decrease) in net assets

     5,468       (4,565        479       (955

Net assets at beginning of year

     40,986       45,551          7,124       8,079  

Net assets at end of year

   $ 46,454     $ 40,986        $ 7,603     $ 7,124  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 42 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     G32 Sub-Account            G31 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1     $ 1         $ 113     $ 128   

Net realized gains (losses)

     2       14          (5     73  

Net change in unrealized appreciation (depreciation)

     6       (23        3,327       (3,775

Increase (decrease) in net assets from operations

     9       (8        3,435       (3,574

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           413       413  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           -        -   

Withdrawals, surrenders, annuitizations and contract charges

     -        (2        (61     (63

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (2     (2        (462     (364

Net increase/decrease from Contract Owner Transactions

     (2     (4        (110     (14

Total increase (decrease) in net assets

     7       (12        3,325       (3,588

Net assets at beginning of year

     84       96          14,471       18,059  

Net assets at end of year

   $ 91     $ 84        $ 17,796     $ 14,471  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 43 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     IB1 Sub-Account            A21 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 60     $ 58         $ 123     $ 249   

Net realized gains (losses)

     451       314          510       243  

Net change in unrealized appreciation (depreciation)

     (66     (588        8,065       (7,720

Increase (decrease) in net assets from operations

     445       (216        8,698       (7,228

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     158       158          79       34,727  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           40,619       1,109  

Withdrawals, surrenders, annuitizations and contract charges

     (13     (15        (139     (88

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (94     (87        (37,900     (22,352

Net increase/decrease from Contract Owner Transactions

     51       56          2,659       13,396  

Total increase (decrease) in net assets

     496       (160        11,357       6,168  

Net assets at beginning of year

     3,447       3,607          45,389       39,221  

Net assets at end of year

   $ 3,943     $ 3,447        $ 56,746     $ 45,389  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 44 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     MB0 Sub-Account            MB1 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 130     $ -         $ 791     $ 670   

Net realized gains (losses)

     1,882       1,622           (72     211  

Net change in unrealized appreciation (depreciation)

     4,171       (7,493        3,084       (4,870

Increase (decrease) in net assets from operations

     6,183       (5,871        3,803       (3,989

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,025       1,025          1,235       1,235  

Transfers between Sub-Accounts (including the Fixed Account), net

     (54     260          (287     483  

Withdrawals, surrenders, annuitizations and contract charges

     (15     (3,154        (11     (1,686

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (928     (781        (1,083     (914

Net increase/decrease from Contract Owner Transactions

     28       (2,650        (146     (882

Total increase (decrease) in net assets

     6,211       (8,521        3,657       (4,871

Net assets at beginning of year

     25,805       34,326          24,052       28,923  

Net assets at end of year

   $ 32,016     $ 25,805        $ 27,709     $ 24,052  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 45 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     MB5 Sub-Account            MA9 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ -      $ -         $ 816     $ 716   

Net realized gains (losses)

     3,502       5,228           617       2,261  

Net change in unrealized appreciation (depreciation)

     12,976       (22,851        1,274       (3,507

Increase (decrease) in net assets from operations

     16,478       (17,623        2,707       (530

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,818       1,818          1,305       1,305  

Transfers between Sub-Accounts (including the Fixed Account), net

     (299     842          360       (949

Withdrawals, surrenders, annuitizations and contract charges

     (35     (4,377        (20     (4,199

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (1,316     (1,083        (1,268     (1,105

Net increase/decrease from Contract Owner Transactions

     168       (2,800        377       (4,948

Total increase (decrease) in net assets

     16,646       (20,423        3,084       (5,478

Net assets at beginning of year

     50,948       71,371          34,874       40,352  

Net assets at end of year

   $ 67,594     $ 50,948        $ 37,958     $ 34,874  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 46 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     MD8 Sub-Account            M35 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 2,381     $ 687         $ 452     $ 365   

Net realized gains (losses)

     -        -           1,082       2,193  

Net change in unrealized appreciation (depreciation)

     -        -           896       (5,210

Increase (decrease) in net assets from operations

     2,381       687          2,430       (2,652

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     1,077       138          -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (1,928     (2        (33     (34

Mortality and expense risk charges

     (27     (33        -        -   

Cost of insurance and administrative expense charges

     (9,771     (12,080        (298     (259

Net increase/decrease from Contract Owner Transactions

     (10,649     (11,977        (331     (293

Total increase (decrease) in net assets

     (8,268     (11,290        2,099       (2,945

Net assets at beginning of year

     57,350       68,640          24,023       26,968  

Net assets at end of year

   $ 49,082     $ 57,350        $ 26,122     $ 24,023  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 47 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     M31 Sub-Account            MF1 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ -      $ -         $ -      $ -   

Net realized gains (losses)

     3,649       376           (10,174     4,119   

Net change in unrealized appreciation (depreciation)

     342       (14,890        15,952       (21,752

Increase (decrease) in net assets from operations

     3,991       (14,514        5,778       (17,633

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        18,407          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     -        3,132          19,767       (9,672

Withdrawals, surrenders, annuitizations and contract charges

     (36     (91        (25,156     (173

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (20,114     (45,390        (2,274     (5,856

Net increase/decrease from Contract Owner Transactions

     (20,150     (23,942        (7,663     (15,701

Total increase (decrease) in net assets

     (16,159     (38,456        (1,885     (33,334

Net assets at beginning of year

     18,416       56,872          33,116       66,450  

Net assets at end of year

   $ 2,257     $ 18,416        $ 31,231     $ 33,116  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 48 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     M05 Sub-Account            M06 Sub-Account  
       December 31,         December 31,              December 31,         December 31,  
     2023     2022          2023     2022

Operations:

           

Net investment income (loss)

   $ -      $ -         $ 4,238     $ 3,894  

Net realized gains (losses)

     (81     2,499          (1,044     817  

Net change in unrealized appreciation (depreciation)

     1,225       (5,808        6,421       (27,221

Increase (decrease) in net assets from operations

     1,144       (3,309        9,615       (22,510

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     481       481          941       941  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           2,566       (300

Withdrawals, surrenders, annuitizations and contract charges

     (44     (46        (2,928     (8,413

Mortality and expense risk charges

     -        -           (43     (45

Cost of insurance and administrative expense charges

     (268     (250        (4,563     (3,990

Net increase/decrease from Contract Owner Transactions

     169       185          (4,027     (11,807

Total increase (decrease) in net assets

     1,313       (3,124        5,588       (34,317

Net assets at beginning of year

     8,025       11,149          132,264       166,581  

Net assets at end of year

   $ 9,338     $ 8,025        $ 137,852     $ 132,264  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 49 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     M33 Sub-Account            M44 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 208     $ 186        $ 95     $ 66  

Net realized gains (losses)

     2,182       6,083          156       120  

Net change in unrealized appreciation (depreciation)

     5,760       (14,098        (310     (170

Increase (decrease) in net assets from operations

     8,150       (7,829        (59     16  

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,340       1,340          79       79  

Transfers between Sub-Accounts (including the Fixed Account), net

     46       (105        -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (43     (4,873        (12     (13

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (1,123     (953        (69     (69

Net increase/decrease from Contract Owner Transactions

     220       (4,591        (2     (3

Total increase (decrease) in net assets

     8,370       (12,420        (61     13  

Net assets at beginning of year

     36,064       48,484          2,724       2,711  

Net assets at end of year

   $ 44,434     $ 36,064        $ 2,663     $ 2,724  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 50 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     M40 Sub-Account            M83 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 630     $ 443        $ 746     $ 1,175  

Net realized gains (losses)

     1,052       782          8,611       6,156  

Net change in unrealized appreciation (depreciation)

     (2,129     (1,132        (5,901     (13,005

Increase (decrease) in net assets from operations

     (447     93          3,456       (5,674

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           366       366  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (508     (10        (37,507     (283

Mortality and expense risk charges

     (7     (7        -        -   

Cost of insurance and administrative expense charges

     (192     (179        (722     (5,125

Net increase/decrease from Contract Owner Transactions

     (707     (196        (37,863     (5,042

Total increase (decrease) in net assets

     (1,154     (103        (34,407     (10,716

Net assets at beginning of year

     20,070       20,173          82,872       93,588  

Net assets at end of year

   $ 18,916     $ 20,070        $ 48,465     $ 82,872  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 51 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     M08 Sub-Account            MB6 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,917     $ 1,586         $ 83     $ 61   

Net realized gains (losses)

     10,388       9,922          525       977  

Net change in unrealized appreciation (depreciation)

     (2,149     (20,912        850       (2,020

Increase (decrease) in net assets from operations

     10,156       (9,404        1,458       (982

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,282       1,282          158       158  

Transfers between Sub-Accounts (including the Fixed Account), net

     401       (605        -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (1,272     (4,206        (25     (25

Mortality and expense risk charges

     (48     (50        -        -   

Cost of insurance and administrative expense charges

     (3,974     (4,067        (150     (137

Net increase/decrease from Contract Owner Transactions

     (3,611     (7,646        (17     (4

Total increase (decrease) in net assets

     6,545       (17,050        1,441       (986

Net assets at beginning of year

     136,630       153,680          5,088       6,074  

Net assets at end of year

   $ 143,175     $ 136,630        $ 6,529     $ 5,088  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 52 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     MA0 Sub-Account            MA1 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,452     $ 1,311         $ 12     $ 64   

Net realized gains (losses)

     (482     2,210          (282     24  

Net change in unrealized appreciation (depreciation)

     2,454       (11,425        328       (558

Increase (decrease) in net assets from operations

     3,424       (7,904        58       (470

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           1,026       136  

Withdrawals, surrenders, annuitizations and contract charges

     (1,298     (1        (1,836     -   

Mortality and expense risk charges

     (19     (21        -        -   

Cost of insurance and administrative expense charges

     (374     (352        (642     (833

Net increase/decrease from Contract Owner Transactions

     (1,691     (374        (1,452     (697

Total increase (decrease) in net assets

     1,733       (8,278        (1,394     (1,167

Net assets at beginning of year

     39,366       47,644          1,395       2,562  

Net assets at end of year

   $ 41,099     $ 39,366        $ 1     $ 1,395  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 53 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     M96 Sub-Account            MA6 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 222     $ 265        $ 3,321     $ 2,085  

Net realized gains (losses)

     (1,330     (29        (3,878     (813

Net change in unrealized appreciation (depreciation)

     1,562       (1,994        6,534       (5,936

Increase (decrease) in net assets from operations

     454       (1,758        5,977       (4,664

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     278       5,691          382       6,943  

Transfers between Sub-Accounts (including the Fixed Account), net

     (40     2          20,111       128  

Withdrawals, surrenders, annuitizations and contract charges

     (5,160     (40        (16,722     (119

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (5,263     (559        (8,829     (5,256

Net increase/decrease from Contract Owner Transactions

     (10,185     5,094          (5,058     1,696  

Total increase (decrease) in net assets

     (9,731     3,336          919       (2,968

Net assets at beginning of year

     17,351       14,015          41,272       44,240  

Net assets at end of year

   $ 7,620     $ 17,351        $ 42,191     $ 41,272  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 54 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     M97 Sub-Account            MD5 Sub-Account
       December 31,         December 31,                December 31,       December 31,    
     2023     2022            2023   2022  

Operations:

           

Net investment income (loss)

   $ 44     $ 15         $ 325     $ 130   

Net realized gains (losses)

     604       89          1,070       2,150  

Net change in unrealized appreciation (depreciation)

     53       (1,765        3,281       (8,337

Increase (decrease) in net assets from operations

     701       (1,661        4,676       (6,057

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        7,579          1,491       1,491  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        403          (174     421  

Withdrawals, surrenders, annuitizations and contract charges

     (11     (18        (15     (2,974

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (7,495     (8,940        (1,089     (917

Net increase/decrease from Contract Owner Transactions

     (7,506     (976        213       (1,979

Total increase (decrease) in net assets

     (6,805     (2,637        4,889       (8,036

Net assets at beginning of year

     7,591       10,228          32,880       40,916  

Net assets at end of year

   $ 786     $ 7,591        $ 37,769     $ 32,880  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 55 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     ME3 Sub-Account            MB8 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 4     $ 10         $ 162     $ 193   

Net realized gains (losses)

     10       19          (1,875     6,042  

Net change in unrealized appreciation (depreciation)

     51       (163        4,527       (11,865

Increase (decrease) in net assets from operations

     65       (134        2,814       (5,630

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           87       119  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           4,208       584  

Withdrawals, surrenders, annuitizations and contract charges

     (15     (15        (12,474     (78

Mortality and expense risk charges

     -        -           (1     (4

Cost of insurance and administrative expense charges

     (67     (57        (3,261     (4,223

Net increase/decrease from Contract Owner Transactions

     (82     (72        (11,441     (3,602

Total increase (decrease) in net assets

     (17     (206        (8,627     (9,232

Net assets at beginning of year

     562       768          23,051       32,283  

Net assets at end of year

   $ 545     $ 562        $ 14,424     $ 23,051  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 56 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     MF6 Sub-Account            MF8 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 397     $ 861         $ -      $ -   

Net realized gains (losses)

     1,559       4,080          -        1  

Net change in unrealized appreciation (depreciation)

     2,593       (22,476        2       (4 )  

Increase (decrease) in net assets from operations

     4,549       (17,535        2       (3

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     1,072       1,072          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     (690     (64        1       (11

Withdrawals, surrenders, annuitizations and contract charges

     (10,772     (226        (5     -   

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (1,896     (2,199        -        -   

Net increase/decrease from Contract Owner Transactions

     (12,286     (1,417        (4     (11

Total increase (decrease) in net assets

     (7,737     (18,952        (2     (14

Net assets at beginning of year

     47,007       65,959          2       16  

Net assets at end of year

   $ 39,270     $ 47,007        $ -      $ 2  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 57 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     MG0 Sub-Account            MF2 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 611     $ 1,005        $ 7,552     $ 8,498   

Net realized gains (losses)

     (7,421     1,369          (2,287     1,164  

Net change in unrealized appreciation (depreciation)

     5,849       (8,139        23,220       (26,784

Increase (decrease) in net assets from operations

     (961     (5,765        28,485       (17,122

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           39,919       39,919  

Transfers between Sub-Accounts (including the Fixed Account), net

     (19,051     -           34,685       21,571  

Withdrawals, surrenders, annuitizations and contract charges

     (683     -           (34,255     (308

Mortality and expense risk charges

     (7     (11        (186     (150

Cost of insurance and administrative expense charges

     (146     (194        (15,068     (13,600

Net increase/decrease from Contract Owner Transactions

     (19,887     (205        25,095       47,432  

Total increase (decrease) in net assets

     (20,848     (5,970        53,580       30,310  

Net assets at beginning of year

     20,848       26,818          438,920       408,610  

Net assets at end of year

   $ -      $ 20,848        $ 492,500     $ 438,920  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 58 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     MG3 Sub-Account            MG5 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 1,172     $ 667         $ 33,657     $ 25,945   

Net realized gains (losses)

     2,594       6,117          74,913       137,926  

Net change in unrealized appreciation (depreciation)

     4,337       (13,331        43,550       (408,003

Increase (decrease) in net assets from operations

     8,103       (6,547        152,120       (244,132

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     138       138          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (38     (39        (1,451     (13

Mortality and expense risk charges

     (31     (32        (609     (622

Cost of insurance and administrative expense charges

     (2,655     (2,921        (29,651     (27,158

Net increase/decrease from Contract Owner Transactions

     (2,586     (2,854        (31,711     (27,793

Total increase (decrease) in net assets

     5,517       (9,401        120,409       (271,925

Net assets at beginning of year

     65,499       74,900          1,189,421       1,461,346  

Net assets at end of year

   $ 71,016     $ 65,499        $ 1,309,830     $ 1,189,421  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 59 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     ME0 Sub-Account            V43 Sub-Account  
       December 31,         December 31,                December 31,         December 31,  
     2023     2022            2023     2022

Operations:

           

Net investment income (loss)

   $ 57     $ 25         $ -      $ -   

Net realized gains (losses)

     178       1,796          (8,109     2,897  

Net change in unrealized appreciation (depreciation)

     5       (3,325        12,936       (23,724

Increase (decrease) in net assets from operations

     240       (1,504        4,827       (20,827

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        8,662          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     -        264          -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (14     (28        (30     (37

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (8,058     (13,761        (1,183     (1,299

Net increase/decrease from Contract Owner Transactions

     (8,072     (4,863        (1,213     (1,336

Total increase (decrease) in net assets

     (7,832     (6,367        3,614       (22,163

Net assets at beginning of year

     8,707       15,074          11,505       33,668  

Net assets at end of year

   $ 875     $ 8,707        $ 15,119     $ 11,505  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 60 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     O01 Sub-Account            O20 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ -      $ -         $ -      $ -   

Net realized gains (losses)

     (44     5,961           4,477       6,564   

Net change in unrealized appreciation (depreciation)

     5,241       (12,576        6,767       (22,386

Increase (decrease) in net assets from operations

     5,197       (6,615        11,244       (15,822

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     354       354          -        -   

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           -        -   

Withdrawals, surrenders, annuitizations and contract charges

     (53     (52        (1,191     -   

Mortality and expense risk charges

     -        -           (18     (18

Cost of insurance and administrative expense charges

     (495     (402        (362     (312

Net increase/decrease from Contract Owner Transactions

     (194     (100        (1,571     (330

Total increase (decrease) in net assets

     5,003       (6,715        9,673       (16,152

Net assets at beginning of year

     14,750       21,465          33,472       49,624  

Net assets at end of year

   $ 19,753     $ 14,750        $ 43,145     $ 33,472  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 61 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     P10 Sub-Account            PK8 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 2,554     $ 4,086         $ 5,233     $ 3,981   

Net realized gains (losses)

     (3,006     112          (5,148     (7,464

Net change in unrealized appreciation (depreciation)

     (310     (2,702        9,574       (11,831

Increase (decrease) in net assets from operations

     (762     1,496          9,659       (15,314

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     -        -           1,527       1,527  

Transfers between Sub-Accounts (including the Fixed Account), net

     (15,449     62          40,309       (21,031

Withdrawals, surrenders, annuitizations and contract charges

     (1,332     -           (13,194     (185

Mortality and expense risk charges

     (5     (9        -        (11

Cost of insurance and administrative expense charges

     (380     (553        (5,118     (4,341

Net increase/decrease from Contract Owner Transactions

     (17,166     (500        23,524       (24,041

Total increase (decrease) in net assets

     (17,928     996          33,183       (39,355

Net assets at beginning of year

     17,928       16,932          58,674       98,029  

Net assets at end of year

   $ -      $ 17,928        $ 91,857     $ 58,674  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 62 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     P06 Sub-Account            P07 Sub-Account  
       December 31,         December 31,                December 31,         December 31,    
     2023     2022            2023     2022  

Operations:

           

Net investment income (loss)

   $ 17     $ 1,757         $ 1,602     $ 1,091   

Net realized gains (losses)

     (1,924     (136        (5,049     (417

Net change in unrealized appreciation (depreciation)

     1,984       (4,871        5,670       (7,423

Increase (decrease) in net assets from operations

     77       (3,250        2,223       (6,749

Contract Owner Transactions:

           

Accumulation Activity:

           

Purchase payments received

     59       59          724       15,947  

Transfers between Sub-Accounts (including the Fixed Account), net

     -        -           (1,191     659  

Withdrawals, surrenders, annuitizations and contract charges

     (21,873     (145        (9,997     (167

Mortality and expense risk charges

     -        -           -        -   

Cost of insurance and administrative expense charges

     (10     (2,846        (15,155     (3,829

Net increase/decrease from Contract Owner Transactions

     (21,824     (2,932        (25,619     12,610  

Total increase (decrease) in net assets

     (21,747     (6,182        (23,396     5,861  

Net assets at beginning of year

     22,256       28,438          52,778       46,917  

Net assets at end of year

   $ 509     $ 22,256        $ 29,382     $ 52,778  
                                   

 

The accompanying notes are an integral part of these financial statements.

 

- 63 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

STATEMENTS OF CHANGES IN NET ASSETS (CONTINUED)

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

 

     307 Sub-Account  
       December 31,         December 31,    
     2023     2022  

Operations:

    

Net investment income (loss)

   $ -      $ -   

Net realized gains (losses)

     31,889       16,512   

Net change in unrealized appreciation (depreciation)

     67,799       (142,777

Increase (decrease) in net assets from operations

     99,688       (126,265

Contract Owner Transactions:

    

Accumulation Activity:

    

Purchase payments received

     1,406       1,406  

Transfers between Sub-Accounts (including the Fixed Account), net

     19,941       (91

Withdrawals, surrenders, annuitizations and contract charges

     (43,007     (740

Mortality and expense risk charges

     -        -   

Cost of insurance and administrative expense charges

     (13,510     (12,475

Net increase/decrease from Contract Owner Transactions

     (35,170     (11,900

Total increase (decrease) in net assets

     64,518       (138,165

Net assets at beginning of year

     194,322       332,487  

Net assets at end of year

   $ 258,840     $ 194,322  
                

 

The accompanying notes are an integral part of these financial statements.

 

- 64 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

NOTES TO FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2023

 

1. BUSINESS AND ORGANIZATION

Delaware Life NY Variable Account D (the “Variable Account”) is a separate account of Nassau Life Insurance Company (“NNY”, the “Company”, the “Sponsor”, “we” or “us”). NNY is a wholly-owned subsidiary of The Nassau Companies of New York (“NCNY”), whose ultimate parent is Nassau Insurance Group Holdings G.P., LLC (“Nassau”). Founded in April 2015, Nassau is a privately held insurance and reinsurance business focused on building a franchise across the insurance value chain. NCNY is a holding company for NNY. On July 1, 2023, NNY completed its acquisition of Delaware Life Insurance Company of New York (“DLNY”) from Delaware Life Insurance Company, after receipt of insurance regulatory approval by the New York Department of Financial Services (the “NYDFS” or the “Department”). Effective July 5, 2023, DLNY merged with and into NNY pursuant to a merger agreement with NNY as the surviving entity.

The assets of the Variable Account are divided into “Sub-Accounts”. Each Sub-Account is invested in shares of a specific mutual fund (collectively the “Funds”), or series thereof, registered under the Investment Company Act of 1940, as amended. The contract owners of the Variable Account direct the deposits into the Sub-Accounts of the Variable Account.

Under applicable insurance law, the assets and liabilities of the Variable Account are clearly identified and distinguished from the Sponsor’s other assets and liabilities. Assets applicable to the Variable Account are not chargeable with liabilities arising out of any other business the Sponsor may conduct.

A summary of the name changes related to Sub-Accounts held by the contract owners of the Variable Account during the current year, is as follows:

 

Sub-Account       Previous Name      Effective Date
A71       AB VPS Growth and Income Portfolio (Class B)      May 1, 2023

There were no Sub-Accounts held by contract owners of the Variable Account that were merged, liquidated or closed during the current year.

There were no Sub-Accounts held by the contract owners of the Variable Account, with commencement dates earlier than the past five years, but for which the first activity occurred within the last five years.

American Funds IS Washington Mutual Investors Fund Class 2 Sub-Account (308), American Funds IS Capital World Growth and Income Fund Class 2 Sub-Account (309) and American Funds IS American High-Income Trust Class 2 Sub-Account (305) are active at December 31, 2023 but have had zero balance for more than five years and therefore are not disclosed in the Statements of Assets and Liabilities, Statements of Changes in Net Assets or the financial highlights in Note 9.

 

-65-


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

General

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of financial statements in conformity with GAAP requires the Sponsor’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

Investment Valuation and Transactions

Investments made in mutual funds are carried at fair value and are valued at their closing net asset value as determined by the respective mutual fund, which in turn value their investments at fair value, as of December 31, 2023. Transactions are recorded on a trade date basis. Realized gains and losses on sales of investments are determined on the first in, first out basis. Dividend income and realized gain distributions are reinvested in additional fund shares and recognized on the ex-dividend date.

Units

The number of units credited is determined by dividing the dollar amount allocated to a Sub-Account by the unit value for that Sub-Account for the period during which the purchase payment was received. The unit value for each Sub-Account is established at $10.00 for the first period of that Sub-Account and is subsequently measured based on the performance of the investments and the contract charges selected by the contract holder, as discussed in Note 5.

Purchase Payments

Upon issuance of new contracts, the initial purchase payment is credited to the contract in the form of units. All subsequent purchase payments are applied using the unit values for the period during which the purchase payment is received.

Transfers

Transfers between Sub-Accounts requested by contract owners are recorded in the new Sub-Account upon receipt of the redemption proceeds at the net asset value at the time of receipt. In addition, transfers can be made between the Sub-Accounts and the “Fixed Account”. The Fixed Account is part of the general account of the Sponsor in which purchase payments or contract values may be allocated or transferred.

Withdrawals

At any time during the accumulation phase (the period before the first annuity payment), the contract owner may elect to receive a cash withdrawal payment under the contract. If the contract owner requests a full withdrawal, the contract owner will receive the value of their account at the end of period, less the contract maintenance charge for the current contract year and any applicable withdrawal charge.

If the contract owner requests a partial withdrawal, the contract owner will receive the amount requested less any applicable withdrawal charge and the account value will be reduced by the amount requested. Any requests for partial withdrawals that would result in the value of the contract owner’s account being reduced to an amount less than the contract maintenance charge for the current contract year is treated as a request for a full withdrawal.

Contract Loans

Contract holders are permitted to borrow against the cash value of their accounts. The loan proceeds are deducted from the Variable Account and recorded in the Sponsor’s general account as an asset. Contract loan activity is reflected in the Transfer between Sub-Accounts (including the Fixed Account), net line on the Statements of Changes in Net Assets.

 

- 66 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Federal Income Taxes

The operations of the Variable Account are part of the operations of the Sponsor and are not taxed separately. The Sponsor qualifies for the federal income tax treatment granted to life insurance companies under Subchapter L of the Internal Revenue Code (the “Code”). Under existing federal income tax law, investment income and realized gain distributions earned by the Variable Account on contract owner reserves are not taxable, and therefore, no provision has been made for federal income taxes. In the event of a change in applicable tax law, the Sponsor will review this policy and if necessary a provision may be made in future years.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires Sponsor’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the period. The most significant estimates are fair value measurements of investments. Actual results could vary from the amounts derived from Sponsor management’s estimates.

Subsequent events

The Sponsor’s management has evaluated events subsequent to December 31, 2023, noting that there are no subsequent events requiring accounting adjustments or disclosure.

3. FAIR VALUE MEASUREMENTS

The Sub-Accounts’ investments are carried at fair value. Fair value is an exit price, representing the amount that would be received from a sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, FASB ASC Topic 820, “Fair Value Measurements and Disclosures”, establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value (i.e., Level 1, 2 and 3). Level 1 inputs are observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Variable Account has the ability to access at the measurement date. Level 2 inputs are observable inputs, other than quoted prices included in Level 1, for the asset or liability or prices for similar assets and liabilities. Level 3 inputs are unobservable inputs reflecting the reporting entity’s estimates of the assumptions that market participants would use in pricing the asset or liability. Topic 820 requires that a fair value measurement technique include an adjustment for risks inherent in a particular valuation technique (such as a pricing model) and/or the risks inherent in the inputs to the model, if market participants would also include such an adjustment.

The Variable Account has categorized its financial instruments, based on the priority of the inputs to the valuation technique, into the three level hierarchy described above. If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.

The Variable Account uses the Funds’ closing net asset value to determine the fair value of its Sub-Accounts. As of December 31, 2023, the net assets held in the Variable Account were categorized as Level 1 assets under the Topic 820 hierarchy levels. There were no Level 2 or 3 investments in the Variable Account during the year ended December 31, 2023. There were no transfers between levels during the year ended December 31, 2023.

 

- 67 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

4. RELATED-PARTY TRANSCATIONS

The Sponsor provides administrative services necessary for the operation of the Variable Account. The Sponsor absorbs all organizational expenses including the fees of registering the Variable Account and its contracts for distribution under federal and state securities laws.

Charges related to contracts sold to persons who are officers, directors, or employees of the Sponsor or an affiliate of the Sponsor may be waived.

5. CONTRACT CHARGES

Mortality and expense risk charges

Charges for mortality and expense risks are based on the value of the Sub-Account and are deducted at the monthly anniversary date from the contract owner’s account to cover the risks assumed by the Sponsor. The deductions are transferred periodically to the Sponsor. For Futurity Accumulator II, Futurity Protector II, Executive VUL, Prime VUL, Futurity Survivorship II VUL, and Prime Survivorship contracts, as of December 31, 2023, the maximum deduction is at an effective annual rate of 0.60%. For Sun Protector VUL, as of December 31, 2023, the maximum deduction is an effective annual rate of 0.75%. These charges are reflected in the Statements of Changes in Net Assets.

Charges for Life Insurance Protection

On the monthly anniversary of the contract, the cost of insurance is deducted from each Sub-Account through a redemption of units to cover the anticipated cost of providing life insurance. The charge is based on the length of time a policy has been in force and other factors, including issue age, sex and rating class of the insured, and will not exceed the guaranteed maximum monthly cost of insurance rates based on the 1980 Commissioners Standard Ordinary Smoker and Nonsmoker Mortality Tables. These charges are reported in the Statements of Changes in Net Assets as part of “Cost of insurance and administrative expense charges”.

Administration charges

Each month on the account anniversary date, an account administration fee (“Account Fee”) is deducted from the participant’s account to reimburse the Sponsor for certain administrative expenses. For the Single Life Products (Futurity Accumulator II, Futurity Protector II, Executive VUL, Protector VUL, and Prime VUL) the Account Fee is deducted in all policy years, as well as a monthly charge based on the specified face amount is deducted in the first ten policy years, and for the first ten policy years following the effective date of each specified face amount increase. For the Survivorship Product (Futurity Survivorship II and Prime Survivorship), the Account Fee is deducted for the first ten policy years, and for the first ten policy years following the effective date of each specified face amount increase. The charge is based on the specified face amount or increase thereof, times a rate determined by the age, sex and rating class of each insured. As of December 31, 2021, the Account Fee is $8 for Futurity Accumulator II, Futurity Protector II, Futurity Survivorship II VUL and Prime VUL, and $10 for Protector VUL and Executive VUL and Prime Survivorship. The Account Fee is reported in the Statements of Changes in Net Assets as part of “Cost of insurance and administrative expense charges”.

 

- 68 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

5. CONTRACT CHARGES (CONTINUED)

 

Surrender charges

A surrender charge (contingent deferred sales charge) may be deducted to cover certain expenses relating to the sale of the contract if the contract holder requests a full withdrawal prior to reaching the pay-out phase. The surrender charge is based on certain factors, including the specified face amount, the insured’s age, sex and rating class. For the Survivorship Products, the surrender charge period will generally end after 15 policy years from the date of policy issue, or 15 policy years from the effective date of each specified face amount increase. For the Futurity Protector II and Futurity Accumulator II products, the surrender charge applies to the first 12 and 9 years respectively, from the date of policy issuance, or the respective policy years from the effective date of each specified face amount increase. For the Protector VUL and Prime VUL products, the surrender charge applies to the first 14 and 10 years respectively, from the date of policy issuance, or the respective policy years from the effective date of each specified face amount increase. Executive VUL does not have a surrender charge. Surrender charges are deducted and retained by the Sponsor. These charges are reported as part of “Withdrawals, surrenders, annuitizations and contract charges” in the Statements of Changes in Net Assets.

Sales charges

Certain charges are deducted from the premium before it is allocated by Sub-Account. These charges consist of premium tax, federal deferred acquisition cost (“DAC”) tax and the sales load. 3.25% of the charge is used to pay premium tax and DAC and the remaining is for sales load. For Futurity Protector II and Futurity Accumulator II , the current charge is 5.25% and is not to exceed 7.25% of the premium. For Protector VUL, the current charge is 3.50% for policy years 11 and thereafter, and the maximum premium charge is 7.50% for all policy years.

For Prime VUL, the current sale charge is 6.50% for all policy years and will not exceed 8.25% of premium if the Long Term Accumulation (“LTA”) rider is not attached to the policy. The sales charge is currently 15.00% for all policy years and is guaranteed not to exceed 15.00% for any policy year if the LTA rider is attached to the policy.

For Executive VUL the current sales charge for policy year 1 is 20% on each premium payment up to and including target premium, 9% in policy years 2-10 and 3.25% thereafter. The sales charge on premium payment up to and including target premium will not exceed 35% for policy year 1, 12% for policy years 2-10 and 5% thereafter. For policies with investment start dates before October 3, 2011, the current sales charge for policy year 1 is 3.5% on each premium payment in excess of Target Premium. For Policies with investment start dates on and after October 3, 2011, the current Premium Expense Load for policy year 1 is 5.0% on each premium payment in excess of target premium. For all Policies, the current sales charge for policy years 2-10 is 3.5% on each premium payment in excess of target premium and 3.25% thereafter. The sales charge on each premium payment in excess of target premium will not exceed 5.0% in any policy year.

Premium Taxes

A deduction, when applicable, is made for premium taxes or similar state or local taxes. It is currently the policy of the Sponsor to make this deduction from the premium payment.

 

- 69 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

6. INVESTMENT PURCHASES AND SALES

The cost of purchases and proceeds from sales of investments for the year ended December 31, 2023 were as follows:

 

     Purchases      Sales  
A71       $       11,347            $       45,234     
A70      2,220          19    
A54      41,502          5,159    
302      2,702          1,670    
B18      1,434          3,590    
C60      1,538          2,516    
D37      22,543          3,283    
D55      1,053          7,096    
S61      669          260    
D18      6,386          37,963    
FD7      12,204          6,148    
F24      2,469          2,495    
F29      7,331          2,955    
F21      125          4,915    
F26      6,412          21,939    
FM7      8,290          112,217    
F41      3,995          9,022    
FM8      667          5,724    
F23      2,234          28,171    
FE3      2,324          979    
T20      2,063          38,462    
F54      903          1,259    
F53      3,701          863    
T28      337          99    
G32      3          2    
G31      320          317    
IB1      684          98    
A21      41,717          38,889    
MB0      3,586          1,460    
MB1      2,266          1,621    
MB5      5,769          2,180    
MA9      3,552          1,811    

 

- 70 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

6. INVESTMENT PURCHASES AND SALES (CONTINUED)

 

     Purchases      Sales  
MD8       $       2,378            $       10,646     
M35      1,530          331    
M31      950          20,150    
MF1      21,126          28,399    
M05      461          292    
M06      7,711          7,500    
M33      4,019          1,398    
M44      316          77    
M40      1,687          707    
M83      4,029          38,008    
M08      13,490          5,574    
MB6      694          164    
MA0      1,452          1,691    
MA1      12          1,452    
M96      445          10,408    
MA6      24,256          25,993    
M97      170          7,506    
MD5      3,461          1,784    
ME3      4          82    
MB8      910          11,483    
MF6      4,328          12,988    
MF8      -           4    
MG0      611          19,887    
MF2      81,991          49,343    
MG3      3,526          2,718    
MG5      113,144          31,707    
ME0      470          8,072    
V43      -           1,213    
O01      152          346    
O20      4,614          1,571    
P10      2,554          17,166    
PK8      47,950          19,193    
P06      75          21,882    
P07      1,820          25,837    
307      21,022          56,192    

 

- 71 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

7. CHANGES IN UNITS OUTSTANDING

The changes in units outstanding for the year ended December 31, 2023 were as follows:

 

   

Units

Issued

   

Units

Redeemed

   

Net Increase

(Decrease)

         
A71            49                   1,163                  (1,114)             
A70     104         1         103       
A54     1,081         251         830       
302     -          36         (36)      
B18     -          157         (157)      
C60     178         212         (34)      
D37     364         115         249       
D55     14         125         (111)      
S61     6         11         (5)      
D18     64         857         (793)      
FD7     74         205         (131)      
F24     -          59         (59)      
F29     25         46         (21)      
F21     2         95         (93)      
F26     706         1,111         (405)      
FM7     81         2,325         (2,244)      
F41     310         527         (217)      
FM8     21         427         (406)      
F23     115         1,109         (994)      
FE3     164         160         4       
T20     54         1,295         (1,241)      
F54     17         65         (48)      
F53     128         119         9       
T28     -          6         (6)      
G31     10         12         (2)      
IB1     4         2         2       
A21     1,405         1,320         85       
MB0     122         119         3       
MB1     433         449         (16)      
MB5     184         177         7       
MA9     235         218         17       
MD8     123         1,119         (996)      

 

- 72 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

7. CHANGES IN UNITS OUTSTANDING (CONTINUED)

 

   

Units

Issued

   

Units

Redeemed

   

Net Increase

(Decrease)

         
M35            -                       18                      (18)    
M31     -          477         (477)    
MF1     696         913         (217)    
M05     16         11         5     
M06     306         644         (338)    
M33     153         145         8     
M44     5         5         -     
M40     -          42         (42)    
M83     12         1,300         (1,288)    
M08     274         454         (180)    
MB6     4         4         -     
MA0     -          92         (92)    
MA1     93         196         (103)    
M96     17         550         (533)    
MA6     751         874         (123)    
M97     -          243         (243)    
MD5     205         200         5     
ME3     -          6         (6)    
MB8     156         425         (269)    
MF6     77         350         (273)    
MG0     -          1,589         (1,589)    
MF2     5,830         3,784         2,046     
MG3     4         72         (68)    
MG5     -          1,099         (1,099)    
ME0     -          183         (183)    
V43     -          27         (27)    
O01     8         12         (4)    
O20     -          49         (49)    
P10     69         2,191         (2,122)    
PK8     1,234         605         629    
P06     3         1,011         (1,008)    
P07     44         1,235         (1,191)    
307     476         876         (400)    

 

- 73 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

7. CHANGES IN UNITS OUTSTANDING (CONTINUED)

 

The changes in units outstanding for the year ended December 31, 2022 were as follows:

 

   

Units

Issued

   

Units

Redeemed

   

Net Increase

(Decrease)

         
A71            438                     562                     (124)    
A54     10         89         (79)    
302     -          8         (8)    
B18     -          156         (156)    
C60     82         231         (149)    
D37     3         46         (43)    
D55     8         15         (7)    
S61     6         9         (3)    
D18     49         118         (69)    
FD7     39         186         (147)    
F24     -          13         (13)    
F29     29         55         (26)    
F21     4         3         1     
F26     281         778         (497)    
FM7     405         311         94     
F41     121         305         (184)    
FM8     21         28         (7)    
F23     92         178         (86)    
FE3     49         114         (65)    
T20     52         169         (117)    
F54     2         199         (197)    
F53     37         33         4     
T28     -          5         (5)    
G31     11         11         -     
IB1     4         3         1     
A21     1,308         865         443     
MB0     43         114         (71)    
MB1     168         242         (74)    
MB5     70         135         (65)    
MA9     58         257         (199)    
MD8     57         1,212         (1,155)    

 

- 74 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

7. CHANGES IN UNITS OUTSTANDING (CONTINUED)

 

   

Units

Issued

   

Units

Redeemed

   

Net Increase

(Decrease)

         
M35            -                  16                 (16)    
M31     770         1,353         (583)    
MF1     5         425         (420)    
M05     17         10         7     
M06     197         1,160         (963)    
M33     44         174         (130)    
M44     5         6         (1)    
M40     -          11         (11)    
M83     13         189         (176)    
M08     70         449         (379)    
MB6     4         5         (1)    
MA0     -          20         (20)    
MA1     44         93         (49)    
M96     302         34         268     
MA6     252         198         54     
M97     335         374         (39)    
MD5     72         139         (67)    
ME3     -          5         (5)    
MB8     74         164         (90)    
MF6     45         85         (40)    
MG0     -          14         (14)    
MF2     4,869         1,120         3,749     
MG3     5         82         (77)    
MG5     -          982         (982)    
ME0     271         380         (109)    
V43     -          25         (25)    
O01     8         11         (3)    
O20     -          11         (11)    
P10     32         87         (55)    
PK8     60         1,358         (1,298)    
P06     3         132         (129)    
P07     809         212         597     
307     29         223         (194)    

8. TAX DIVERSIFICATION REQUIREMENTS

Under the provisions of Section 817(h) of the Code, a variable life contract, other than a pension plan contract, is not treated as a life contract for federal tax purposes for any period in which the investments of the segregated asset account on which the contract is based are not adequately diversified. The Code provides that the “adequately diversified” requirement may be met if the underlying investments satisfy either a statutory safe harbor test or diversification requirements set forth in regulations issued by the Secretary of Treasury. The Sponsor believes that the Variable Account satisfies the current requirements of the regulations, and it intends that the Variable Account will continue to meet such requirements.

 

- 75 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

9. FINANCIAL HIGHLIGHTS

The summary of units outstanding, unit value (some of which may be rounded), net assets, investment income ratios and the total return, for each of the five years in the period ended December 31, is as follows:

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

A71

                      

2023

     2,132           $42.3776         $ 90,362           1.28%       11.72%  

2022

     3,246           37.9314           123,112           1.08       (4.42)  

2021

     3,369           39.6852           133,705           0.63       27.84  

2020

     3,498           31.0437           108,587           1.35       2.47  

2019

     4,051           30.2945           122,714           0.94       23.61  

A70

                      

2023

     103           22.4732           2,305           -        15.70  

A54

                      

2023

     1,153           49.6823           57,282           -        23.17  

2022

     323           40.3356           13,021           -        (36.07)  

2021

     402           63.0958           25,361           -        4.20  

2020

     1,118           60.5498           67,675           -        64.63  

2019

     1,177           36.7797           43,305           -        30.26  

302

                      

2023

     836           54.7030           45,731           -       26.14  

2022

     872           43.3679           37,815           1.29       (16.49)  

2021

     880           51.9331           45,695           1.15       24.10  

2020

     887           41.8495           37,108           1.39       13.55  

2019

     898           36.8570           33,108           1.74       26.14  

B18

                      

2023

     2,394           24.7053           59,147           2.52       12.49  

2022

     2,551           21.9622           56,009           -       (16.07)  

2021

     2,707           26.1685           70,828           0.83       6.42  

2020

     2,854           24.5909           70,176           1.30       20.71  

2019

     3,041           20.3722           61,945           1.15       17.76  

C60

                      

2023

     1,305           29.5488           38,548           -        42.77  

2022

     1,338           20.6973           27,699           -        (31.53)  

2021

     1,487           30.2297           44,966           -        28.35  

2020

     1,583           23.5521           37,292           -        34.41  

2019

     1,652           17.5225           28,953           -        35.53  

D37

                      

2023

     416           74.5243           31,005           1.31       16.45  

2022

     167           63.9958           10,659           0.41       (13.73)  

2021

     210           74.1807           15,567           0.95       23.18  

2020

     586           60.2228           35,290           0.55       11.08  

2019

     618           54.2135           33,495           0.56       29.63  

D55

                      

2023

     321        65.7538        to         65.7538        21,111           0.85       16.33  

2022

     432        28.8155        to         56.5237        24,406           0.62       (20.89)  

2021

     439        36.4235        to         71.4475        31,377           0.55       14.18  

2020

     445        31.8997        to         62.5736        27,846           0.92       19.09  

2019

     518        26.7865        to         52.5436        27,197           0.78       24.87  

 

- 76 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

S61

                      

2023

     285           $45.5009         $ 12,946           1.15%       14.95%  

2022

     289           39.5837           11,438           0.85       (15.80)  

2021

     292           47.0134           13,725           1.23       30.50  

2020

     293           36.0256           10,557           1.41       (0.80)  

2019

     293           36.3156           10,644           0.72       21.51  

D18

                      

2023

     2,611           49.2480           128,570           0.80       18.31  

2022

     3,404           41.6259           141,694           0.72       (14.08)  

2021

     3,474           48.4457           168,281           0.61       25.88  

2020

     3,462           38.4848           133,254           0.83       8.11  

2019

     3,745           35.5992           133,302           0.64       20.18  

FD7

                      

2023

     5,322           44.2255           235,369           1.56       21.23  

2022

     5,454           36.4795           198,956           1.05       (18.19)  

2021

     5,601           44.5890           249,709           0.70       17.99  

2020

     6,990           37.7902           264,137           1.26       22.13  

2019

     7,367           30.9435           227,960           1.56       24.11  

F24

                      

2023

     1,378           50.4142           69,475           0.27       33.12  

2022

     1,437           37.8724           54,438           0.26       (26.49)  

2021

     1,450           51.5185           74,728           0.03       27.51  

2020

     1,462           40.4033           59,058           0.08       30.23  

2019

     1,481           31.0237           45,936           0.22       31.27  

F29

                      

2023

     2,109           76.7840           161,950           0.40       33.34  

2022

     2,130           57.5857           122,670           0.41       (26.38)  

2021

     2,156           78.2229           168,680           0.05       27.71  

2020

     2,179           61.2509           133,490           0.15       30.43  

2019

     2,206           46.9606           103,608           0.30       31.45  

F21

                      

2022

     93           43.7198           4,049           0.49       (24.52)  

2021

     91           57.9247           5,292           -        23.08  

2020

     90           47.0619           4,244           0.06       43.75  

2019

     88           32.7390           2,880           0.16       34.18  

F26

                      

2023

     2,868        41.5268        to         51.6616        119,101           1.19       25.88  

2022

     3,273        32.9894        to         41.0407        110,946           1.16       (18.42)  

2021

     3,770        40.4373        to         50.3063        157,871           1.03       28.26  

2020

     4,174        31.5284        to         39.2230        137,734           1.53       17.95  

2019

     4,481        26.7313        to         33.2552        126,978           1.82       31.02  

 

- 77 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

FM7

                      

2023

     5,210           $53.8428         $ 280,497           1.42%       26.07%  

2022

     7,453           42.7088           318,329           1.36       (18.30)  

2021

     7,360           52.2724           384,703           1.19       28.45  

2020

     7,071           40.6960           287,758           1.62       18.13  

2019

     7,729           34.4515           266,287           1.89       31.22  

F41

                      

2023

     2,418        31.1032        to         39.2237        84,165           0.37       14.80  

2022

     2,636        27.0930        to         34.1665        80,812           0.26       (14.97)  

2021

     2,819        31.8617        to         40.1802        101,677           0.37       25.31  

2020

     3,005        25.4271        to         32.0656        86,700           0.40       17.87  

2019

     3,146        21.5726        to         27.2049        77,484           0.71       23.17  

FM8

                      

2023

     463           13.8033           6,392           4.73       4.80  

2022

     869           13.1709           11,449           1.35       1.36  

2021

     877           12.9938           11,391           0.00       0.01  

2020

     807           12.9924           10,483           0.29       0.28  

2019

     964           12.9560           12,491           1.90       1.92  

F23

                      

2023

     4,243           28.7567           122,020           0.87       20.41  

2022

     5,237           23.8826           125,076           0.97       (24.58)  

2021

     5,324           31.6676           168,594           0.46       19.57  

2020

     5,293           26.4839           140,187           0.34       15.49  

2019

     5,735           22.9310           131,517           1.68       27.67  

FE3

                      

2023

     856        19.8164        to         19.8164        16,969           -        10.08  

2022

     852        18.0025        to         21.0538        15,341           2.08       (8.17)  

2021

     917        19.6033        to         22.9259        17,970           0.95       4.44  

2020

     903        18.7696        to         21.9509        16,952           2.83       6.85  

2019

     856        17.5658        to         20.5431        15,039           0.33       17.38  

T20

                      

2023

     1,317           33.1974           43,725           3.00       20.76  

2022

     2,557           27.4912           70,301           3.06       (7.61)  

2021

     2,674           29.7541           79,575           1.84       4.16  

2020

     2,648           28.5662           75,629           3.45       (1.16)  

2019

     2,694           28.9008           77,855           1.82       12.53  

 

- 78 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

F54

                      

2023

     264      $ 21.1274        to       $ 21.1274      $ 5,579           1.85%       13.46%  

2022

     312        18.6205        to         22.9734        5,802           1.56       (7.43)  

2021

     508        20.1153        to         24.8176        10,222           2.78       19.17  

2020

     642        16.8798        to         20.8258        10,842           2.96       (5.04)  

2019

     598        17.7763        to         21.9318        10,640           1.85       22.57  

F53

                      

2023

     1,359        32.9285        to         35.6360        46,454           0.52       12.75  

2022

     1,351        29.2062        to         31.6076        40,986           0.99       (10.06)  

2021

     1,347        32.4746        to         35.1448        45,551           1.03       25.37  

2020

     1,348        25.9039        to         28.0338        36,417           1.48       5.19  

2019

     1,340        24.6261        to         26.6509        34,516           1.06       26.35  

T28

                      

2023

     434        17.5303        to         17.5303        7,603           4.61       8.18  

2022

     440        16.2045        to         16.5166        7,124           4.27       (10.75)  

2021

     445        18.1566        to         18.5064        8,079           3.31       2.11  

2020

     449        17.7816        to         18.1241        7,988           4.98       3.43  

2019

     454        17.1920        to         17.5232        7,808           3.74       8.05  

G32

                      

2023

     2           54.8432           91           1.17       11.42  

2022

     2           49.2226           84           1.15       (9.99)  

2021

     2           54.6843           96           0.48       30.95  

2020

     2           41.7598           76           -        8.40  

2019

     2           38.5226           72           1.52       31.53  

G31

                      

2023

     370           48.1000           17,796           0.71       23.81  

2022

     372           38.8508           14,471           0.82       (19.74)  

2021

     373           48.4055           18,059           0.84       29.41  

2020

     371           37.4061           13,891           0.90       17.55  

2019

     368           31.8225           11,715           1.32       25.21  

IB1

                      

2023

     82           48.2959           3,943           1.65       12.66  

2022

     80           42.8681           3,447           1.67       (5.75)  

2021

     79           45.4842           3,607           1.59       28.51  

2020

     78           35.3948           2,746           2.37       2.09  

2019

     74           34.6691           2,553           1.88       25.19  

A21

                      

2023

     1,619        17.0442        to         35.4267        56,746           0.19       18.15  

2022

     1,533        14.4265        to         29.9858        45,389           0.98       (18.31)  

2021

     1,090        17.6591        to         36.7047        39,221           1.21       5.89  

2020

     2,142        16.6770        to         34.6634        73,442           2.27       14.00  

2019

     2,902        14.6296        to         30.4078        87,454           1.32       28.57  

 

- 79 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

MB0

                      

2023

     806           $39.7314         $ 32,016           0.45%       23.56%  

2022

     803           32.1561           25,805           -        (18.14)  

2021

     874           39.2814           34,326           -        17.74  

2020

     930           33.3635           31,015           -        17.73  

2019

     906           28.3396           25,670           0.34       28.85  

MB1

                      

2023

     2,287           12.1175           27,709           3.08       16.00  

2022

     2,303           10.4457           24,052           2.68       (14.16)  

2021

     2,377           12.1684           28,923           2.42       11.05  

2020

     2,422           10.9580           26,541           1.73       8.90  

2019

     2,300           10.0627           23,144           2.89       20.32  

MB5

                      

2023

     1,461           46.2902           67,594           -        32.04  

2022

     1,454           35.0585           50,948           -        (25.41)  

2021

     1,519           47.0015           71,371           -        21.49  

2020

     1,548           38.6861           59,853           -        28.89  

2019

     1,573           30.0140           47,186           -        36.09  

MA9

                      

2023

     1,435           26.4480           37,958           2.30       7.60  

2022

     1,419           24.5788           34,874           2.00       (1.45)  

2021

     1,618           24.9405           40,352           1.61       30.01  

2020

     1,734           19.1840           33,250           2.04       (3.16)  

2019

     1,631           19.8104           32,295           1.81       21.52  

MD8

                      

2023

     4,484           10.9477           49,082           4.46       4.59  

2022

     5,479           10.4670           57,350           1.10       1.17  

2021

     6,635           10.3457           68,640           -       -  

2020

     7,857           10.3457           81,285           0.20       1.17  

2019

     5,653           10.3230           58,346           1.21       1.64  

M35

                      

2023

     1,321           19.7790           26,122           1.84       10.22  

2022

     1,339           17.9455           24,023           1.48       (9.84)  

2021

     1,355           19.9038           26,968           1.62       13.84  

2020

     1,368           17.4847           23,917           2.10       9.52  

2019

     1,383           15.9654           22,079           2.15       20.12  

M31

                      

2023

     47        47.6968        to         47.6968        2,257           -        35.86  

2022

     524        34.5512        to         35.1065        18,416           -        (31.63)  

2021

     1,107        50.5391        to         51.3514        56,872           -        23.53  

2020

     1,281        40.9115        to         41.5691        53,243           -        31.86  

2019

     1,589        31.0273        to         31.5259        50,095           -        38.15  

MF1

                      

2023

     758        41.2143        to         41.2143        31,231           -        21.32  

2022

     975        33.2315        to         33.9711        33,116           -        (28.70)  

2021

     1,395        46.6065        to         47.6438        66,450           -        14.11  

2020

     2,519        40.8425        to         41.7515        105,188           -        36.48  

2019

     2,570        29.9257        to         30.5918        78,618           -        38.66  

M05

                      

2023

     297        31.4153        to         31.4153        9,338           -        14.41  

2022

     292        26.8603        to         27.4581        8,025           -        (29.76)  

2021

     285        38.2396        to         39.0905        11,149           -        1.80  

2020

     281        37.5634        to         38.3993        10,772           -        45.89  

2019

     277        25.7483        to         26.3213        7,286           -        41.70  

M06

                      

2023

     11,171        12.3700        to         12.3700        137,852           3.17       7.38  

2022

     11,509        11.4772        to         11.5199        132,264           2.70       (13.94)  

2021

     12,473        13.3355        to         13.3851        166,581           2.68       (0.81)  

2020

     12,568        13.4448        to         13.4949        169,223           3.47       8.47  

2019

     12,657        12.3952        to         12.4413        157,110           3.66       10.21  

 

- 80 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

M33

                      

2023

     1,164      $ 38.1665        to       $ 38.1665      $ 44,434           0.52%       22.42%  

2022

     1,157        30.5561        to         31.1771        36,064           0.47       (17.21)  

2021

     1,287        36.9083        to         37.6584        48,484           0.54       24.80  

2020

     1,344        29.5735        to         30.1746        40,548           0.73       16.59  

2019

     1,337        25.3647        to         25.8802        34,593           0.80       32.95  

M44

                      

2023

     157           16.9721           2,663           3.59       (2.11)  

2022

     157           17.3376           2,724           2.44       0.76  

2021

     158           17.2077           2,711           1.76       14.09  

2020

     157           15.0824           2,364           2.52       5.90  

2019

     155           14.2417           2,212           5.13       25.07  

M40

                      

2023

     1,157        16.2633        to         16.3894        18,916           3.32       (2.33)  

2022

     1,198        16.6513        to         16.7805        20,070           2.23       0.48  

2021

     1,210        16.5719        to         16.7005        20,173           1.55       13.82  

2020

     1,219        14.5594        to         14.6723        17,870           2.24       5.62  

2019

     1,236        13.7845        to         13.8914        17,129           4.29       24.80  

M83

                      

2023

     1,523        31.8228        to         31.8228        48,465           1.45       7.93  

2022

     2,811        28.7012        to         29.4842        82,872           1.39       (5.91)  

2021

     2,987        30.5032        to         31.3354        93,588           1.34       25.45  

2020

     3,063        24.3146        to         24.9779        76,515           1.59       3.48  

2019

     3,018        23.4980        to         24.1390        72,846           2.20       29.80  

M08

                      

2023

     6,635        21.5631        to         21.6185        143,175           1.41       7.63  

2022

     6,815        20.0339        to         20.0854        136,630           1.15       (6.14)  

2021

     7,195        21.3451        to         21.4000        153,680           1.17       25.16  

2020

     7,455        17.0546        to         17.0984        127,229           1.35       3.22  

2019

     7,598        16.5224        to         16.5649        125,626           1.94       29.51  

MB6

                      

2023

     122           53.5737           6,529           1.43       28.53  

2022

     122           41.6834           5,088           1.12       (16.00)  

2021

     122           49.6257           6,074           1.12       29.53  

2020

     122           38.3131           4,675           1.68       15.34  

2019

     120           33.2178           3,994           1.50       29.17  

MA0

                      

2023

     2,129           19.3004           41,099           3.67       8.89  

2022

     2,221           17.7242           39,366           3.14       (16.62)  

2021

     2,241           21.2578           47,644           2.71       (1.66)  

2020

     2,259           21.6162           48,822           3.31       10.34  

2019

     2,288           19.5908           44,820           4.23       14.46  

MA1

                      

2023

     -           14.9485           1           1.32       10.71  

2022

     103           13.5029           1,395           3.58       (19.94)  

2021

     152           16.8669           2,562           0.26       (7.02)  

2020

     219           18.1413           3,974           2.90       10.33  

2019

     300           16.4423           4,940           0.31       20.18  

M96

                      

2023

     388           19.6301           7,620           1.49       4.15  

2022

     921           18.8487           17,351           2.00       (12.26)  

2021

     652           21.4816           14,015           2.08       (1.89)  

2020

     718           21.8950           15,729           2.97       6.38  

2019

     975           20.5821           20,074           2.05       6.53  

 

- 81 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

MA6

                      

2023

     1,228      $ 15.8572        to       $ 34.5002      $ 42,191           6.23%       12.41%  

2022

     1,351        13.8721        to         30.6919        41,272           5.38       (10.51)  

2021

     1,297        15.5021        to         34.2983        44,240           4.98       3.49  

2020

     1,726        14.9798        to         33.1427        56,951           5.70       5.09  

2019

     2,064        14.2548        to         31.5387        64,814           5.53       14.81  

M97

                      

2023

     24           32.6022           786           0.91       14.72  

2022

     267           28.4193           7,591           0.29       (14.95)  

2021

     306           33.4165           10,228           0.46       9.27  

2020

     405           30.5825           12,399           1.38       15.84  

2019

     577           26.4013           15,236           0.91       27.30  

MD5

                      

2023

     1,204           31.3609           37,769           0.92       14.39  

2022

     1,199           27.4149           32,880           0.38       (15.18)  

2021

     1,266           32.3220           40,916           0.39       8.99  

2020

     1,269           29.6552           37,635           1.28       15.50  

2019

     1,247           25.6753           32,008           1.01       27.11  

ME3

                      

2023

     37        14.6357        to         14.6357        545           0.72       12.83  

2022

     43        12.9717        to         17.5138        562           1.63       (17.80)  

2021

     48        15.7808        to         21.3065        768           0.67       11.27  

2020

     53        14.1828        to         19.1490        751           1.85       12.71  

2019

     57        12.5831        to         16.9891        725           1.19       27.67  

MB8

                      

2023

     246        42.3831        to         58.6956        14,424           0.78       18.96  

2022

     515        35.6289        to         49.3417        23,051           0.73       (18.37)  

2021

     604        43.6489        to         60.4485        32,283           0.88       29.64  

2020

     706        33.6702        to         46.6292        28,229           0.84       2.23  

2019

     833        32.9346        to         45.6105        31,701           0.66       26.78  

MF6

                      

2023

     716        21.8403        to         54.8141        39,270           0.86       11.46  

2022

     989        19.5954        to         49.1799        47,007           1.61       (26.94)  

2021

     1,029        26.8199        to         67.3116        65,959           1.52       30.12  

2020

     1,050        20.6109        to         51.7286        50,686           4.88       1.49  

2019

     1,178        20.3092        to         50.9714        55,133           3.57       26.87  

MF8

                      

2022

     -            33.2956           2           -        (18.27)  

2021

     -            40.7379           16           -        15.76  

2020

     26,618           35.1929           936,790           2.11       15.80  

2019

     27,256           30.3921           828,366           2.31       26.96  

 

- 82 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

MG0

                      

2023

     -           $13.4806         $ -           4.28%       2.74%  

2022

     1,589           13.1209           20,848               4.34       (21.55)  

2021

     1,603           16.7255           26,818           1.05       1.63  

2020

     1,616           16.4580           26,593           0.47       13.55  

2019

     1,637           14.4943           23,723           1.83       8.26  

MF2

                      

2023

     36,779        13.3647        to         13.5453        492,500           1.60       6.08  

2022

     34,733        12.5987        to         12.7689        438,920           2.10       (4.14)  

2021

     30,983        13.1422        to         13.3198        408,610           2.19       0.16  

2020

     28,673        13.1216        to         13.2990        377,593           3.21       4.34  

2019

     30,665        12.5759        to         12.7458        387,132           2.78       5.19  

MG3

                      

2023

     1,731        37.5996        to         41.2828        71,016           1.76       12.73  

2022

     1,799        33.3549        to         36.6222        65,499           0.98       (8.79)  

2021

     1,875        36.5674        to         40.1495        74,900           0.81       30.99  

2020

     1,958        27.9169        to         30.6515        59,704           1.23       3.87  

2019

     2,058        26.8770        to         29.5098        60,444           1.32       31.12  

MG5

                      

2023

     42,211           31.0301           1,309,830           2.72       12.99  

2022

     43,311           27.4623           1,189,421           2.05       (16.76)  

2021

     44,292           32.9932           1,461,346           2.03       11.61  

2020

     12,751           29.5623           376,969           2.38       14.29  

2019

     13,073           25.8654           338,128           2.59       22.23  

ME0

                      

2023

     18           48.1529           875           1.08       11.46  

2022

     202           43.2018           8,707           0.32       (10.96)  

2021

     311           48.5189           15,074           0.74       34.05  

2020

     396           36.1936           14,322           0.97       4.19  

2019

     572           34.7388           19,859           0.67       33.65  

V43

                      

2023

     275           54.9903           15,119           -        44.13  

2022

     302           38.1538           11,505           -        (62.97)  

2021

     327           103.0271           33,668           -        (11.19)  

2020

     342           116.0142           39,666           -        152.04  

2019

     -           -           -           -        -  

O01

                      

2023

     359           55.0420           19,753           -        35.38  

2022

     363           40.6588           14,750           -        (30.78)  

2021

     365           58.7406           21,465           -        22.57  

2020

     366           47.9249           17,558           -        36.59  

2019

     366           35.0874           12,849           0.06       36.20  

O20

                      

2023

     1,145           37.6831           43,145           -        34.45  

2022

     1,194           28.0285           33,472           -        (31.94)  

2021

     1,205           41.1798           49,624           -        15.17  

2020

     1,214           35.7554           43,419           0.45       27.34  

2019

     1,230           28.0794           34,539           0.65       31.45  

 

- 83 -


Table of Contents

DELAWARE LIFE NY VARIABLE ACCOUNT D

(A Separate Account of Delaware Life Insurance Company of New York)

 

9. FINANCIAL HIGHLIGHTS (CONTINUED)

 

     At December 31,             For the years ended December 31,  
     Units     

Unit Value

    lowest to highest3,4      

    

Net

    Assets    

         

 Investment 

Income

Ratio1

        Total Return      

P10

                      

2023

     -           $7.7849         $ -            22.09%       -7.85%  

2022

     2,122           8.4484           17,928           21.20       8.61  

2021

     2,177           7.7783           16,932           4.30       33.34  

2020

     2,243           5.8334           13,082           6.35       13.55  

2019

     2,330           5.7556           13,408           4.48       11.43  

PK8

                      

2023

     2,167        42.3937        to         42.3937        91,857           5.88       11.14  

2022

     1,538        17.4357        to         38.1434        58,674           4.85       (15.73)  

2021

     2,836        20.6859        to         45.2649        98,029           4.51       (2.57)  

2020

     3,405        21.2296        to         46.4610        126,822           4.63       6.70  

2019

     3,588        19.8956        to         43.5419        126,446           4.52       14.80  

PK9

                      

2020

     1,972        16.1225        to         16.4673        32,466           7.95       16.83  

2019

     1,910        13.7995        to         14.0946        26,916           2.22       17.06  

P06

                      

2023

     23        22.3838        to         22.3838        509           0.44       3.67  

2022

     1,031        15.0451        to         21.5912        22,256           7.01       (11.91)  

2021

     1,160        17.0780        to         24.5104        28,438           4.98       5.61  

2020

     1,192        16.1745        to         23.2087        27,656           1.46       11.72  

2019

     1,130        14.4787        to         20.7744        23,480           1.71       8.45  

P07

                      

2023

     1,318        22.2874        to         22.2874        29,382           3.59       5.94  

2022

     2,509        15.3712        to         21.0379        52,778           2.56       (14.31)  

2021

     1,911        17.9360        to         24.5506        46,917           1.82       (1.27)  

2020

     2,133        18.1660        to         24.8657        53,046           2.14       8.66  

2019

     2,637        16.7201        to         22.8838        60,338           2.90       8.37  

307

                      

2023

     3,309           78.2303           258,840           -        49.29  

2022

     3,708           52.4019           194,322           -        (38.50)  

2021

     3,902           85.2092           332,487           -        17.62  

2020

     4,412           72.4438           319,611           -        34.28  

2019

     3,597           53.9502           194,063           -        29.89  

1 Represents the dividends, excluding distributions of capital gains, received by the Sub-Account from the underlying mutual fund, net of management fees assessed by the fund manager, divided by the average net assets. The recognition of investment income by the Sub-Account is affected by the timing of the declaration of dividends by the underlying fund in which the Sub-Accounts invest.

2 Ratio represents the total return for the year indicated, including changes in the value of the underlying fund. The total return does not include any expenses assessed through the redemption of units; inclusion of these expenses in the calculation would result in reduction in the total return presented. The total return is calculated for each period indicated or from the effective date through the end of the reporting period.

3 These unit values are not a direct calculation of net asset over the number of units allocated to the Sub-Account. Due to the timing difference of the launch date of certain VUL products, some Sub-Accounts may have multiple unit values even though these products have no expense charges that result in a direct reduction to unit values.

4 Due to the timing difference of the launch date of certain VUL products, some Sub-Accounts may have multiple unit values even though these products have no expense charges that result in a direct reduction to unit values.

 

- 84 -


Table of Contents











Nassau Life
Insurance Company
(a wholly owned subsidiary of
The Nassau Companies of New York)
Statutory Financial Statements and
Supplemental Schedules
December 31, 2023, 2022 and 2021






Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Table of Contents
 


Page
Statutory Financial Statements:
1-3
4
5
6
7-52
Supplemental Schedules:
53-54


i






Independent Auditors’ Report

The Board of Directors
Nassau Life Insurance Company:

Opinions

We have audited the financial statements of Nassau Life Insurance Company (the Company), which comprise the statements of admitted assets, liabilities, capital and surplus as of December 31, 2023 and 2022, and the related statements of income and changes in capital and surplus, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes to the financial statements.

Unmodified Opinion on Statutory Basis of Accounting

In our opinion, the accompanying financial statements present fairly, in all material respects, the admitted assets, liabilities, capital and surplus of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2023, in accordance with accounting practices prescribed or permitted by the New York State Department of Financial Services described in Note 2.

Adverse Opinion on U.S. Generally Accepted Accounting Principles

In our opinion, because of the significance of the matter discussed in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the financial statements do not present fairly, in accordance with U.S. generally accepted accounting principles, the financial position of the Company as of December 31, 2023 and 2022, or the results of its operations or its cash flows for each of the years in the three-year period ended December 31, 2023.

Basis for Opinions

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles

As described in Note 2 to the financial statements, the financial statements are prepared by the Company using accounting practices prescribed or permitted by the New York State Department of Financial Services, which is a basis of accounting other than U.S. generally accepted accounting principles. Accordingly, the financial statements are not intended to be presented in accordance with U.S. generally accepted accounting principles. The effects on the financial statements of the variances between the statutory accounting practices described in Note 2 and U.S. generally accepted accounting principles, although not reasonably determinable, are presumed to be material and pervasive.

1


Emphasis of Matter

Nassau Life Insurance Company and Delaware Life Insurance Company of New York merged effective July 1, 2023 with Nassau Life Insurance Company as the survivor. As discussed in Note 1, Note 3, and Note 19 to the financial statements, accounting practices prescribed or permitted by the New York State Department of Financial Services require that the financial statements of Nassau Life Insurance Company be revised to reflect the merger as of the beginning of the prior period. Our opinions on the financial statements are not modified with respect to this matter.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting practices prescribed or permitted by the New York State Department of Financial Services. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date that the financial statements are issued.

Auditors’ Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

●    Exercise professional judgment and maintain professional skepticism throughout the audit.

●    Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

●    Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

●    Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

●    Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

2


We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.

Supplementary Information

Our audits were conducted for the purpose of forming an opinion on the financial statements as a whole. The supplementary information included in the summary of Investments - other than investments in related parties, the supplementary insurance information, and the supplementary schedule - reinsurance, is presented for purposes of additional analysis and is not a required part of the financial statements but is supplementary information required by the Securities and Exchange Commission. Such information is the responsibility of management and was derived from and relates directly to the underlying accounting and other records used to prepare the financial statements. The information has been subjected to the auditing procedures applied in the audits of the financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the financial statements or to the financial statements themselves, and other additional procedures in accordance with GAAS. In our opinion, the information is fairly stated in all material respects in relation to the financial statements as a whole.

/s/ KPMG LLP

Hartford, Connecticut
April 1, 2024



3


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Statements of Admitted Assets, Liabilities, Capital and Surplus
 
(in thousands)
As of December 31,
2023 2022 [1]
Assets:
Bonds $ 6,993,422  $ 7,545,870 
Contract loans 2,496,443  2,482,361 
Real estate, at depreciated cost 27,446  27,148 
Preferred stock 49,028  50,783 
Common stock 143,650  27,213 
Mortgage loans 517,608  535,875 
Cash, cash equivalents and short-term investments 162,242  148,609 
Derivatives 3,547  — 
Other invested assets 445,747  447,577 
Receivables for securities 5,820  3,163 
Derivative collateral 63,468  70,474 
Total cash and invested assets 10,908,421  11,339,073 
Deferred and uncollected premiums 59,164  59,163 
Due and accrued investment income 172,735  175,111 
Current federal and foreign income tax
11,007  — 
Reinsurance recoverables 6,291  11,029 
Deferred tax asset 41,533  66,291 
Receivables from affiliates 10,503  18,463 
Other assets 7,743  10,274 
Separate account assets 3,033,301  2,926,015 
Total assets $ 14,250,698  $ 14,605,419 
Liabilities:
Reserves for future policy benefits 9,364,960  9,804,086 
Policyholders’ funds 605,799  411,844 
Dividends to policyholders 107,165  112,411 
Policy benefits in course of settlement 198,925  116,175 
Amounts payable on reinsurance 11,778  34,171 
Accrued expenses and general liabilities 161,842  84,700 
Current federal and foreign income tax —  16,792 
Reinsurance funds withheld liability 328,562  357,459 
Interest maintenance reserve (“IMR”) 68,250  97,902 
Transfers to (from) separate account due and accrued (65,380) (30,847)
Asset valuation reserve (“AVR”) 117,069  126,354 
Purchase price payable and merger adjustments —  178,922 
Separate account liabilities 3,033,301  2,926,015 
Total liabilities 13,932,271  14,235,984 
Capital and surplus:
Common stock, $1,000 par value (10,000 shares authorized; 10,000 shares issued and outstanding) 10,000  10,000 
Paid-in surplus 634,333  614,333 
Surplus notes 126,418  126,392 
Special surplus funds 2,500  2,500 
Unassigned surplus (454,824) (383,790)
Total surplus 318,427  369,435 
Total liabilities, capital and surplus $ 14,250,698   $ 14,605,419  
———————
[1]Amounts for 2022 have been restated for the merger of Nassau Life Insurance Company with Delaware Life Insurance Company of New York.
The accompanying notes are an integral part of these financial statements.

4


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Statements of Income and Changes in Capital and Surplus
 
(in thousands)
For the years ended  
December 31,
2023 2022 [1] 2021 [1]
Income:
Premium and annuity considerations $ 343,202  $ 305,818  $ 309,570 
Net investment income and amortization of IMR
578,124  621,969  718,275 
Commissions and expense allowances on reinsurance ceded 14,037  14,710  14,432 
Reserve adjustments on reinsurance ceded (223,767) (238,878) (209,653)
Fees associated with separate account and other miscellaneous income 98,416  107,029  123,076 
Total income 810,012  810,648  955,700 
Current and future benefits:
Death benefits 566,114  464,636  470,510 
Disability and health benefits 3,126  2,457  2,686 
Annuity benefits and matured endowments 70,219  72,568  65,660 
Surrender benefits 632,220  503,057  524,203 
Interest on policy or contract funds 22,851  12,331  10,141 
Settlement option payments 22,254  22,669  16,586 
Net transfers to (from) separate accounts, net of reinsurance (267,135) (178,166) (298,598)
Change in reserves for future policy benefits and policyholders’ funds (439,129) (329,194) (217,516)
Total current and future benefits 610,520  570,358  573,672 
Operating expenses:
Direct commissions 8,528  6,962  8,689 
Commissions and expense allowances on reinsurance assumed 5,998  5,167  5,366 
Premium, payroll and miscellaneous taxes 6,088  9,440  7,644 
Other operating expenses 93,395  95,906  129,696 
Total operating expenses 114,009  117,475  151,395 
Net gain (loss) from operations before dividends and federal income taxes 85,483  122,815  230,633 
Dividends to policyholders 69,339  78,002  57,291 
Net gain from operations after dividends and before federal income taxes 16,144  44,813  173,342 
Federal and foreign income tax expense (benefit) (16,814) 6,143  28,581 
Net gain from operations before realized capital gains (losses) 32,958  38,670  144,761 
Realized capital gains (losses), net of income taxes and IMR (40,550) 13,343  (3,380)
Net income (loss) (7,592) 52,013  141,381 
Changes in capital and surplus:
Change in unrealized capital gains (loss), net of tax (8,145) (58,141) 4,184 
Change in deferred income taxes 737  1,101  (9,241)
Change in non-admitted assets (27,743) (22,579) 15,042 
Change in asset valuation reserve 9,286  37,108  (12,381)
Change in surplus notes 26  26  26 
Dividends to stockholder —  (274,026) (78,232)
Capital and paid-in surplus 20,000  —  — 
Other surplus changes, net (27,490) (7,570) 13,968 
Merger adjustments (10,087) 283,650  (12,233)
Net increase (decrease) in capital and surplus (51,008) 11,582  62,514 
Capital and surplus, beginning of year 369,435  357,853  295,339 
Capital and surplus, end of year $ 318,427   $ 369,435   $ 357,853  
———————
[1]Amounts for 2022 and 2021 have been restated for the merger of Nassau Life Insurance Company with Delaware Life Insurance Company of New York.
The accompanying notes are an integral part of these financial statements.

5


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Statements of Cash Flows
 
(in thousands)
For the years ended  
December 31,
2023 2022 [1] 2021 [1]
Cash provided by (used for) operations:
Premiums $ 405,807  $ 372,950  $ 376,015 
Investment and other income 811,315  849,743  990,688 
Claims and benefits (1,668,638) (1,580,595) (1,477,741)
Dividends paid (110,858) (90,841) (100,329)
Commissions and other expenses (106,755) (106,853) (136,438)
Net transfers from separate accounts 232,602  232,885  288,286 
Federal income taxes recovered (paid) (17,812) (16,327) (21,062)
Net cash provided by (used for) operations (454,339) (339,038) (80,581)
Cash provided by (used for) investments:
Proceeds from sales, maturities and repayments of bonds 850,727  1,118,031  1,544,755 
Proceeds from sales, maturities and repayments of stocks 2,426  16,489  77,692 
Proceeds from sales, maturities and repayments of mortgage loans 39,311  123,722  46,607 
Proceeds from sales, maturities and repayments of other invested assets 48,048  301,759  39,793 
Proceeds from sales, maturities and repayments of other investments —  —  1,831 
Cost of bonds acquired (343,941) (632,663) (1,366,825)
Cost of stocks acquired (303,285) (4,117) (21,458)
Cost of mortgage loans acquired (22,514) (55,370) (105,812)
Cost of other invested assets acquired (53,803) (169,566) (107,755)
Cost of other investments acquired (9,544) (74,539) (12,778)
Net decrease (increase) in contract loans (14,161) 20,317  (23,665)
Net cash provided by (used for) investments 193,264  644,063  72,385 
Cash provided by (used for) financing and miscellaneous sources:
Capital and paid-in surplus 20,000  —  — 
Net deposits (withdrawals) of deposit-type contracts 193,955  (13,309) (50,429)
Dividends to stockholder —  (274,026) (78,232)
Other cash provided (applied) 60,753  11,689  (23,795)
Net cash provided by (used for) financing and miscellaneous uses 274,708  (275,646) (152,456)
Net increase (decrease) in cash and short-term investments 13,633  29,379  (160,652)
Cash and short-term investments, beginning of year 148,609  119,230  279,882 
Cash and short-term investments, end of year $ 162,242   $ 148,609   $ 119,230  
———————
[1]Amounts for 2022 and 2021 have been restated for the merger of Nassau Life Insurance Company with Delaware Life Insurance Company of New York.












The accompanying notes are an integral part of these financial statements.

6


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
 
(in thousands except where noted in millions)

1.     Description of Business

Nassau Life Insurance Company (“NNY” or the “Company”), domiciled in the State of New York, is a wholly-owned subsidiary of the Nassau Companies of New York (“NCNY” or the “Parent”) and an indirect subsidiary of Nassau Financial Group, L.P. (“Nassau”). Nassau is a financial services company providing life insurance and annuities, reinsurance and asset management.

On July 1, 2023, NNY completed its acquisition of Delaware Life Insurance Company of New York (“DLNY”) from Delaware Life Insurance Company, after receipt of insurance regulatory approval by the New York Department of Financial Services (the “NYDFS” or the “Department”). Effective July 5, 2023, DLNY merged with and into NNY pursuant to a merger agreement with NNY as the surviving entity. In accordance with Statement of Statutory Accounting Principles (“SSAP”) No. 68, Business Combinations and Goodwill, the acquisition was treated as a statutory merger. Under the statutory merger method of accounting, the former statutory bases of accounting for DLNY were retained, and the accounts of NNY were restated to include the accounts of DLNY. DLNY was a provider of life insurance and annuity products with approximately 16,000 policyholders and $1.6 billion in assets. This acquisition provides scale benefits to the Company and supports continued focus on building the Nassau franchise.

NNY is a provider of life insurance and annuity products. The Company’s life insurance products include whole life, universal life, variable universal life, variable life and other insurance products. NNY offers single-life and multiple-life products. Most of the Company’s whole life policies were written prior to its demutualization in 2001 and are part of a closed block (the “Closed Block”) of existing in-force traditional participating life insurance business established at the time of the demutualization to protect the future dividends of these policyholders. The Company also offers annuity products including both deferred and immediate varieties. Deferred annuities accumulate for a number of years before periodic payments begin and enable the contract owner to save for retirement and provide options that protect against outliving assets during retirement. Immediate annuities are purchased by means of a single lump sum payment and begin paying periodic income within the first year.


2.    Summary of Significant Accounting Policies

Basis of presentation

The significant accounting policies, which are used by NNY in the preparation of the statutory financial statements, are described below.

These financial statements were prepared on the basis of accounting practices (“STAT”) prescribed or permitted by the NYDFS. These practices are predominately promulgated by the National Association of Insurance Commissioners (the “NAIC”).

These practices differ from accounting principles generally accepted in the United States of America (“U.S. GAAP”). The major differences from U.S. GAAP practices are as follows:

The costs related to acquiring business, principally commissions and certain policy issue expenses, are charged to income in the year incurred for STAT and are capitalized as deferred acquisition costs (“DAC”) and then amortized for U.S. GAAP.
Statutory concepts such as non-admitted assets, asset valuation reserve and interest maintenance reserve are recognized only for STAT.
Bonds are primarily carried at amortized cost for STAT and at fair value for U.S. GAAP.
For certain deposit-type contracts in the accumulation stage and for annuity products, deposits are reported as annuity considerations (a revenue item) for statutory reporting, while U.S. GAAP reports these as deposits via the balance sheet.

7


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
For STAT, wholly owned subsidiaries are not consolidated, but subsidiary earnings and losses and other changes in capital and surplus are accounted for as unrealized gains and losses. Dividends received from subsidiaries are treated as investment income. For U.S. GAAP, results of wholly owned subsidiaries are consolidated.
Under STAT, for universal life, variable life, interest sensitive life, variable universal life policies and variable annuity contracts, premiums or deposits are recognized as revenue and withdrawals are recognized as surrender benefits. Benefits, losses and related expenses are matched with premiums over the related contract periods. For U.S. GAAP, amounts received as payments for universal life, variable life, variable universal life and other investment-type contracts are considered deposits and are not included in premiums. Withdrawals taken from these contracts are generally considered returns of policyholder account balances and are not included in surrender benefits for U.S. GAAP.
Statutory reserves are based on different assumptions than they are under U.S. GAAP.
For STAT, the cost of employee pension benefits, including prior service costs, is recognized as the employer contributions are made to fund the costs.
Assets and liabilities are reported net of reinsurance balances for STAT and gross for U.S. GAAP.
Surplus notes issued by the Company are recorded as a component of surplus for STAT and as debt for U.S. GAAP.
The statutory provision for federal income taxes represents estimated amounts currently payable based on taxable income or loss reported in the current accounting period as well as changes in estimates related to prior year taxes. Deferred income taxes are provided in accordance with SSAP No. 101, Income Taxes, a Replacement of SSAP No. 10R and SSAP No. 10, and changes in deferred income taxes are recorded through surplus. SSAP No. 101 adopts the U.S. GAAP valuation allowance standard and also limits the recognition of deferred tax assets (“DTAs”) based on certain admissibility criteria. The U.S. GAAP provision would include a provision for taxes currently payable as well as deferred taxes, both of which would be recorded in the income statement. Under SSAP No. 101, in conjunction with SSAP No. 5R as modified to replace the “probable” standard with a “more likely than not” standard, companies must establish a liability related to uncertain tax positions where management determines that it is more likely than not a claimed tax benefit would not be sustained if audited. SSAP No. 101 specifically rejects the corresponding U.S. GAAP guidance. For U.S. GAAP, the Company accounts for income taxes in accordance with Accounting Standards Codification (“ASC”) 740, Accounting for Income Taxes. Income tax expense or benefit is recognized based upon amounts reported in the financial statements and the provisions of currently enacted tax laws. Deferred tax assets and/or liabilities are determined by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled. Valuation allowances on deferred tax assets are recorded to the extent that management concludes that it is more likely than not that an asset will not be realized. For both STAT and U.S. GAAP, the Company assesses all significant tax positions to determine if a liability for an uncertain tax position is necessary and, if so, the impact on the current or deferred income tax balances.
Merged entities’ financial statements are restated as if the merger occurred at the beginning of the earliest period presented. For U.S. GAAP, financial statements are typically not restated, but post-acquisition activity and balance sheet amounts are reflected from the acquisition date.
Acquired entities are carried at statutory book value with the difference between purchase price and book value recorded directly against statutory surplus. For U.S. GAAP, acquired entities are carried at fair value as of the acquisition date with any difference between purchase price and fair value recorded to goodwill.

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In applying these estimates and assumptions, management makes subjective and complex judgments that frequently require assumptions about matters that are uncertain and inherently subject to change, such as possibility for elevated mortality rates and market volatility. Actual results may differ from those estimates. Significant estimates and assumptions used in determining insurance and contractholder liabilities, income taxes, contingencies and valuation allowances for invested assets are discussed throughout the Notes to Statutory Financial Statements. To be consistent with the current year presentation, certain prior year reclassifications have been made.


8


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Recent accounting pronouncements

In 2023, the NAIC adopted revisions to SSAP No. 26R, Bonds, and SSAP No. 43R, Loan-Backed and Structured Securities, to incorporate the principles-based bond definition for use in determining whether an investment (i.e., security) qualifies for reporting as a bond into statutory accounting guidance and to address the accounting treatment for securities that do qualify as bonds. SSAP No. 2R, Cash, Cash Equivalents, Drafts and Short-Term Investments, was also revised to exclude asset-backed securities from being reported as a cash equivalent or short-term investment. These revisions have an effective date of January 1, 2025, and the Company is assessing the impact on its financial position and results of operations.

The Company did not adopt any accounting standards during 2023 that had a material impact on these financial statements.

Going concern

Management has evaluated the Company’s ability to continue as a going concern and concluded that there is not substantial doubt about the Company’s ability to continue as a going concern.

Liquidity and regulatory capital requirements

NCNY serves as the holding company for NNY and does not have any significant operations of its own. In addition to existing cash and securities, the holding company’s primary source of liquidity consists of dividends from NNY. Dividends to the Parent from NNY are limited under the insurance company laws of New York.

NNY is required to report risk-based capital (“RBC”) under the insurance company laws of New York. RBC is based on a formula calculated by applying factors to various assets, premium and statutory reserve items taking into account the risk characteristics of the insurer, including asset risk, insurance risk, interest rate risk and business risk. The insurance laws give the states explicit regulatory authority to require various actions by, or take various actions against, insurers whose total adjusted capital (“TAC”) does not exceed certain RBC levels. NNY has RBC ratios in excess of the minimum levels required by the applicable insurance regulations.

In connection with the July 2023 acquisition of DLNY, Nassau committed to the NYDFS to maintain NNY’s Company Action Level RBC at or above 300% and its surplus to policyholder reserves ratio (excluding separate accounts) at or above 3.5% through June 2028, during which time NNY can pay ordinary dividends without prior approval when those ratios are maintained. Further, this commitment may be terminated earlier under certain circumstances. As of December 31, 2023, RBC and the surplus to policyholder reserves ratio were in excess of these levels.

In addition to the statutory limitations on paying dividends, the Company also considers the level of statutory capital and RBC of the entity and other liquidity requirements. NNY may have less flexibility to pay dividends to the parent company if the Company experiences declines in either statutory capital or RBC in the future.

Investments

Investments are recognized in accordance with methods prescribed by the NAIC.

Investments in bonds include public and private placement bonds and mortgage-backed securities. Bonds with an NAIC designation of 1-5 are carried at amortized cost using the interest method while those with an NAIC designation of 6 are carried at the lower of amortized cost or fair value. Mortgage-backed and structured securities are assigned an NAIC designation in accordance with SSAP No. 43R, Loan-Backed and Structured Securities. Amortized cost for mortgage-backed and structured securities is determined using the interest method, utilizing anticipated cash flows based upon prepayment assumptions. When actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date and any resulting adjustment is included in net investment income. Amortization is adjusted for significant changes in estimated cash flows from the original purchase assumptions.


9


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Redeemable preferred stock that has a NAIC designation of 1-3 is stated at amortized cost and those with a designation of 4-6 are carried at the lower of amortized cost or fair value. Mandatory convertible preferred, redeemable or perpetual and perpetual preferred stocks are carried at the lower of fair value or the current effective call price.

With the exception of the Company’s investment in Federal Home Loan Bank (“FHLB”) common stock, unaffiliated common stock is carried at fair value. The Company’s investment in FHLB common stock is carried at cost, which represents the price at which the FHLB will repurchase the stock.

Mortgage loans on real estate are carried at the outstanding principal balance, less any allowances for credit losses.

Contract loans are generally reported at their unpaid balances and are collateralized by the cash values of the related policies.

Short-term investments and cash equivalents are carried at amortized cost. NNY considers highly liquid investments purchased between ninety days and one year of maturity to be short-term investments and highly liquid investments purchased with ninety days or less of maturity to be cash equivalents.

Other invested assets primarily include limited partnerships, limited liability companies and residual tranches of securitizations. Interests in limited partnerships and limited liability companies are carried at cost adjusted for NNY’s equity in undistributed earnings or losses since acquisition, less allowances for other-than-temporary declines in value, based upon audited financial statements in accordance with SSAP No. 48, Joint Ventures, Partnerships and Limited Liability Companies. Residual tranches of securitizations are reported at the lower of cost or market. Recognition of net investment income occurs when cash distributions of income are received.

Investments in affiliates represent direct and indirect ownership in the common stock of subsidiaries that are included in common stock. The Company has an investment in subsidiary, Nassau Life Insurance Company ABS A-I LLC (“ABS A” or “NNY A-1”), an investment SPV, that was formed in 2023. The Company admits the underlying GAAP equity in accordance with SSAP No. 97, Investments in Subsidiary, Controlled and Affiliated (“SCA”) Entities.

Home office real estate is generally valued at depreciated cost. Depreciation of real estate is calculated using the straight-line method over the estimated lives of the assets (generally 40 years).

Realized capital gains and losses on investments are determined using the first-in, first-out (“FIFO”) method. Those realized capital gains and losses resulting from interest rate changes are deferred and amortized to income over the stated maturity of the disposed investment utilizing the Interest Maintenance Reserve (“IMR”) Grouped Method. Unrealized capital gains and losses, resulting from changes in the difference between cost and the carrying value of investments, are reflected in the Statements of Income and Changes in Capital and Surplus.

The Company’s accounting policy requires that a decline in the value of a bond or equity security below its cost or amortized cost basis be assessed to determine if the decline is other-than-temporary. In addition, for securities expected to be sold, an other-than-temporary impairment (“OTTI”) charge is recognized if the Company does not expect the fair value of a security to recover to its cost or amortized cost basis prior to the expected date of sale.

Securities that are in an unrealized loss position are reviewed at least quarterly to determine if an OTTI is present based on certain quantitative and qualitative factors. The primary factors considered in evaluating whether a decline in value for securities not subject to SSAP No. 43R is other-than-temporary include: (a) the length of time and the extent to which the fair value has been less than cost or amortized cost, (b) changes in the financial condition, credit rating and near-term prospects of the issuer, and (c) whether the debtor is current on contractually obligated payments.

For securities that are not subject to SSAP No. 43R, if the decline in value of a bond or equity security is other-than-temporary, a charge is recorded in net realized capital losses equal to the difference between the fair value and cost or amortized cost basis of the security. Impairment losses are recorded through the IMR.


10


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
For certain securitized financial assets with contractual cash flows (including asset-backed securities), SSAP No. 43R requires the Company to periodically update its best estimate of cash flows over the life of the security. If management determines that its best estimate of expected future cash flows discounted at the security’s effective yield prior to the impairment are less than its amortized cost, then an OTTI charge is recognized equal to the difference between the amortized cost and the Company’s best estimate of expected future cash flows discounted at the security’s effective yield prior to the impairment. The Company’s best estimate of expected future cash flows discounted at the security’s effective yield prior to the impairment becomes its new cost basis. Estimating future cash flows is a quantitative and qualitative process that incorporates information received from third party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. As a result, actual results may differ from estimates. In addition, if the Company does not have the intent and ability to hold a security subject to the provisions of SSAP No. 43R until the recovery of value, the security is written down to fair value.

Loans are occasionally restructured in a troubled debt restructuring. These restructurings generally include one or more of the following: full or partial payoffs outside of the original contract terms; changes to interest rates; extensions of maturity; or additions or modifications to covenants. When restructurings occur, they are evaluated individually to determine whether the restructuring or modification constitutes a “troubled debt restructuring” as defined by authoritative accounting guidance. In a troubled debt restructuring where the Company receives assets in full or partial satisfaction of the debt, any specific valuation allowance is reversed and a direct write down of the loan is recorded for the amount of the allowance and any additional loss, net of recoveries, or any gain is recorded for the difference between the fair value of the assets received and the recorded investment in the loan. Any remaining loan is evaluated prospectively for impairment. When a loan is restructured in a troubled debt restructuring, the impairment of the loan is remeasured using the modified terms and the loan’s original effective yield and the allowance for loss is adjusted accordingly. Subsequent to the modification, income is recognized prospectively based on the modified terms of the loans.

Derivatives

Equity Index Options

An equity index option gives the option holder the right to buy or sell the equity index at a predetermined price (strike price) at a specified time (maturity) agreed upon at the inception of the contract. An equity index put option affords the holder the right to sell the equity index at a strike price at the maturity date while an equity index call option affords the holder the right to buy the equity index at the strike price.

The Company uses equity index call options. The Company is exposed to credit-related losses in the event of nonperformance by a counterparty’s failure to meet its obligations. Given the Company enters into derivative contracts with highly rated counterparties and diversifies this exposure across a number of counterparties, the Company is exposed to minimum credit risk.

The Company uses equity index options in two instances: 1) To hedge against market risks from changes in equity index price associated with certain annuity products; or 2) To replicate the option payoff profile associated with certain equity-linked life and annuity products. The statutory accounting treatment for these hedges is that they are valued at fair or market value, and changes in the value of these hedges are reflected directly through surplus.

The unrealized gain/(loss) during the period representing equity index options was $(2.6) million, $0 and $0 as of December 31, 2023, 2022 and 2021, respectively.


11


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Interest Rate Swaps

An interest rate swap is an agreement between two parties to exchange cash flows in the future. Typically, one of the cash flow streams is based on a fixed interest rate set at the inception of the contract, and the other is a floating rate indexed to a reference rate that resets periodically. At the outset of the contract, generally, there is neither an exchange of cash nor a payment of principal by the parties; hence the term “notional principal.” At each settlement date, the fixed and floating interest rates times the notional principal determine the cash flows to be exchanged, and the resulting net payment amount between these interest cash flows is made from one party to the other.

The Company uses interest rate swaps to hedge against market risks in assets or liabilities from substantial changes in interest rates. In an interest rate swap, the Company agrees with another party (referred to as the counterparty) to exchange cash flows at specified intervals for a set length of time, based on the specified notional principal amount.

The Company uses interest rate swaps to hedge exposure to changes in interest rates. The Company uses interest rate swaps to manage interest rate exposure to certain floating rate available-for-sale debt securities where the terms or expected cash flows of the hedged item closely match the terms or expected cash flows of the swap.

Foreign Currency Forwards

The Company uses foreign currency forwards to hedge against market risks from changes in foreign currency exchange rates. Currency forward contracts are used to hedge collateralized loan obligation (“CLO”) asset exposure denominated in a foreign (EUR) currency back to U.S. dollars. Under foreign currency forwards, the Company agrees with another counterparty to lock in the exchange rate for the purchase or sale of a currency on a future date.

The unrealized gain(loss) for non-qualified hedges representing foreign currency forwards was ($0.1) million, $0 and $(0.1) million for the years ended December 31, 2023, 2022 and 2021, respectively.

The Company had derivatives accounted for as cash flow hedges of forecasted transactions and no derivative contracts with financing premiums.

Net investment income

Net investment income primarily represents interest and dividends received or accrued on bonds, common and preferred stock, short-term investments, mortgage loans and real estate. It also includes amortization of any purchase premium or discount using the interest method, adjusted retrospectively for any change in estimated yield-to-maturity. For partnership investments, income is earned when cash distributions of income are received. Investment income due and accrued that is deemed uncollectible is charged against net investment income in the period such determination is made, while investment income greater than 90 days past due is non-admitted and charged directly to surplus. There was $173.7 million and $176.9 million gross due and accrued investment income at December 31, 2023 and 2022, respectively. There was $1.0 million and $1.8 million due and accrued investment income non-admitted at December 31, 2023 and 2022, respectively. There was $172.7 million and $175.1 million net due and accrued investment income at December 31, 2023 and 2022, respectively.

Non-admitted assets

In accordance with regulatory requirements, certain assets, including certain receivables, certain investments in limited liability companies, certain deferred tax assets, prepaid expenses and furniture and equipment, are not allowable and must be charged against surplus and are reported in the Statements of Income and Changes in Capital and Surplus. Total non-admitted assets at December 31, 2023 and 2022 were $110.1 million and $82.4 million, respectively. Changes for the years ended December 31, 2023, 2022 and 2021 increased (decreased) surplus by $(27.7) million, $(22.6) million and $15.0 million, respectively.


12


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Separate accounts

Separate account assets and liabilities are funds maintained in accounts to meet specific investment objectives of contractholders who bear the investment risk. Investment income and investment gains and losses accrue directly to such contractholders. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of NNY. The assets are carried at fair value and the liabilities are set equal to the assets. Net investment income and realized investment gains and losses for these accounts are excluded from revenues, and the related liability increases are excluded from benefits and expenses. Amounts assessed to the contractholders for management services are included in revenues.

Appreciation or depreciation of NNY’s interest in the separate accounts, including undistributed net investment income, is reflected in net investment income. Contractholders’ interests in net investment income and realized and unrealized capital gains and losses on separate account assets are not reflected in net income.

NNY’s separate account products include variable annuities and variable life insurance contracts. Many of NNY’s contracts offer various guaranteed minimum death, accumulation, withdrawal and income benefits. The Company currently reinsures a significant portion of the death benefit guarantees associated with its in-force block of business. Reserves for the guaranteed minimum death, accumulation, withdrawal and income benefits are determined in accordance with NYDFS Insurance Regulation 213 (“Reg 213”).

Insurance liabilities

Benefit and loss reserves, included in reserves for future policy benefits, are established in amounts adequate to meet estimated future obligations on policies in force. Benefits to policyholders are charged to operations as incurred.

Reserves for future policy benefits are determined using assumed rates of interest, mortality and morbidity consistent with statutory requirements. Most life insurance reserves for which the 1958 CSO and 1980 CSO mortality tables are used as the mortality basis are determined using a modified preliminary term reserve method. The net level premium method is used in determining life insurance reserves based on earlier mortality tables. For certain products issued on or after January 1, 2000, NNY adopted the 20 year select factors in the NAIC Valuation of Life Insurance Policies Model Regulation for both the basic and the deficiency reserve, and NNY’s X factors for the deficiency reserve. Annuity reserves principally use Actuarial Guideline (“AG”) 33 and Reg 213 to calculate reserve balances. AG33 uses prescribed methods and assumptions to determine the minimum statutory reserves. Reg 213, which was effective beginning in 2020, requires that reserves for contracts are based on the greater of the Standard Scenario Amount (“SSA”) and the Valuation Manual Section 21 (“VM-21”) reserve, which uses stochastic projections under company and prescribed assumptions to determine the final reserve. The Company holds reserves greater than those developed under the minimum statutory reserving rules when it is determined that the minimum statutory reserves are inadequate. Actual results could differ from these estimates and may result in the establishment of additional reserves. The Company monitors actual experience and, where circumstances warrant, revises assumptions and the related estimates for policy reserves.

As of December 31, 2023 and 2022, the Company calculated its reserves for variable annuity products under Reg 213.

As of December 31, 2023 and 2022, there were $82.0 million and $116.9 million, respectively, of cash flow testing reserves resulting from asset adequacy testing.

Claim and loss liabilities, included in reserves for future policy benefits, are established in amounts estimated to cover incurred losses. These liabilities are based on individual case estimates for reported losses and estimates of unreported losses based on past experience.


13


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Fees associated with separate accounts and other miscellaneous income

Fees consist of contract charges assessed against the fund values and are recognized, when earned.

Premium income and related expenses

Generally, premium income and annuity considerations for fixed payment policies are recognized as income when due and premium income and annuity considerations for variable payment policies or contracts is recognized as income when paid. Related underwriting expenses, commissions and other costs of acquiring the policies and contracts are charged to operations as incurred. For certain deposit-type variable contracts in the accumulation stage, NNY reports deposits as revenues and withdrawals as benefits. This method of reporting applies to deposits and withdrawals for both general account activity and transfers to/from separate accounts.

Stockholder dividends

New York Insurance Law allows a domestic stock life insurer to distribute an ordinary dividend where the aggregate amount of such dividend in any calendar year does not exceed the greater of 10% of its surplus to policyholders as of the immediately preceding calendar year or its net gain from operations for the immediately preceding calendar year, not including realized capital gains, not to exceed 30% of its surplus to policyholders as of the immediately preceding calendar year. The foregoing ordinary dividend can only be paid out of earned surplus, which is defined as an insurer’s positive unassigned funds, excluding 85% of the change in net unrealized gains or losses less capital gains tax for the preceding year. Under this section, an insurer cannot distribute an ordinary dividend in the calendar year immediately following a calendar year for which the insurer’s net gain from operations, not including realized capital gains, was negative. If a company does not have sufficient positive earned surplus to pay an ordinary dividend, an ordinary dividend can still be paid where the aggregate amount is the lesser of 10% of its surplus to policyholders as of the immediately preceding calendar year or its net gain from operations for the immediately preceding calendar year, not including realized capital gains. Based on this calculation, NNY has the capacity to pay dividends of $30.8 million in 2024.

During 2023, 2022 and 2021, the Company paid cash dividends of $0, $274.0 million and $78.2 million, respectively, to its Parent.

Reinsurance

NNY utilizes reinsurance agreements to provide for greater diversification of business, allow management to control exposure to potential losses arising from large risks and provide additional capacity for growth. Reinsurance arrangements do not relieve the Company as primary obligor for policyholder liabilities.

Assets and liabilities related to reinsurance ceded contracts are reported on a net basis.

Policyholder dividends

Certain life insurance policies contain dividend payment provisions that enable the policyholder to participate in the earnings of NNY. The amount of policyholder dividends to be paid is determined annually by NNY’s Board of Directors. The aggregate amount of policyholder dividends is related to the actual interest, mortality, morbidity and expense experience for the year and NNY’s judgment as to the appropriate level of statutory surplus to be retained (see Note 3 – “Significant Transactions, Closed Block”).

Income taxes

The Company is included in the consolidated federal income tax return of The Nassau Companies, Inc. (“NC”) and its subsidiaries. The method of allocation among affiliates of the Company is subject to written agreement approved by the Board of Directors and based upon separate return calculations with current credit for net losses to the extent the losses provide a benefit in the consolidated tax return.

14


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Deferred income taxes result from temporary differences between the tax basis of assets and liabilities and their recorded amounts for financial reporting purposes. Deferred tax assets are admitted in accordance with the admissibility test prescribed by SSAP No. 101. The change in deferred tax is recorded as a component of surplus.

Employee benefit plans

NCNY sponsors a non-contributory, qualified defined benefit pension plan (“Pension Plan”). Retirement benefits are a function of both years of service and level of compensation. NCNY also sponsors a non-qualified supplemental defined benefit plan (“Supplemental Plan”) to provide benefits in excess of amounts allowed pursuant to the Internal Revenue Code. NCNY’s funding policy is to contribute annually an amount equal to at least the minimum required contribution in accordance with minimum funding standards established by the Employee Retirement Income Security Act of 1974 (“ERISA”). NCNY also provides certain health care and life insurance benefits for active employees.

The Company participates in the Pension Plan and Supplemental Plan. For purposes of statutory accounting, the Company has no legal obligation for benefits under these plans. The Company’s share of net expenses for these plans was $0.5 million, $4.3 million and $9.1 million for 2023, 2022 and 2021, respectively.

Nassau employees are covered by a qualified defined contribution plan sponsored by NCNY. NCNY’s match percentage is dollar for dollar to a maximum of 5% of eligible 401(k) earnings. The Company’s contribution for the plan was $0.8 million, $0.9 million and $0.9 million for 2023, 2022 and 2021, respectively.

The Company historically provided certain other postretirement benefits to retired employees through a plan sponsored by NCNY. For purposes of statutory accounting, the Company has no legal obligation for benefits under this plan. The Company had net benefits of $0, $0 and $0 for 2023, 2022 and 2021, respectively.

Applicable information regarding the actuarial present value of vested and non-vested accumulated plan benefits and the net assets of the plans available for benefits is omitted, as the information is not separately calculated for NNY’s participation in the plans. NCNY, the plan sponsor, establishes an accrued liability and charges any applicable employee benefit expenses to NNY through a cost allocation process. Effective March 31, 2010, all benefit accruals under the funded and unfunded defined benefit plans were frozen.

Surplus

The portion of unassigned surplus increased/(reduced) by cumulative unrealized gains/(losses) was $61.0 million, $(44.4) million and $29.5 million as of December 31, 2023, 2022 and 2021, respectively.

Pursuant to SSAP No. 72, Surplus and Quasi-Reorganizations, the Company reclassified its negative unassigned surplus balance of $896.9 million to gross paid-in and contributed surplus as of June 30, 2016, which had the effect of setting the Company’s statutory unassigned surplus to zero as of this date. This change in accounting was approved by the NYDFS. This change had no immediate impact on dividend capacity and no impact to risk-based capital.

Non-cash items

The Statements of Cash Flows exclude non-cash items, such as the following:

Non-cash investment transactions, such as tax-free exchanges;
Accretion of amortization or accrual of discount for investments;
Depreciation expense;
Modified coinsurance (“MODCO”) reinsurance adjustments, including inception ceded/assumed premium amounts; and
Accruals of capital contributions approved by the domiciliary commissioner.


15


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The Statements of Cash Flows exclude the following significant non-cash items for the years ended December 31, 2023, 2022 and 2021:

$0, $24.2 million and $54.2 million of non-cash investment exchanges as of December 31, 2023, 2022 and 2021, respectively.


3.    Significant Transactions

Closed block

On the date of demutualization, NNY established the closed block for the benefit of holders of certain individual participating life insurance policies and annuities of NNY for which NNY had a dividend scale payable at the time of demutualization. Assets were allocated to the closed block in an amount that will produce cash flows which, together with anticipated revenues from the policies included in the closed block, are reasonably expected to be sufficient to support obligations and liabilities relating to these policies. This includes, but is not limited to, provisions for the payment of claims and certain expenses and taxes, and to provide for the continuation of policyholder dividend scales in effect at the time of demutualization, if the experience underlying such dividend scales continues, and for appropriate adjustments in such scales if such experience changes. The closed block assets, the cash flows generated by the closed block assets and the anticipated revenues from the policies in the closed block will benefit only the holders of the policies in the closed block. To the extent that, over time, cash flows from the assets allocated to the closed block and claims and other experience related to the closed block are, in the aggregate, more or less favorable than what was assumed when the closed block was established, total dividends paid to closed block policyholders in the future may be greater than or less than the total dividends that would have been paid to these policyholders if the policyholder dividend scales in effect at the time of demutualization had been continued. Any cash flows in excess of amounts assumed will be available for distribution over time to closed block policyholders and will not be available to stockholders. If the closed block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside of the closed block. The closed block will continue in effect as long as any policy in the closed block remains in force.

The excess of closed block liabilities over closed block assets at the effective date of the demutualization represents the estimated maximum future earnings from the closed block expected to result from operations attributed to the closed block after income taxes. Earnings of the closed block are recognized in income over the period the policies and contracts in the closed block remain in force. Management believes that over time the actual cumulative earnings of the closed block will approximately equal the expected cumulative earnings due to the effect of dividend changes. If, over the period the closed block remains in existence, the actual cumulative earnings of the closed block are greater than the expected cumulative earnings of the closed block, NNY will pay the excess of the actual cumulative earnings of the closed block over the expected cumulative earnings to closed block policyholders as additional policyholder dividends unless offset by future unfavorable experience of the closed block. If over such period, the actual cumulative earnings of the closed block are less than the expected cumulative earnings of the closed block, NNY will recognize only the actual earnings in income.

The principal cash flow items that affect the amount of closed block assets and liabilities are premiums, net investment income, purchases and sales of investments, policyholders’ benefits, policyholder dividends, premium taxes and income taxes. The principal income and expense items excluded from the closed block are management, maintenance, commission and certain investment expenses of the closed block.


16


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Delaware Life acquisition and merger

After NNY completed its 2023 acquisition of DLNY, DLNY was merged with and into NNY pursuant to a merger agreement with NNY as the surviving entity. In accordance with SSAP No. 68, Business Combinations and Goodwill, the acquisition was treated as a statutory merger. Income of the combined reporting entity is required to include income of the constituents for the entire fiscal period in which the combination occurs and the balance sheet and the statements of operations for all years presented shall be restated, as required by SSAP No. 3, Accounting Changes and Corrections of Errors. The statements of operations and cash flow were restated for 2022 and 2021. Refer below to Note 19 – “The Merger” for further details regarding the merger and restatement. All 2023 amounts in the Notes to the Statutory Financial Statements were restated to reflect the statutory merger, unless otherwise indicated.


4.    Investments

Information pertaining to NNY’s investments, net investment income and capital gains and losses on investments follows.

Bonds, common stock and preferred stock

The carrying value and fair value of investments in bonds, common stock and preferred stock as of December 31, 2023 were as follows:

Carrying
Value
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
U.S. government $ 240,740  $ $ (73,111) $ 167,630 
All other governments 102,769  605  (15,190) 88,184 
States, territories and possessions 34,814  208  (2,578) 32,444 
Political subdivisions of states, territories
and possessions
64,588  367  (4,949) 60,006 
Special revenue 381,050  1,364  (37,390) 345,024 
Industrial and miscellaneous (unaffiliated) 4,303,925  30,077  (443,448) 3,890,554 
Parent, subsidiaries and affiliates 60,719  407  (5,551) 55,575 
Hybrid securities 147,094  177  (11,345) 135,926 
Mortgage-backed and asset-backed securities 1,657,723  7,122  (187,672) 1,477,173 
Total bonds $ 6,993,422  $ 40,328  $ (781,234) $ 6,252,516 
Preferred stock $ 49,028  $ 668  $ (1,460) $ 48,236 
Common stock $ 38,368  $   $   $ 38,368 
Common stock - affiliate
$ 105,282   $   $   $ 105,282  


17


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The carrying value and fair value of investments in bonds, common stock and preferred stock as of December 31, 2022 were as follows:

Carrying
Value
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
U.S. government $ 241,993  $ $ (74,238) $ 167,757 
All other governments 105,654  901  (16,599) 89,956 
States, territories and possessions 34,023  151  (2,703) 31,471 
Political subdivisions of states, territories
and possessions
75,803  171  (7,191) 68,783 
Special revenue 434,440  762  (50,898) 384,304 
Industrial and miscellaneous (unaffiliated) 4,870,550  18,452  (610,516) 4,278,486 
Parent, subsidiaries and affiliates 59,032  431  (5,631) 53,832 
Hybrid securities 170,313  51  (18,121) 152,243 
Mortgage-backed and asset-backed securities 1,554,062  2,962  (194,088) 1,362,936 
Total bonds $ 7,545,870  $ 23,883  $ (979,985) $ 6,589,768 
Preferred stock $ 50,783  $ 479  $ (2,550) $ 48,712 
Common stock $ 27,213   $   $   $ 27,213  

The gross unrealized capital gains (losses) on bonds and preferred stock were not reflected in surplus for the years ended December 31, 2023 and 2022.

The aging of temporarily impaired general account debt securities as of December 31, 2023 was as follows:

Less than 12 months Greater than 12 months Total
Fair
Value
Unrealized
Losses
Fair
Value
Unrealized
Losses
Fair
Value
Unrealized
Losses
Debt Securities
U.S. government $ 483  $ (69) $ 167,014  $ (73,042) $ 167,497  $ (73,111)
All other governments 11,583  (329) 70,368  (14,861) 81,951  (15,190)
States, territories and possessions 2,663  (291) 23,986  (2,287) 26,649  (2,578)
Political subdivisions 6,415  (451) 38,476  (4,498) 44,891  (4,949)
Special revenue 42,521  (3,100) 254,730  (34,290) 297,251  (37,390)
Industrial and miscellaneous (unaffiliated) 388,043  (58,285) 2,953,840  (385,163) 3,341,883  (443,448)
Parent, subsidiaries and affiliates 23,859  (1,296) 28,431  (4,255) 52,290  (5,551)
Hybrid securities 17,457  (2,087) 110,289  (9,258) 127,746  (11,345)
Mortgage-backed and asset-backed securities 195,894  (10,797) 954,632  (176,875) 1,150,526  (187,672)
Total bonds $ 688,918  $ (76,705) $ 4,601,766  $ (704,529) $ 5,290,684  $ (781,234)
Number of positions at unrealized loss 501  1,852  2,353 

The Company reported $6.5 million and $10.6 million of gross unrealized gains and $(9.4) million and $(0.1) million of gross unrealized losses related to common stock for the periods ended December 31, 2023 and 2022, respectively, which reflected the difference between cost and fair value for common stock. For the period ended December 31, 2023, the fair value of common stock securities in a continuous unrealized loss position for less than 12 months was $18.8 million with unrealized losses of $9.4 million and the fair value of common stock securities in a continuous unrealized loss position for greater than 12 months was $0 with unrealized losses of $0.


18


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
As of December 31, 2023, there are 71 below investment grade debt securities that have been in an unrealized loss position for greater than 12 months. Below investment grade unrealized losses greater than 12 months are $34.7 million. Securities in an unrealized loss position for over 12 months consisted of 1,852 securities. Unrealized losses were not recognized in earnings on these debt securities since the Company neither intends to sell the securities nor does it believe that it is more likely than not that it will be required to sell these securities before recovery of their amortized cost basis. Additionally, based on a security-by-security analysis, the Company expects to recover the entire amortized cost basis of these securities. In its evaluation of each security, management considered the actual recovery periods for these securities in previous periods of broad market declines. For securities with significant declines, individual security level analysis was performed, which considered any credit enhancements, expectations of defaults on underlying collateral and other available market data, including industry analyst reports and forecasts. Although there may be sustained losses for greater than 12 months on these securities, additional information was obtained related to company performance which did not indicate that the additional losses were other-than-temporary.

The aging of temporarily impaired general account debt securities as of December 31, 2022 was as follows:

Less than 12 months Greater than 12 months Total
Fair
Value
Unrealized
Losses
Fair
Value
Unrealized
Losses
Fair
Value
Unrealized
Losses
Debt Securities
U.S. government $ 80,084  $ (10,009) $ 87,540  $ (64,229) $ 167,624  $ (74,238)
All other governments 69,866  (11,187) 13,565  (5,412) 83,431  (16,599)
States, territories and possessions 24,533  (2,703) —  —  24,533  (2,703)
Political subdivisions 55,952  (7,191) —  —  55,952  (7,191)
Special revenue 307,480  (36,649) 34,218  (14,249) 341,698  (50,898)
Industrial and miscellaneous (unaffiliated) 3,487,828  (504,289) 328,394  (106,227) 3,816,222  (610,516)
Parents, subsidiaries and affiliates 34,841  (4,460) 15,783  (1,171) 50,624  (5,631)
Hybrid securities 109,364  (12,135) 36,325  (5,986) 145,689  (18,121)
Mortgage-backed and asset-backed securities
907,941  (101,721) 312,325  (92,367) 1,220,266  (194,088)
Total bonds $ 5,077,889  $ (690,344) $ 828,150  $ (289,641) $ 5,906,039  $ (979,985)
Number of positions at unrealized loss 2,309  483  2,792 

For the period ended December 31, 2022, the fair value of common stock securities in a continuous unrealized loss position for less than 12 months was $1.1 million with unrealized losses of $0.1 million and the fair value of common stock securities in a continuous unrealized loss position for greater than 12 months was $0 with unrealized losses of $0.

As of December 31, 2022, there are 37 below investment grade debt securities that have been in an unrealized loss position for greater than 12 months. Below investment grade unrealized losses greater than 12 months are $17.9 million. Securities in an unrealized loss position for over 12 months consisted of 483 securities. Unrealized losses were not recognized in earnings on these debt securities since the Company neither intends to sell the securities nor does it believe that it is more likely than not that it will be required to sell these securities before recovery of their amortized cost basis. Additionally, based on a security-by-security analysis, the Company expects to recover the entire amortized cost basis of these securities. In its evaluation of each security, management considered the actual recovery periods for these securities in previous periods of broad market declines. For securities with significant declines, individual security level analysis was performed, which considered any credit enhancements, expectations of defaults on underlying collateral and other available market data, including industry analyst reports and forecasts. Although there may be sustained losses for greater than 12 months on these securities, additional information was obtained related to company performance which did not indicate that the additional losses were other-than-temporary.


19


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The carrying value and fair value of bonds as of December 31, 2023 by maturity are shown below.

Carrying
Value
Fair
Value
Due in one year or less $ 137,767  $ 130,498 
Due after one year through five years 1,559,174  1,432,622 
Due after five years through ten years 1,288,754  1,216,474 
Due after ten years 4,007,727  3,472,922 
Total $ 6,993,422   $ 6,252,516  

Corporate bonds are shown based on contractual maturity or contractual sinking fund payments. Expected maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties, or NNY may have the right to put or sell the obligations back to the issuers. Mortgage-backed and asset-backed securities (“ABS”) are not due at a single maturity date and therefore are shown based on the expected cash flows of the underlying loans, which includes estimates of anticipated future prepayments.

The carrying value of OTTI securities was $13.7 million and $32.3 million as of December 31, 2023 and 2022, respectively. OTTIs were $18.4 million, $13.0 million and $27.8 million in 2023, 2022 and 2021, respectively.

Internal and external prepayment models, which are widely accepted by the industry, are used in calculating the effective yield used in determining the carrying value of mortgage-backed and asset-backed securities. The retrospective method is applied in determining the prepayment adjustment.

Loan-backed securities

The Company has elected to use the book value as of January 1, 1994 as the cost for applying the retrospective adjustment method to securities purchased prior to that date, where historical cash flows are not readily available.

Prepayment assumptions for loan-backed bonds and structured securities were obtained from industry prepayment models or internal estimates. These assumptions are consistent with current interest rates and the economic environment. The retrospective adjustment method is used to value these securities.

In 2023, 2022 and 2021, the Company had no OTTI recognized because the present value of cash flows expected to be collected is greater than the amortized cost basis of the securities.

Real estate

Real estate, which represents the home office used in Nassau’s operations, carried net of accumulated depreciation, as of December 31 is summarized below:

2023 2022
Real estate $ 27,446  $ 27,148 
Total real estate $ 27,446   $ 27,148  


20


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Mortgage loans

The Company invests in mortgage loans that are collateralized by commercial properties, including multi-family residential buildings, which are managed as a single class of commercial mortgage loans. Mortgage loans are stated at original cost, net of principal payments and amortization. The Company segregates its portfolio by property type and geographic location. As of December 31, 2023 and 2022, the Company had $517.6 million and $535.9 million, respectively, in mortgage loans. The allowance for loan losses at December 31, 2023 and 2022 were $1.8 million and 1.7 million, respectively.

The following tables reflect the distribution of mortgage loans by property type as of December 31:

2023 2022
(in millions)
Industrial $ 64.7  $ 60.1 
Multifamily 102.2  107.6 
Office 94.3  96.5 
Retail 130.0  133.5 
Self-storage 50.3  49.7 
Warehouse 45.4  46.0 
Other 32.5  44.2 
Total mortgage loans 519.4  537.6 
Less: Allowance for loan losses 1.8  1.7 
Net mortgage loans $ 517.6   $ 535.9  

The following tables reflect the distribution of mortgage loans by geographic region as of December 31:

2023 2022
(in millions)
East North Central $ 64.6  $ 76.6 
Middle Atlantic 15.0  17.5 
Mountain 82.9  83.8 
New England 15.2  15.4 
Pacific 124.9  133.1 
South Atlantic 115.9  118.4 
West North Central 51.4  52.4 
West South Central 49.5  40.4 
Total mortgage loans 519.4  537.6 
Less: Allowance for loan losses 1.8  1.7 
Net mortgage loans $ 517.6   $ 535.9  


21


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The following tables summarize the Company’s commercial mortgage loan portfolio, net of allowance, loan-to-value (“LTV”) ratios and debt-service coverage (“DSC”) ratios using available data as of December 31. The ratios are updated as information becomes available.

December 31, 2023
DSC Ratios
($ in millions) Greater
than 2.0x
1.8x to
2.0x
1.5x to
1.8x
1.2x to
1.5x
1.0x to
1.2x
Less than
1.0x
Total
LTV Ratios
0% - 50% $ 146.6  $ —  $ 36.7  $ —  $ —  $ —  $ 183.3 
50% - 60% 40.8  18.2  34.8  36.7  —  —  130.5 
60% - 70% 48.4  13.5  21.4  36.2  —  —  119.5 
70% - 80% 20.7  —  24.0  5.9  —  10.5  61.1 
80% and greater 2.7  —  6.3  8.5  —  5.7  23.2 
Total $ 259.2  $ 31.7  $ 123.2  $ 87.3  $   $ 16.2  $ 517.6 

December 31, 2022
DSC Ratios
($ in millions) Greater
than 2.0x
1.8x to
2.0x
1.5x to
1.8x
1.2x to
1.5x
1.0x to
1.2x
Less than
1.0x
Total
LTV Ratios
0% - 50% $ 155.3  $ 26.8  $ 23.0  $ 4.9  $ —  $ —  $ 210.0 
50% - 60% 39.0  34.2  52.8  20.1  12.5  —  158.6 
60% - 70% 33.3  6.5  21.9  13.4  14.5  10.4  100.0 
70% - 80% —  —  39.5  —  5.9  10.8  56.2 
80% and greater —  —  —  —  8.3  2.8  11.1 
Total $ 227.6  $ 67.5  $ 137.2  $ 38.4  $ 41.2  $ 24.0  $ 535.9 

LTV and DSC ratios are measures frequently used in commercial real estate to determine the quality of a mortgage loan. The LTV ratio is a comparison between the current loan balance and the value assigned to the property and is expressed as a percentage. If the LTV is greater than 100%, this would indicate that the loan amount exceeds the value of the property.

The DSC ratio compares the property’s net operating income to its mortgage debt service payments. If the DSC ratio is less than 1.0x, this would indicate that the property is not generating enough income after expenses to cover the mortgage payment. Therefore, a higher DSC ratio could indicate a better quality loan.

To monitor credit quality, the Company primarily uses RBC code, which is the risk category used in the RBC calculation that is based on debt service coverage ratio and loan-to-value. The codes range from CM1 to CM7, with CM1 being the most stable. The Company holds $405.0 million CM1 loans, $114.4 million CM2 loans and $0 CM3 loans as of December 31, 2023. The Company held $415.2 million CM1 loans, $103.5 million CM2 loans and $18.8 million CM3 loans as of December 31, 2022. The maximum percentage of any one loan to the value of the collateral security at the time of the loan, exclusive of insured, guaranteed or purchase money mortgages, acquired during 2023 and 2022 was 59.1% and 68.8%, respectively. As of December 31, 2023 and 2022, all loans were current.

During 2023, the minimum and maximum lending rates for mortgage loans were 3.2% and 6.3% respectively. There were no taxes, assessments, or amounts advanced not included in the mortgage loan total. There were no impairments on mortgage loans or any loans derecognized as a result of foreclosure for the years ended December 31, 2023, 2022 and 2021.


22


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Other invested assets

Other invested assets as of December 31 are summarized below:

2023 2022
Private equity $ 33,544  $ 21,853 
Mezzanine partnerships 2,132  2,300 
Collateralized fund obligation 36,523  47,083 
Mortgage and real estate 41,964  22,386 
Direct equity 116,922  122,991 
Credit funds 23,779  19,259 
Surplus debentures
100,113  99,157 
Residual tranches
88,183  112,548 
Other alternative assets 2,587  — 
Total other invested assets $ 445,747   $ 447,577  

The Company has unfunded commitments related to its investments in limited partnerships in the amount of $104.9 million and $122.8 million as of December 31, 2023 and 2022, respectively. The Company has no investments in joint ventures, partnerships or limited liability companies that exceed 10% of its admitted assets.

Derivative instruments

Derivative instruments as of December 31 are summarized below:

2023 2022
(in thousands)
Put options:
Notional amount $ 210,413  $ — 
Fair value $ 3,232  $ — 
Carrying value $ 3,232  $ — 
Swaps:
Notional amount $ 900,000  $ 300,000 
Fair value $ (49,529) $ (57,720)
Carrying value $ 500  $ — 
Foreign currency forwards:
Notional amount $ 18,423  $ 11,199 
Fair value $ (185) $ (81)
Carrying value $ (185) $ (81)

NNY is exposed to credit risk in the event of nonperformance by counterparties to these financial instruments. NNY does not expect its counterparties to fail to meet their financial obligations because the Company contracts with highly rated counterparties. The credit exposure of these instruments is the positive market value at the reporting date. Management of NNY considers the likelihood of any material loss due to credit risk on these guarantees, interest rate swaps or floors to be remote.


23


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Offsetting and netting of assets and liabilities

For the year ended December 31, 2023, the Company had net derivative assets of $3.5 million, which represented $57.0 million of gross derivative assets offset by $53.5 million in derivative liabilities.

Restricted assets

Restricted assets (including pledged) relate mainly to statutory requirements of various jurisdictions, FHLB Stock and derivative collateral. Restricted assets were $488.4 million and $82.7 million as of December 31, 2023 and 2022, respectively. These are included as assets on the Statements of Admitted Assets, Liabilities, Capital and Surplus.

The Company is a member of the FHLB of Boston. Membership with the FHLB is part of the Company’s strategy to access funds to support various spread-based businesses and enhance liquidity management. The Company has determined the estimated maximum borrowing capacity as $714.7 million. The Company calculated this amount in accordance with New York Consolidated Laws, Insurance Law - ISC § 1411 Authorization of, and Restrictions on, 1nvestments, whereby the loan shall not exceed, when the loan is made, 5% of its admitted assets as shown by its last sworn statement to the superintendent.

5GI Securities

NAIC 5GI is assigned by an insurance company to certain obligations that meet all of the following criteria: (1) documentation necessary to permit a full credit analysis of a security by the NAIC Securities Valuation Office (“SVO”) does not exist or an NAIC Credit Rating Provider (“CRP”) credit rating for a Filing Exemption (“FE”) or Private Letter (“PL”) security is not available; and (2) the issuer or obligor is current on all contracted interest and principal payments; and (3) the insurer has an actual expectation of ultimate payment of all contracted interest and principal.

5GI securities as of December 31 are summarized below:

Number of 5GI Securities
Aggregate BACV*
Aggregate Fair Value
Current
Year
Prior
Year
Current
Year
Prior
Year
Current
Year
Prior
Year
Investment
(1) Bonds - Amortized Cost $ 10,422  $ 16,114  $ 10,250  $ 16,114 
(2) Loan-backed and structured securities
         - Amortized Cost
—  —  —  —  —  — 
(3) Preferred Stock - Amortized Cost 1,338  1,338  2,006  1,818 
(4) Preferred Stock - Fair Value 3,887  4,628  3,887  4,628 
(5) Total (1+2+3+4) 14  10  $ 15,647   $ 22,080   $ 16,143   $ 22,560  
———————
*Book Adjusted Carrying Value

Investments in subsidiaries

In 2023, the Company formed two new subsidiaries, Nassau Life Insurance Company ABS A-I LLC and Nassau Life Insurance Company ABS B-I LLC (“ABS B”). NNY funded and filed a Sub-1 filing with the NAIC for ABS A. The NAIC accepted that filing and completed review on January 19, 2024. The Company admitted $105.3 million within common stock based on the underlying GAAP equity for ABS A as of December 31, 2023. ABS B was not funded and has no underlying value ascribed to it. No subsidiary equity for ABS B was admitted as of December 31, 2023.

The Company has three other subsidiaries, PM Holdings, Nassau 2019 CFO LLC and Foresters Financial Holding Company, Inc., with no underlying value ascribed to them and no subsidiary equity was admitted as of December 31, 2023 and 2022 for these three companies.

24


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Concentration of credit risk of financial instruments

Credit exposure related to issuers and derivatives counterparties is inherent in investments and derivative contracts with positive fair value or asset balances. The Company manages credit risk through the analysis of the underlying obligors, issuers and transaction structures. The Company reviews its debt security portfolio regularly to monitor the performance of obligors and assess the stability of their credit ratings. The Company also manages credit risk through industry and issuer diversification and asset allocation. The Company classifies debt securities into investment grade and below-investment-grade securities based on ratings prescribed by the NAIC. In a majority of cases, these classifications will coincide with ratings assigned by one or more Nationally Recognized Statistical Rating Organizations (“NRSRO”); however, for certain structured securities, the NAIC designations may differ from NRSRO designations based on the amortized cost of the securities in its portfolio. Maximum exposure to an issuer or derivative counterparty is defined by quality ratings, with higher quality issuers having larger exposure limits. As of December 31, 2023, the Company was not exposed to the credit concentration risk of any issuer other than U.S. government and government agencies backed by the faith and credit of the U.S. government, defined as exposure greater than 10% of total admitted assets. The top five largest exposures were The Goldman Sachs Group, Inc., Wells Fargo & Company, Bank of America Corporation, Oracle Corporation and Anheuser-Busch Company. The Company monitors credit exposures by actively monitoring dollar limits on transactions with specific counterparties. The Company has an overall limit on below-investment-grade rated issuer exposure. Additionally, the creditworthiness of counterparties is reviewed periodically. The Company uses ISDA Master Agreements with derivative counterparties which may include Credit Support Annexes with collateral provisions to reduce counterparty credit exposures. To further mitigate the risk of loss on derivatives, the Company only enters into contracts in which the counterparty is a financial institution with a rating of A or higher from at least one NRSRO.

Net investment income

The principal components of net investment income for the years ended December 31 were as follows:

2023 2022 2021
Bonds $ 337,372  $ 337,779  $ 367,058 
Contract loans 208,166  214,940  198,388 
Cash and short-term investments 11,766  4,532  931 
Real estate, net of expenses 4,852  4,676  5,266 
Preferred stock 2,128  2,810  3,806 
Common stock 743  362  3,032 
Mortgage loans 21,019  26,159  24,429 
Other invested assets 38,680  58,394  133,942 
Derivative instruments (14,469) (1,796) 2,335 
Amortization of IMR 8,461  16,449  18,191 
Less:
Interest expense 9,086  9,086  9,086 
Other investment expenses 31,508  33,250  30,017 
Net investment income $ 578,124   $ 621,969   $ 718,275  

For the year ended December 31, 2023, the Company had 0 securities called or redeemed by the issuer, resulting in income from prepayment penalties and acceleration fees of $0. For the year ended December 31, 2022, the Company had 17 securities called or redeemed by the issuer, resulting in income from prepayment penalties and acceleration fees of $0.5 million. For the year ended December 31, 2021, the Company had 42 securities called or redeemed by the issuer, resulting in income from prepayment penalties and acceleration fees of $5.8 million.


25


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Capital gains and losses

The principal components of realized gains (losses) and changes in unrealized capital gains (losses) on investments for the years ended December 31 were as follows:

Realized Change in Unrealized
2023 2022 2021 2023 2022 2021
Bonds $ (20,684) $ (5,391) $ (13,302) $ 278  $ 4,676  $ (580)
Investments in affiliates —  —  —  2,987  —  — 
Preferred stock (1,017) (3,452) 693  1,600  (6,380) 3,351 
Common stock 2,072  24,850  896  320  (15,063)
Mortgage loans (1,442) (65) (24) —  —  — 
Other invested assets (10,794) 19,259  (9,897) (16,381) (72,232) 17,690 
Derivative instruments (181) 900  (1,944) (2,167) 20  (102)
Miscellaneous 387  52  226  697  —  — 
(33,723) 13,375  602  (12,090) (73,596) 5,296 
Income tax benefit (expense) (6,827) (32) (3,982) 3,945  15,455  (1,112)
Net capital gains (losses) $ (40,550) $ 13,343   $ (3,380) $ (8,145) $ (58,141) $ 4,184  

Realized losses for 2023 include other-than-temporary impairments of $18.4 million, including impairments on bonds of $16.0 million, preferred stock of $0.5 million and other invested assets of $1.9 million. Realized losses for 2022 include other-than-temporary impairments of $13.0 million, including impairments on bonds of $3.1 million, common stock of $1.9 million, preferred stock of $3.3 million and other invested assets of $4.8 million. Realized losses for 2021 include other-than-temporary impairments of $27.8 million, including impairments on bonds of $14.4 million, common stock of $1.7 million, preferred stock of $1.9 million and other invested assets of $9.9 million.

The proceeds and related gross realized gains and losses from sales of stocks and bonds for the years ended December 31 were as follows:

2023 2022 2021
Proceeds from sales $ 855,975  $ 1,119,452  $ 1,673,662 
Gross gains on sales 4,484  25,382  98,873 
Gross losses on sales (63,087) (27,092) 39,031 



26


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
5.    Reserves for Future Policy Benefits and Reinsurance

The balances for NNY’s major categories of reserves for future policy benefits as of December 31 are summarized below:

2023 2022
Life insurance $ 9,082,502  $ 9,273,899 
Health insurance 30,560  34,213 
Total life and health insurance 9,113,062  9,308,112 
Annuities 1,020,376  1,189,760 
Subtotal 10,133,438  10,497,872 
Supplementary contracts with life contingencies 134,383  136,401 
All other 82,000  160,936 
Total before reinsurance ceded 10,349,821  10,795,209 
Less: Reinsurance ceded 984,861  991,123 
Reserves for future policy benefits $ 9,364,960   $ 9,804,086  

NNY waives deduction of deferred fractional premiums upon death of the insured and returns any portion of the final premium beyond date of death. Surrender values promised in excess of legally computed reserves have been included in miscellaneous reserves.

For a policy on which the substandard extra premium is based upon a multiple of standard mortality, the substandard extra reserve is based upon the excess of such multiple over standard mortality. For a policy carrying a flat extra premium, the extra reserve is one half of the flat extra premium.

As of December 31, 2023 and 2022, the Company had $1.8 billion and $1.9 billion, respectively, of life insurance in force for which the gross premiums are less than the net premiums according to the standard of valuation set by the Department. As of December 31, 2023 and 2022, the Company carried an associated reserve of $45.3 million and $48.3 million, respectively, included in reserves for future policy benefits. Anticipated investment income was utilized in the calculation.

Tabular cost has been determined from the basic data for the calculation of policy reserves. Tabular less actual reserves released has been determined from the basic data for the calculation of reserves and reserves released. Tabular interest has been determined from the basic data for the calculation of policy reserves.

As of December 31, 2023 and 2022, there were $82.0 million and $116.9 million, respectively, of cash flow testing reserves from asset adequacy testing in the general account. Of those amounts, $37.0 million was ceded as of December 31, 2023 and 2022. In addition, there were $15.0 million of cash flow testing reserves resulting from asset adequacy testing in the separate account as of December 31, 2023 and 2022.

In 2021, NNY updated its reserve methodology for a subset of payout annuities issued by FLIAC to increase the statutory valuation interest rates to equal allowable maximums, which resulted in a beginning reserve reduction of $18.1 million. NNY also updated its mortality method for the same subset of payout annuities, which resulted in a beginning reserve increase of $3.2 million. The net $14.9 million reduction in beginning reserves was recorded as a change in reserve basis included in other surplus changes, net for the year ended December 31, 2021.


27


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Withdrawal characteristics

Withdrawal characteristics of annuity actuarial reserves and deposit liabilities as of December 31 were as follows:

2023
General
Account
Separate
Account
with
Guarantees
Separate
Account
Non-
guaranteed
Total % of total
Individual Annuities
Subject to discretionary withdrawal:
- with market value adjustment $ 73,570  $ 205,691  $ —  $ 279,261  11  %
- at book value less surrender charge of 5% or more 4,335  —  —  4,335  —  %
- at market value —  —  1,056,105  1,056,105  44  %
Total with market value adjustment or at fair value 77,905  205,691  1,056,105  1,339,701  55  %
- at book value (minimal or no charge or adjustment) 693,135  —  —  693,135  28  %
Not subject to discretionary withdrawal 394,901  15,000  8,936  418,837  17  %
Total individual annuity actuarial reserves 1,165,941  220,691  1,065,041  2,451,673  100  %
Less: Reinsurance ceded 10,457  —  —  10,457 
Total individual annuity actuarial reserves,
  net of reinsurance
$ 1,155,484  $ 220,691  $ 1,065,041  $ 2,441,216 
Amounts included in at book value less surrender charge of
  5% or more that will move to at book value (minimal or no
  charge or adjustment) for the first time within the year after
  the statement date
$ 1,212  $ —  $ —  $ 1,212 

2022
General
Account
Separate
Account
with
Guarantees
Separate
Account
Non-
guaranteed
Total % of total
Individual Annuities
Subject to discretionary withdrawal:
- with market value adjustment $ 29,102  $ 247,727  $ —  $ 276,829  11  %
- at book value less surrender charge of 5% or more 31,877  —  —  31,877  %
- at market value —  —  1,094,042  1,094,042  42  %
Total with market value adjustment or at fair value 60,979  247,727  1,094,042  1,402,748  54  %
- at book value (minimal or no charge or adjustment) 873,828  —  —  873,828  33  %
Not subject to discretionary withdrawal 326,307  —  7,702  334,009  13  %
Total individual annuity actuarial reserves 1,261,114  247,727  1,101,744  2,610,585  100  %
Less: Reinsurance ceded 7,798  —  —  7,798 
Total individual annuity actuarial reserves,
  net of reinsurance
$ 1,253,316  $ 247,727  $ 1,101,744  $ 2,602,787 
Amounts included in at book value less surrender charge of
  5% or more that will move to at book value (minimal or no
  charge or adjustment) for the first time within the year after
  the statement date
$ 27,933  $ —  $ —  $ 27,933 


28


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
2023
General
Account
Separate
Account
with
Guarantees
Separate
Account
Non-guaranteed
Total % of total
Group Annuities
Subject to discretionary withdrawal:
- with market value adjustment $ —  $ —  $ —  $ —  —  %
- at book value less surrender charge of 5% or more —  —  —  —  —  %
- at market value —  —  295  295  %
Total with market value adjustment or at fair value —  —  295  295  %
- at book value (minimal or no charge or adjustment) 13,322  —  —  13,322  39  %
Not subject to discretionary withdrawal 20,497  —  —  20,497  60  %
Total group annuity actuarial reserves 33,819    295  34,114  100  %
Less: Reinsurance ceded —  —  —  — 
Total group annuity actuarial reserves,
  net of reinsurance
$ 33,819   $   $ 295   $ 34,114  

2022
General
Account
Separate
Account
with
Guarantees
Separate
Account
Non-guaranteed
Total % of total
Group Annuities
Subject to discretionary withdrawal:
- with market value adjustment $ —  $ —  $ —  $ —  —  %
- at book value less surrender charge of 5% or more —  —  —  —  —  %
- at market value —  —  411  411  %
Total with market value adjustment or at fair value —  —  411  411  %
- at book value (minimal or no charge or adjustment) 15,005  —  —  15,005  40  %
Not subject to discretionary withdrawal 21,750  —  —  21,750  59  %
Total group annuity actuarial reserves 36,755    411  37,166  100  %
Less: Reinsurance ceded —  —  —  — 
Total group annuity actuarial reserves,
  net of reinsurance
$ 36,755   $   $ 411   $ 37,166  

2023
General
Account
Separate
Account
with
Guarantees
Separate
Account
Non-guaranteed
Total % of total
Deposit-Type Contracts (no life contingencies)
Subject to discretionary withdrawal:
- with market value adjustment $ —  $ —  $ —  $ —  —  %
- at book value less surrender charge of 5% or more —  —  —  —  —  %
- at market value —  —  954  954  —  %
Total with market value adjustment or at fair value —  —  954  954  —  %
- at book value (minimal or no charge or adjustment) 329,236  —  —  329,236  54  %
Not subject to discretionary withdrawal 276,563  —  —  276,563  46  %
Total deposit fund liabilities 605,799    954  606,753  100  %
Less: Reinsurance ceded —  —  —  — 
Total deposit fund liabilities, net of reinsurance $ 605,799   $   $ 954   $ 606,753  


29


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
2022
General
Account
Separate
Account
with
Guarantees
Separate
Account
Non-guaranteed
Total % of total
Deposit-Type Contracts (no life contingencies)
Subject to discretionary withdrawal:
- with market value adjustment $ —  $ —  $ —  $ —  —  %
- at book value less surrender charge of 5% or more —  —  —  —  —  %
- at market value —  —  863  863  —  %
Total with market value adjustment or at fair value —  —  863  863  —  %
- at book value (minimal or no charge or adjustment) 387,219  —  —  387,219  94  %
Not subject to discretionary withdrawal 24,625  —  —  24,625  %
Total deposit fund liabilities 411,844    863  412,707  100  %
Less: Reinsurance ceded —  —  —  — 
Total deposit fund liabilities, net of reinsurance $ 411,844   $   $ 863   $ 412,707  

Reconciliation of total annuity actuarial reserves and deposit fund liabilities for the year ended December 31, 2023:

Amount
Life and Accident & Health Annual Statement:
Exhibit 5, Annuities section, total (net) $ 1,054,920 
Exhibit 5, Supplementary contracts with life contingencies section, total (net) 134,383 
Exhibit 7, Deposit-type contracts, line 14, column 1 605,799 
Subtotal 1,795,102 
Separate Accounts Annual Statement:
Exhibit 3, Line 0299999, column 2 1,277,497 
Exhibit 3, Line 0399999, column 2 8,530 
Policyholder dividend and coupon accumulations — 
Policyholder premiums — 
Guaranteed interest contracts — 
Other deposit funds 954 
Subtotal 1,286,981 
Combined total $ 3,082,083  


30


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Withdrawal characteristics of life actuarial reserves as of December 31, 2023 were as follows:

General Account Separate Account - Non-guaranteed
Account
Value
General
Account
Cash Value
Reserve Account
Value
Cash
Value
Reserve
Subject to discretionary withdrawal,
surrender values or policy loans:
- Term policies with cash value $ 2,148  $ 2,148  $ 9,478  $ —  $ —  $ — 
- Universal life 596,660  598,272  625,284  —  —  — 
- Universal life with secondary guarantees 186,307  179,703  683,302  —  —  — 
- Indexed universal life —  —  —  —  —  — 
- Indexed universal life with secondary
guarantees
—  —  —  —  —  — 
- Indexed life —  —  —  —  —  — 
- Other permanent cash value life insurance 7,096,967  7,094,187  7,392,133  —  —  — 
- Variable life 87,020  87,022  100,746  898,049  891,216  892,429 
- Variable universal life 82,716  82,710  83,211  800,413  787,136  788,763 
- Miscellaneous reserves 1,068  1,068  1,243  —  —  — 
Not subject to discretionary withdrawal,
with no cash value:
- Term policies without cash value XXX XXX 101,076  XXX XXX — 
- Accidental death benefits XXX XXX 468  XXX XXX — 
- Disability-active lives XXX XXX 6,136  XXX XXX — 
- Disability-disabled lives XXX XXX 16,663  XXX XXX — 
- Miscellaneous reserves XXX XXX 99,760  XXX XXX — 
Total (gross: direct + assumed) 8,052,886  8,045,110  9,119,500  1,698,462  1,678,352  1,681,192 
Less: Reinsurance ceded 343,805  337,512  943,844  —  —  — 
Total, net $ 7,709,081   $ 7,707,598   $ 8,175,656   $ 1,698,462   $ 1,678,352   $ 1,681,192  


31


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Withdrawal characteristics of life actuarial reserves as of December 31, 2022 were as follows:

General Account Separate Account - Non-guaranteed
Account
Value
General
Account
Cash Value
Reserve Account
Value
Cash
Value
Reserve
Subject to discretionary withdrawal,
surrender values or policy loans:
- Term policies with cash value $ 1,741  $ 1,741  $ 9,047  $ —  $ —  $ — 
- Universal life 644,858  643,540  670,901  —  —  — 
- Universal life with secondary guarantees 188,800  179,810  666,234  —  —  — 
- Indexed universal life —  —  —  —  —  — 
- Indexed universal life with secondary
guarantees
—  —  —  —  —  — 
- Indexed life —  —  —  —  —  — 
- Other permanent cash value life insurance 7,277,478  7,273,442  7,585,497  —  —  — 
- Variable life 86,040  85,422  98,709  842,012  835,864  836,363 
- Variable universal life 84,845  84,393  85,774  705,274  690,350  693,058 
- Miscellaneous reserves 1,024  1,024  1,199  —  —  — 
Not subject to discretionary withdrawal,
with no cash value:
- Term policies without cash value XXX XXX 107,382  XXX XXX — 
- Accidental death benefits XXX XXX 512  XXX XXX — 
- Disability-active lives XXX XXX 6,880  XXX XXX — 
- Disability-disabled lives XXX XXX 19,429  XXX XXX — 
- Miscellaneous reserves XXX XXX 103,340  XXX XXX — 
Total (gross: direct + assumed) 8,284,786  8,269,372  9,354,904  1,547,286  1,526,214  1,529,421 
Less: Reinsurance ceded 352,795  344,436  949,115  —  —  — 
Total, net $ 7,931,991   $ 7,924,936   $ 8,405,789   $ 1,547,286   $ 1,526,214   $ 1,529,421  

Reconciliation of total life insurance reserves for the year ended December 31, 2023:

Amount
Exhibit 5, Life insurance section, total (net) $ 8,136,474 
Exhibit 5, Accidental death benefits section, total (net) 468 
Exhibit 5, Disability active lives section, total (net) 5,927 
Exhibit 5, Disability disabled lives section, total (net) 11,749 
Exhibit 5, Miscellaneous reserves section, total (net) 21,038 
Subtotal 8,175,656 
Separate Accounts Annual Statement:
Exhibit 3, Line 0299999, column 2 1,681,192 
Exhibit 3, Line 0399999, column 2 — 
Exhibit 3, Line 0599999, column 2 — 
Subtotal 1,681,192 
Combined total $ 9,856,848  


32


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Reinsurance with unauthorized companies

NNY has ceded insurance liabilities to insurers not licensed in the State of New York. To the extent such liabilities are not collateralized, New York insurance regulators require the establishment of a liability through a charge to surplus equal to the ceded liabilities placed with such companies. These liabilities were $27.4 million and $7.2 million as of December 31, 2023 and 2022, respectively, and are included in accrued expenses and general liabilities.

On July 18, 2023, Scottish Re (US), Inc. (“SRUS”) was ordered into liquidation by the State of Delaware. As a result of the Liquidation Order, all reinsurance agreements in which SRUS was the reinsurer were terminated on September 30, 2023. As a result, management recorded an impairment of $1.8 million on net claims recoverable from SRUS. As a result of the SRUS termination, the Company recaptured the associated SRUS treaties. The related reserve credit in the amount of $4.5 million was reduced to $0 as of the termination date .

Reinsurance agreements with affiliates

An affiliate, PHL Variable Insurance Company (“PHL”) has a treaty in force with the Company, whereby NNY has assumed, on a 90% coinsurance basis, all Phoenix Accumulator Universal Life III and IV sold by PHL from January 1 to December 31, 2008. The reserves ceded to NNY for these policies were $56.4 million and $58.9 million at December 31, 2023 and 2022, respectively.

Effective June 30, 2015, the Company entered into a MODCO reinsurance agreement with PHL. This agreement provides that the Company retrocedes, and PHL reinsures, 80% of the inforce group executive ordinary (“GEO”) corporate-owned whole life insurance policies assumed by the Company from a third-party. Under MODCO, the assets, which are equal to the statutory reserves held for the reinsured policies, and liabilities associated with the assumed business are retained by the Company. The MODCO reserves under this treaty were $1.3 billion and $1.2 billion as of December 31, 2023 and 2022, respectively.

Direct business written and reinsurance assumed and ceded

As is customary practice in the insurance industry, NNY assumes and cedes reinsurance as a means of diversifying underwriting risk.

NNY’s reinsurance program varies based on the type of risk, for example:

For business sold prior to December 31, 2010, the Company’s retention limit on any one life is $10 million for single life and joint first-to-die policies and $12 million for joint last-to-die policies. Beginning January 1, 2011, the Company’s retention limit on new business is $5 million for single life and joint first-to-die policies and $6 million for second-to-die policies.
NNY cedes up to 80% on policies in its term life insurance.
Under one DLNY premerger reinsurance agreement, certain of DLNY universal life insurance policies acquired are reinsured on a coinsurance and funds held coinsurance basis. The Company had liabilities for the funds held under this treaty of $160.8 million and $160.4 million as of December 31, 2023 and 2022, respectively. Pursuant to another DLNY premerger reinsurance agreement, the Company ceded 100% of the liabilities under its DLNY group insurance policies on an indemnity coinsurance basis.


33


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Additional information on direct business written and reinsurance assumed and ceded for the years ended December 31 is set forth below:

2023 2022 2021
Direct premiums and annuity considerations $ 417,539  $ 390,010  $ 402,797 
Reinsurance assumed - non-affiliate 6,145  7,376  8,375 
Reinsurance assumed - affiliate 33,536  25,754  26,752 
Reinsurance ceded - non-affiliate (110,154) (112,450) (122,583)
Reinsurance ceded - affiliate (3,864) (4,872) (5,771)
Net premiums and annuity considerations $ 343,202  $ 305,818  $ 309,570 
Direct commissions and expense allowance $ 8,528  $ 6,962  $ 8,689 
Reinsurance assumed - non-affiliate 269  310  314 
Reinsurance assumed - affiliate 5,729  4,857  5,052 
Reinsurance ceded - non-affiliate (4,256) (5,300) (5,520)
Reinsurance ceded - affiliate (9,781) (9,410) (8,912)
Net commissions and expense allowance $ 489  $ (2,581) $ (377)
Direct policy and contract claims incurred $ 822,123  $ 738,534  $ 715,007 
Reinsurance assumed - non-affiliate 108,548  102,812  30,373 
Reinsurance assumed - affiliate 35,563  20,736  29,565 
Reinsurance ceded - non affiliate (221,766) (218,116) (196,162)
Reinsurance ceded - affiliate (82,755) (81,636) (23,340)
Net policy and contract claims incurred $ 661,713  $ 562,330  $ 555,443 
Direct policy and contract claims payable $ 158,453  $ 109,755 
Reinsurance assumed - non-affiliate 59,323  37,087 
Reinsurance assumed - affiliate 1,483  793 
Reinsurance ceded - non-affiliate (20,334) (31,460)
Net policy and contract claims payable $ 198,925  $ 116,175 
Direct life insurance in force $ 29,778,130  $ 32,184,980 
Reinsurance assumed 3,002,453  3,036,110 
Reinsurance ceded (12,733,268) (14,055,740)
Net insurance in force $ 20,047,315   $ 21,165,350  

In the event all reinsurance agreements were to be terminated, the Company estimates the aggregate reduction in surplus would be $15.1 million, $78.3 million and $89.0 million for the years ended December 31, 2023, 2022 and 2021, respectively.


34


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Change in incurred losses and loss adjustment expenses

Reserves on Group Accident and Health policies were $15.7 million as of December 31, 2020. As of December 31, 2021, $2.3 million has been paid for incurred losses attributable to insured events of prior years. Reserves remaining for prior years are now $14.2 million as a result of unpaid claims principally on the Group Accident and Health line of business. Therefore, there has been $0.8 million of favorable prior year development since December 31, 2020. Increases or (decreases) are generally the result of ongoing analysis of recent loss development trends. Original estimates are increased or decreased as additional information becomes known regarding individual claims.

Reserves on Group Accident and Health policies were $14.2 million as of December 31, 2021. As of December 31, 2022, $0.9 million has been paid for incurred losses attributable to insured events of prior years. Reserves remaining for prior years are now $14.0 million as a result of unpaid claims principally on the Group Accident and Health line of business. Therefore, there has been $0.7 million of unfavorable prior year development since December 31, 2021. Increases or (decreases) are generally the result of ongoing analysis of recent loss development trends. Original estimates are increased or decreased as additional information becomes known regarding individual claims.

Reserves on Group Accident and Health policies were $14.0 million as of December 31, 2022. As of December 31, 2023, $0.8 million has been paid for incurred losses attributable to insured events of prior years. Reserves remaining for prior years are now $14.7 million as a result of unpaid claims principally on the Group Accident and Health line of business. Therefore, there has been $1.5 million of unfavorable prior year development since December 31, 2022. Increases or (decreases) are generally the result of ongoing analysis of recent loss development trends. Original estimates are increased or decreased as additional information becomes known regarding individual claims.

FHLB

The Company is a member of the FHLB of Boston. In 2023, NNY issued funding agreements to the FHLB of Boston to support various spread-based businesses. The funding agreements are issued through the general account and are included in the liability for Policyholders’ funds in the accompanying Statements of Admitted Assets, Liabilities, Capital and Surplus. When a funding agreement is issued, the Company is required to post collateral in the form of eligible securities for each of the advances received. Upon any event of default by the Company, the FHLB of Boston’s recovery on the collateral is limited to the amount of the Company’s liability to the FHLB of Boston.

The amount of FHLB of Boston common stock held, in aggregate, exclusively in the Company’s general account at December 31, 2023 and 2022 was as follows:

2023 2022
Membership stock - class B [1]
$ 5.0  $ 5.0 
Activity stock
11.3  — 
Aggregate total
$ 16.3  $ 5.0 
Actual or estimated borrowing capacity as determined by the insurer
$ 714.7  $ 644.5 
———————
[1]Membership stock is not eligible for redemption.


35


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The amount of collateral pledged to the FHLB of Boston in the Company’s general account at December 31, 2023 and 2022 was as follows:

2023 2022
Fair value
$ 385.5  $ — 
Carrying value
$ 403.6  $ — 
Aggregate total borrowing $ 252.9  $ — 

The maximum amount of collateral pledged and aggregate total borrowing to the FHLB of Boston in the Company’s general account during the years ended December 31, 2023 and 2022 was as follows:

2023 2022
Fair value
$ 385.5  $ 4.8 
Carrying value
$ 445.9  $ 4.8 
Aggregate total borrowing $ 272.9  $ — 

The following table reflects the amount borrowed from the FHLB of Boston in the form of funding agreements or debt at December 31, 2023 and 2022:

2023 2022
Funding agreements issued
$ 252.9  $ — 
Funding agreements reserves established
$ 254.1  $ — 
Maximum amount of funding agreements borrowed during the year
$ 252.9  $ — 
Maximum amount of debt borrowed during the year
$ 252.9  $ 4.8 

The Company does not have any prepayment obligations for these funding agreement arrangements.


6.    Leases and Rentals

Rental expense for operating leases, principally with respect to office equipment and office space, amounted to $0.6 million, $0.7 million and $0.8 million in 2023, 2022 and 2021, respectively. Future minimum rental payments under non-cancelable operating leases were approximately $0.3 million as of December 31, 2023, payable as follows: 2024 - $0.3 million; 2025 - $0; 2026 - $0; 2027 - $0 and 2028 - $0.


7.    Electronic Data Processing Equipment

Electronic data processing (“EDP”) equipment and software, gross, as of December 31, 2023 and 2022 was $34.5 million and $34.2 million, respectively. EDP accumulated depreciation as of December 31, 2023 and 2022 was $34.2 million and $34.2 million, respectively. Depreciation for the year ended December 31, 2023, 2022 and 2021 was $0, $0 and $1.9 million, respectively. EDP equipment and software are depreciated over 3 to 7 years, using the straight-line and method. Non-admitted EDP equipment totaled $0.4 million and $0 as of December 31, 2023 and 2022, respectively.



36


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
8.    Furniture and Fixtures

Furniture and equipment cost as of December 31, 2023 and 2022 was $5.0 million and $5.0 million, respectively. Accumulated depreciation as of December 31, 2023 and 2022 was $5.0 million and $4.9 million, respectively. Depreciation for the years ended December 31, 2023, 2022 and 2021 was $0, $0.1 million and $0.1 million, respectively. Non-admitted furniture and equipment totaled $0 and $0.1 million as of December 31, 2023 and 2022, respectively.

Depreciation or amortization periods are generally 7 to 39 years for furniture and equipment, leasehold improvements, and building improvements. Depreciation or amortization is generally calculated using the straight-line method.


9.    Premium and Annuity Considerations Deferred and Uncollected

Deferred and uncollected life insurance premiums and annuity considerations as of December 31, 2023 were as follows:

Type of Business Gross Net of Loading
Ordinary new $ 110  $ 103 
Ordinary renewal 59,745  59,061 
Total $ 59,855   $ 59,164  

Deferred and uncollected life insurance premiums and annuity considerations as of December 31, 2022 were as follows:

Type of Business Gross Net of Loading
Ordinary new $ 331  $ 246 
Ordinary renewal 59,643  58,917 
Total $ 59,974   $ 59,163  


10.    Separate Accounts

The Company utilizes separate accounts to record and account for assets and liabilities for particular lines of business and/or transactions. For the current reporting year, the Company reported assets and liabilities from the following product lines/transactions into a separate account: variable annuity, variable payout annuity, variable universal life, variable life and supplemental contracts. All separate account products are authorized under New York Insurance Law, §4240.

After the merger with DLNY, NNY also has non-insulated Separate Accounts for certain DLNY contracts that include an MVA feature associated with fixed rates, including for amounts allocated to the fixed portion of certain combination fixed and variable deferred annuity contracts. The assets in the non-insulated Separate Account are carried at fair value. The assets of the non-insulated Separate Account are not legally insulated and can be used by the Company to satisfy claims resulting from the General Account.

In accordance with the products/transactions recorded within the separate account, the legal insulation of the separate account assets prevents such assets from being generally available to satisfy claims resulting from the general account. As of December 31, 2023 and 2022, the Company maintained separate account assets totaling $3,033.3 million and $2,926.0 million, respectively. As of December 31, 2023 and 2022, The Company’s Separate Account statements included legally insulated assets of $2,776.7 million and $2,664.4 million, respectively.


37


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
In accordance with the products/transactions recorded within the separate account, some separate account liabilities are guaranteed by the general account. In accordance with the guarantees provided, if the investment proceeds are insufficient to cover the rate of return guaranteed for the product, the policyholder proceeds will be remitted by the general account.

To compensate the general account for the risk taken, the separate account paid risk charges of $5.6 million, $5.9 million, $6.2 million, $6.3 million and $6.6 million for the years ended December 31, 2023, 2022, 2021, 2020 and 2019, respectively. The general account paid $1.1 million, $0.8 million, $0.9 million, $0.7 million and $0.6 million relating to separate account guarantees for the years ended December 31, 2023, 2022, 2021, 2020 and 2019, respectively.

The Company does not engage in securities lending transactions within the separate accounts.

Reserves for separate account liabilities were $2,968.2 million and $2,895.2 million as of December 31, 2023 and 2022, respectively. Separate account premiums and other considerations received were $46.9 million, $51.7 million and $61.0 million for the years ended December 31, 2023 and 2022, and 2021 respectively, and were reported as revenue in the Statements of Income and Changes in Capital and Surplus. Withdrawals at market value were $244.8 million, $217.5 million and $284.6 million for the years ended December 31, 2023, 2022 and 2021, respectively, and were reported as benefits in the Statements of Income and Changes in Capital and Surplus.

The net transfers to and from the separate accounts, included in the change in reserves for future policy benefits and policyholders’ funds, in the Statements of Income and Changes in Capital and Surplus were as follows:

2023 2022 2021
Transfers to separate accounts $ 46,942  $ 51,716  $ 60,956 
Transfers from separate accounts (314,077) (229,882) (358,638)
Other —  —  (916)
Net transfers from separate account (267,135) (178,166) (298,598)
Transfers as reported in the Statements of Income and
Changes in Capital and Surplus
$ (267,135) $ (178,166) $ (298,598)


11.    Federal Income Taxes

The components of the net deferred tax asset/(liability) at period end and the change in those components are as follows:

December 31, 2023 December 31, 2022 Change
Ordinary Capital Total Ordinary Capital Total Ordinary Capital Total
Gross deferred tax assets $ 194,378  $ 23,312  $ 217,690  $ 189,266  $ 15,500  $ 204,766  $ 5,112  $ 7,812  $ 12,924 
Statutory valuation allowance —  2,402  2,402  —  —  —  —  2,402  2,402 
Adjusted gross deferred tax assets 194,378  20,910  215,288  189,266  15,500  204,766  5,112  5,410  10,522 
Less: Deferred tax assets non-admitted 104,299  —  104,299  71,067  1,848  72,915  33,232  (1,848) 31,384 
Subtotal net admitted deferred tax assets 90,079  20,910  110,989  118,199  13,652  131,851  (28,120) 7,258  (20,862)
Less: Deferred tax liabilities 48,286  21,170  69,456  53,683  11,877  65,560  (5,397) 9,293  3,896 
Net deferred tax assets $ 41,793   $ (260) $ 41,533   $ 64,516   $ 1,775   $ 66,291   $ (22,723) $ (2,035) $ (24,758)


38


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
December 31, 2023 December 31, 2022 Change
Ordinary Capital Total Ordinary Capital Total Ordinary Capital Total
Federal income taxes paid in prior years
recoverable through loss carrybacks
$ —  $ —  $ —  $ —  $ 1,203  $ 1,203  $ —  $ (1,203) $ (1,203)
Adjusted gross deferred tax assets expected to be
realized after application of the threshold
limitation
41,793  (260) 41,533  64,516  572  65,088  (22,723) (832) (23,555)
1) Adjusted gross deferred tax assets expected to
be realized following the balance sheet date
41,793  (260) 41,533  65,530  602  66,132  (23,737) (862) (24,599)
2) Adjusted gross deferred tax assets allowed
per limitation threshold
XXX XXX 41,534  XXX XXX 72,309  XXX XXX (30,775)
Adjusted gross deferred tax assets offset by
gross deferred tax liabilities
48,286  21,170  69,456  53,683  11,877  65,560  (5,397) 9,293  3,896 
Deferred tax assets admitted as the result of
application of SSAP No, 101
$ 90,079   $ 20,910   $ 110,989   $ 118,199   $ 13,652   $ 131,851   $ (28,120) $ 7,258   $ (20,862)

2023
Ratio percentage used to determine recovery period and threshold limitation amount 621  %
Amount of adjusted capital and surplus used to determine recovery period and threshold limitation $ 276,893 

For the year ended December 31, 2022, the ratio percentage and amount of adjusted capital and surplus for NNY and DLNY on a separate-company basis are shown in the below table:

NNY
DLNY
Ratio percentage used to determine recovery period and threshold limitation amount 822  % 1,202  %
Amount of adjusted capital and surplus used to determine recovery period and threshold limitation $ 343,635  $ 138,429 

December 31, 2023 December 31, 2022 Change
Ordinary Capital Ordinary Capital Ordinary Capital
Impact of tax planning strategies
Adjusted gross DTAs $ 194,378  $ 20,910  $ 189,266  $ 15,500  $ 5,112  $ 5,410 
% of total adjusted gross DTAs —  % —  % —  % —  % —  % —  %
Net admitted adjusted gross DTAs $ 90,079  $ 20,910  $ 118,199  $ 13,652  $ (28,120) $ 7,258 
% of total net admitted adjusted gross DTAs —  % —  % —  % —  % —  % —  %

Management believes that it is more likely than not that the Company will be able to utilize the DTAs in the future without any tax planning strategies.

The Company believes that there is sufficient positive evidence to support that it is more likely than not that NNY will realize the full tax benefits associated with its DTAs, with the exception of $2.4 million in realized capital losses of DLNY. The realized losses of DLNY are limited under IRC 382 and management believes it is more likely than not that the realized losses will expire before they can be utilized. As a result, the Company established a $2.4 million valuation allowance on the full DLNY realized loss population as of December 31, 2023.

Regarding deferred tax liabilities that are not recognized, the Company has no temporary differences for which deferred tax liabilities have not been established.

The components of current income taxes incurred in the Statements of Income and Changes in Capital and Surplus and the net deferred tax asset/(liability) recognized in the Company’s Statutory Statements of Admitted Assets and Statutory Statements of Liabilities, Capital and Surplus at December 31, 2023 and 2022 were as follows:

39


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)

2023 2022 Change
Current income tax:
Federal $ (16,814) $ 6,143  $ (22,957)
Subtotal (16,814) 6,143  (22,957)
Federal income tax on net capital gains 6,827  32  6,795 
Federal and foreign income tax expense (benefit) incurred $ (9,987) $ 6,175  $ (16,162)
Deferred tax assets:
Ordinary:
Future policyholder benefits $ 60,273  $ 70,748  $ (10,475)
Investments 55,350  56,578  (1,228)
Deferred acquisition costs 26,022  27,529  (1,507)
Policyholder dividends accrual 22,213  23,319  (1,106)
Fixed assets 1,489  1,489  — 
Compensation and benefits accrual 3,117  3,463  (346)
Prior period adjustments
—  272  (272)
Net operating loss carryforward 16,010  —  16,010 
Tax credit carryforward —  —  — 
Other (including items <5% of total ordinary tax assets) 9,904  5,868  4,036 
Subtotal 194,378  189,266  5,112 
Non-admitted 104,299  71,067  33,232 
Admitted ordinary deferred tax assets $ 90,079  $ 118,199  $ (28,120)
Capital:
Investments $ 18,059  $ 14,637  $ 3,422 
Net capital loss carryforward 4,949  —  4,949 
Other (including items <5% of total capital tax assets) 304  863  (559)
Subtotal 23,312  15,500  7,812 
Statutory valuation allowance
2,402  —  2,402 
Non-admitted —  1,848  (1,848)
Admitted capital deferred tax assets 20,910  13,652  7,258 
Admitted deferred tax assets $ 110,989  $ 131,851  $ (20,862)
Deferred tax liabilities:
Ordinary:
Investments $ 30,515  $ 30,365  $ 150 
Fixed assets 2,264  2,073  191 
Compensation 5,543  5,550  (7)
Policyholder reserves 9,961  15,546  (5,585)
Deferred and uncollected premiums —  —  — 
Other (including items <5% of total ordinary tax liabilities) 149  (146)
Subtotal 48,286  53,683  (5,397)
Capital:
Investments 21,170  11,877  9,293 
Other (including items <5% of total ordinary tax liabilities) —  —  — 
Subtotal 21,170  11,877  9,293 
Deferred tax liabilities 69,456  65,560  3,896 
Net admitted deferred tax assets (liabilities) $ 41,533   $ 66,291   $ (24,758)


40


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Reconciliation of federal income tax rate to actual effective rate:

December 31, 2023
Amount Tax Effect Effective
Tax Rate
Income before taxes $ (25,860) $ (5,431) 21.0  %
Interest maintenance reserve (21,373) (4,488) 17.4  %
Dividends received deduction (2,731) (573) 2.2  %
Return to provision (224) (47) 0.2  %
Change in non-admitted assets (14,465) (3,038) 11.7  %
Change in valuation allowance
11,437  2,402  (9.3  %)
Other, including prior year true-up 2,146  451  (1.7  %)
Total statutory income tax $ (51,070) $ (10,725) 41.5  %
Federal income taxes incurred $ (3,827) 14.8  %
Tax on capital gains/(losses) 6,827  (26.4  %)
Prior year overaccrual/(underaccrual) (12,987) 50.2  %
Change in net deferred income tax expense/(benefit) (737) 2.8  %
Total statutory income tax $ (10,725) 41.5  %

December 31, 2022
Amount Tax Effect Effective
Tax Rate
Income before taxes $ 53,426  $ 11,219  21.0  %
Investment related
(297) (62) (0.1  %)
Tax credits
(299) (63) (0.1  %)
Interest maintenance reserve (19,903) (4,180) (7.8  %)
Dividends received deduction (2,800) (588) (1.1  %)
Return to provision (4,496) (944) (1.8  %)
Change in non-admitted assets (2,592) (544) (1.0  %)
Miscellaneous —  —  %
Other, including prior year true-up 1,121  235  0.4  %
Total statutory income tax $ 24,162  $ 5,074  9.5  %
Federal income taxes incurred $ 5,631  10.5  %
Tax on capital gains/(losses) 2,574  4.8  %
Prior year overaccrual/(underaccrual) (2,030) (3.8  %)
Change in net deferred income tax expense/(benefit) (1,101) (2.1  %)
Total statutory income tax $ 5,074   9.5  %


41


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
December 31, 2021
Amount Tax Effect Effective
Tax Rate
(in thousands)
Income before taxes $ 110,946  $ 23,299  21.0  %
Interest maintenance reserve (9,572) (2,010) (1.8  %)
Dividends received deduction (2,310) (485) (0.4  %)
NOL carryback 5,335  1,120  1.0  %
Return to provision 6,837  1,436  1.3  %
Change in non-admitted assets 8,141  1,710  1.5  %
Other, including prior year true-up 20,949  4,399  4.0  %
Total statutory income tax $ 140,326  $ 29,468  26.6  %
Federal income taxes incurred $ 18,819  17.0  %
Tax on capital gains/(losses) 3,066  2.8  %
Prior year overaccrual/(underaccrual) 1,680  1.5  %
Change in net deferred income tax expense/(benefit) 5,903  5.3  %
Total statutory income tax $ 29,468   26.6  %

Carryforwards, recoverable taxes and IRC 6603 deposits:

2023 2022
The Company had net operating loss carryforwards of $ 76,240  $ — 
The Company had capital loss carryforwards of 23,569  — 

As of December 31, 2023, the Company has approximately $76.2 million of net operating loss carryforwards and $23.6 million of capital loss carryforwards, respectively, The balance of the Company’s net operating losses are not subject to expiration and the Company's capital loss carryforwards expire in 2028 .

The Company had no income tax expense for 2023, 2022 and 2021 that is available for recoupment in the event of future net capital losses.

There was no aggregate amount of deposits reported as admitted assets under Section 6603 of the Internal Revenue Code as of December 31, 2023 or 2022.

The Company’s U.S. federal income tax return for years 2020 and after may be selected for review by tax authorities. The Company does not anticipate any material assessments or adjustments to the Company’s liability resulting from the tax examinations of prior open year periods.

Uncertain tax positions are assessed under the applicable statutory accounting guidance. There were no unrecognized tax benefits relating to uncertain tax positions for the years ended December 31, 2023 and 2022. As of December 31, 2023, the Company has recognized no amount for interest or penalties related to uncertain tax positions. Based upon existing information, the Company does not expect a material change in the recognized liability in the next 12 months. The Company has no tax loss contingencies for which it is reasonably possible that the total liability will significantly increase within twelve months of the reporting date.

Effective July 1, 2023, NNY completed its acquisition of DLNY. On July 5, 2023, DLNY merged into NNY with NNY surviving pursuant to a merger agreement. See Note 1 – “Description of Business” and Note 3 – “Significant Transactions, Delaware Life acquisition and merger” for additional information regarding the acquisition.

42


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The Company is included in the consolidated federal income tax return of The Nassau Companies, NCNY and its subsidiaries. The following companies were included in the consolidated federal income tax return for 2023:

The Nassau Companies
The Nassau Companies of New York, Inc.
PM Holdings, Inc.
Nassau Life Insurance Company
Phoenix Founders, Inc.
Nassau Re Imagine
Delaware Life Insurance Company of New York

The method of allocation among affiliates of the Company is subject to written agreement approved by the Board of Directors and based upon separate return calculations with current credit for net losses to the extent the losses provide a benefit in the consolidated tax return.

The Tax Cuts and Jobs Act provides a base erosion and anti-abuse tax (“BEAT”) which represents minimum tax calculated on a base equal to the taxpayer’s taxable income determined without regard to: (1) the tax benefits arising from base erosion payments, and (2) the applicable base erosion percentage of any NOL allowed for the tax year. The BEAT rate is 10% for tax years beginning in 2019 through 2025 and 12.5% for tax years beginning after December 31, 2025. The Company is a member of an “Aggregate Group” within the meaning of the IRC and the Aggregate Group’s base erosion payments are less than 3% of the Aggregate Group’s total deductions for the years ended December 31, 2023 and 2022. Accordingly, the BEAT liability was $0 for the years ended December 31, 2023 and 2022.

On August 16, 2022, President Biden signed into law the Inflation Reduction Act (the “Act”). Effective for tax years beginning after December 31, 2022, the Act includes a new corporate alternative minimum tax (“CAMT”) on certain corporations. The Company has determined, as of the reporting date, that they are not subject to the CAMT in 2023.


12.    Related Party Transactions

NCNY provides services and facilities to the Company that are reimbursed through a shared service agreement/cost allocation process. Expenses allocated by NCNY on the Company’s behalf were $76.2 million, $76.1 million and $94.9 million for the years ended December 31, 2023, 2022 and 2021, respectively. The amounts receivable from/(payable to) NCNY were $(5.6) million and $2.1 million as of December 31, 2023 and 2022, respectively.

1851 Securities, Inc. (“1851”), a wholly-owned subsidiary of NSRE BD Holdco LLC, an affiliate, is the principal underwriter of the Company’s variable universal life insurance policies and variable annuity contracts. The Company reimburses 1851 for commissions incurred on behalf of PHL and Nassau Life and Annuity Company (“NLA”). Commissions paid by the Company on behalf of PHL were $2.4 million, $2.7 million and $3.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. PHL and NLA reimburse NNY for these payments. There were no amounts receivable from PHL or NLA as of December 31, 2023 and 2022.

The Company pays commissions to producers who sell non-registered life and annuity products on behalf of PHL and NLA. Commissions paid by the Company on behalf of PHL were $4.4 million, $4.7 million and $3.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. Commissions paid by the Company on behalf of NLA were $135.3 million, $101.2 million and $87.8 million for the years ended December 31, 2023, 2022 and 2021. The Company had amounts receivable from PHL and NLA of $0.2 million and $9.7 million as of December 31, 2023, respectively. The Company had amounts receivable from PHL and NLA of $0.2 million and $7.8 million as of December 31, 2022, respectively.

The Company’s affiliate, Nassau Asset Management LLC (“NAMCO”), provides investment and related advisory services through an Investment Management Agreement. Expenses incurred under this agreement were $25.5 million, $24.8 million and $22.5 million for the years ended December 31, 2023, 2022 and 2021, respectively. Amounts payable to NAMCO were $0 and $0 for the years ended December 31, 2023 and 2022, respectively.

43


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The Company has investments in various classes of notes of Nassau 2017-I Ltd., Nassau 2017-II Ltd., Nassau 2018-I Ltd., Nassau 2018-II Ltd., Nassau 2019-I Ltd., Nassau 2019-II Ltd., Nassau 2020-I Ltd., Nassau Euro CLO I DAC, Nassau Euro CLO III DAC and Angel Island Capital 2023-I Ltd. (the “Nassau CLOs”) totaling $208.2 million par with a fair value of $170.8 million and $94.1 million par with a fair value of $42.6 million at December 31, 2023 and 2022, respectively. The Nassau CLOs are managed by NGC CLO Manager, LLC and NGC UK LLP, affiliates of NNY. These are recorded in other invested assets.

The Company has investments in NCNY long-term bonds, which have a par value of $78.2 million and $77.6 million at December 31, 2023 and 2022, respectively, and a fair value of $55.6 million and $53.8 million at December 31, 2023 and 2022, respectively.

In September 2019, the Company sold certain of its limited partnership and other invested assets to Nassau CFO Fund, LLC (“Nassau CFO”), a collateralized fund obligation managed by an affiliate. The Company received cash and certain equity interests in Nassau CFO as consideration with no gain or loss recognized on the sale. The Company invested in Class B Notes issued by Nassau CFO which have a par value of $9.2 million and $9.5 million at December 31, 2023 and 2022, respectively, and a fair value of $8.4 million and $8.5 million at December 31, 2023 and 2022, respectively, and recognized $0.7 million and $0.8 million of net investment income for the years ended December 31, 2023 and 2022, respectively. The Company’s equity investment in Nassau CFO was $36.5 million and $47.1 million at December 31, 2023 and 2022, respectively, and the Company recorded net investment income from Nassau CFO of $0 and $22.8 million for the years ended December 31, 2023 and 2022, respectively.

In July 2019, the Company committed $10 million to Nassau Private Credit Onshore Fund LP. In April 2021, the Company made an additional commitment of $10 million. In June 2022, the Company made an additional commitment of $6.0 million. The Company's investment in Nassau Private Credit Onshore Fund LP has a fair value of $14.9 million and a remaining commitment of $13.7 million as of December 31, 2023.

In September 2022, the Company sold certain of its limited partnership and other invested assets to Nassau CFO 2022, a collateralized fund obligation managed by an affiliate. The Company received cash, Class C Notes and Subordinated Notes issued by Nassau CFO 2022 as consideration with no gain or loss recognized on the sale. The Company's investment in Class C Notes issued by Nassau CFO 2022 have a par of $7.6 million and fair value of $7.6 million and a par of $7.0 million and fair value of $7.0 million at December 31, 2023 and 2022, respectively. The Company’s investment in Subordinated Notes issued by Nassau CFO 2022 have a par of $61.5 million and fair value of $61.5 million and a par of $77.4 million and fair value of $77.4 million at December 31, 2023 and 2022, respectively.

See Note 5 for additional information on reinsurance agreements with affiliates.

The Company has written intercompany agreements in place with its affiliates that contain a settlement date for amounts owed, which are settled monthly, in accordance with admissibility requirements. As of December 31, 2023, no amounts were overdue.


13.    Fair Value Disclosures of Financial Instruments

The fair value of an asset is the amount at which that asset could be bought or sold in a current arms-length transaction. Included in several investment related line items in the financial statements are certain financial instruments carried at fair value. Other financial instruments are periodically measured at fair value, such as when impaired, or, for certain bonds and preferred stock when carried at the lower of cost or market. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts which could be realized upon immediate liquidation. In cases where market prices are not available, estimates of fair value are based on discounted cash flow analyses, which utilize current interest rates for similar financial instruments, which have comparable terms and credit quality.


44


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The following methods and assumptions were used to estimate the fair value of each class of financial instruments:

Bonds and preferred stock

The Company uses pricing vendors to estimate fair value for the majority of its public bonds and preferred stocks. The pricing vendors’ estimates are based on market data and use pricing models that vary by asset class and incorporate available trade, bid and other market information. When pricing vendors are unable to obtain evaluations based on market data, fair value is determined by obtaining a direct broker quote or by using an internal model. For the majority of private bonds and preferred stock, fair value is determined using a discounted cash flow model, which utilizes a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions. When the discounted cash flow model is not appropriate, the Company uses third party broker quotes or other internally developed values. Short-term investments include securities with a maturity of one year or less but greater than three months at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value.

Common stock

Fair values are based on quoted market prices, where available. If a quoted market price is not available, fair values are estimated using independent pricing sources or internally developed pricing models. For fair values of common stock investments in subsidiaries, the Company uses the underlying GAAP equity in the subsidiary.

Cash, cash equivalents, and short-term investments

The carrying amounts reported in the accompanying balance sheets for these financial instruments approximate their fair values.

Other invested assets

Fair values for surplus debentures, residual tranches and certified capital companies (“capcos”) are based on quoted market prices, where available, or quoted market prices of comparable instruments. If a quoted market price is not available, fair values are estimated using independent pricing sources or internally developed pricing models.

Investment contracts

The fair value of guaranteed interest contracts was assumed to be the same as book value.

The fair value of deferred annuities and supplementary contracts without life contingencies with an interest guarantee of one year or less is valued at the amount of the policy reserve. In determining the fair value of deferred annuities and supplementary contracts without life contingencies with interest guarantees greater than one year, a discount rate equal to the appropriate Treasury rate, plus 100 basis points, was used to determine the present value of the projected account value of the policy at the end of the current guarantee period.

Deposit-type funds, including pension deposit administration contracts, dividend accumulations, and other funds left on deposit not involving life contingencies, have interest guarantees of less than one year for which interest credited is closely tied to rates earned on owned assets. For such liabilities, fair value is assumed to be equal to the stated liability balances.

Mortgage loans

The Company’s mortgage loans on real estate are all commercial mortgage loans, which are reported at amortized cost, less impairment write-downs and allowance for loan losses. Loans are considered impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the contractual terms of the loan agreement. When the Company determines that a loan is impaired, a valuation allowance is established for the excess carrying value of the loan over its estimated collateral value.

45


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Derivatives

Fair values for over-the-counter (“OTC”) derivative financial instruments, principally forwards, options and swaps, represent the present value of amounts estimated to be received from or paid to a marketplace participant in settlement of these instruments (i.e., the amount the Company would expect to receive in a derivative asset assignment or would expect to pay to have a derivative liability assumed). These derivatives are valued using pricing models based on the net present value of estimated future cash flows and directly observed prices from exchange-traded derivatives or other OTC trades, while taking into account the counterparty’s credit ratings, or the Company’s own credit ratings, as appropriate. Determining the fair value for OTC derivative contracts can require a significant level of estimation and management judgment.

New and/or complex instruments may have immature or limited markets. As a result, the pricing models used for valuation often incorporate significant estimates and assumptions that market participants would use in pricing the instrument, which may impact the results of operations reported in the financial statements. For long-dated and illiquid contracts, extrapolation methods are applied to observed market data in order to estimate inputs and assumptions that are not directly observable. This enables us to mark to market all positions consistently when only a subset of prices are directly observable. Values for OTC derivatives are verified using observed information about the costs of hedging the risk and other trades in the market. As the markets for these products develop, the Company will continually refine its pricing models to correlate more closely to the market risk of these instruments.

Financial assets and liabilities measured at fair value

The Company’s financial assets and liabilities carried at fair value have been classified, for disclosure purposes, based on a hierarchy defined by ASC 820, Fair Value Measurements. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset’s or a liability’s classification is based on the lowest level input that is significant to its measurement. For example, a Level 3 fair value measurement may include inputs that are both observable (Levels 1 and 2) and unobservable (Level 3). The levels of the fair value hierarchy are as follows:

Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 1 securities include highly liquid government bonds and exchange-traded equities.
Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Examples of such instruments include government-backed mortgage products, certain collateralized mortgage and debt obligations and certain high-yield debt securities.
Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement. Unobservable inputs reflect management’s own assumptions about inputs in which market participants would use in pricing these types of assets or liabilities. Level 3 financial instruments include values which are determined using pricing models and third-party evaluation. Additionally, the determination of some fair value estimates utilizes significant management judgments or best estimates.


46


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The following tables provide information as of December 31 about the Company’s financial assets and liabilities measured and reported at fair value on a recurring basis.

2023
Level 1 Level 2 Level 3
NAV
Total
Assets at fair value:
Bonds $ —  $ 5,334  $ 12,470  $ —  $ 17,804 
Preferred stock —  21,801  7,600  —  29,401 
Common stock [1] —  —  38,368  —  38,368 
Subtotal —  27,135  58,438  —  85,573 
Derivative assets —  57,077  —  —  57,077 
Other invested assets
—  18,913  66,104  —  85,017 
Separate account assets 2,811,809  221,154  338  —  3,033,301 
Total assets at fair value $ 2,811,809  $ 324,279  $ 124,880  $   $ 3,260,968 
Liabilities at fair value:
Derivative liabilities $ —  $ 53,530  $ —  $ —  $ 53,530 
Total liabilities at fair value $   $ 53,530   $   $   $ 53,530  
———————
[1]Includes $5,000 Class B Membership FHLB common stock.

2022
Level 1 Level 2 Level 3
NAV
Total
Assets at fair value:
Bonds $ —  $ 3,277  $ 2,352  $ —  $ 5,629 
Preferred stock —  24,358  7,051  —  31,409 
Common stock [1] —  —  27,213  —  27,213 
Subtotal —  27,635  36,616  —  64,251 
Other invested assets
—  20,598  81,349  —  101,947 
Separate account assets 2,654,450  250,874  8,663  8,891  2,922,878 
Total assets at fair value $ 2,654,450  $ 299,107  $ 126,628  $ 8,891  $ 3,089,076 
Liabilities at fair value:
Derivative liabilities $ —  $ 57,801  $ —  $ —  $ 57,801 
Total liabilities at fair value $   $ 57,801   $   $   $ 57,801  
———————
[1]Includes $5,000 Class B Membership FHLB common stock.

Fair values and changes in the fair values of separate account assets generally accrue directly to the policyholders and are not included in the Company’s revenues and expenses or surplus.


47


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Changes in Level 3 Assets and Liabilities Measured at Fair Value

The following table summarizes the changes in assets and liabilities classified in Level 3. Gains and losses reported in this table may include changes in fair value that are attributable to both observable and unobservable inputs.

2023 2022
Level 3 Assets:
Balance, beginning of period $ 126,628  $ 110,359 
Purchases 4,063  83,102 
Sales (21,669) (14,784)
Settlements —  (5,553)
Transfers into Level 3 10,868  16,815 
Transfers out of Level 3 (3,496) (50,161)
Realized gains (losses) 4,844  (3,481)
Unrealized gains (losses) 3,642  (9,669)
Balance, end of period $ 124,880   $ 126,628  

Transfers in and out of Level 3 occur at the beginning of each period. The securities which were transferred into Level 3 for the years ended December 31, 2023 and 2022 were due to decreased market observability of similar assets and/or changes to NAIC ratings. Transfers out of Level 3 for the year ended December 31, 2023 were due to the increased market observability of similar assets and/or securities previously being held at fair value now being carried at amortized cost. Transfers out of Level 3 for the year ended December 31, 2022 were due to the implementation of due diligence procedures which allowed for a refinement of the analysis of observable inputs as described in more detail above. There were no transfers from Level 2 to Level 1 recorded during the years ended December 31, 2023 and 2022.

For Level 3, inputs to the valuation methodology are unobservable and significant to the fair value measurement. Unobservable inputs reflect management’s best estimate of what hypothetical market participants would use to determine fair value. Examples of valuation techniques used based on unobservable inputs include, but are not limited to, internal models, direct broker quotes and professional judgment.

Below is a listing of the aggregate fair value for all financial instruments as of December 31, 2023 and the level within the fair value hierarchy:

Aggregate
Fair Value
Admitted
Assets
Level 1 Level 2 Level 3
NAV
Not
Practicable
(Carrying
Value)
Financial Instruments:
Bonds $ 6,252,516  $ 6,993,422  $ —  $ 4,462,184  $ 1,790,332  $ —  $ — 
Preferred stock 48,236  49,028  —  31,727  16,509  —  — 
Common stock 38,368  38,368  —  —  38,368  —  — 
Mortgage loans 470,665  517,608  —  —  470,665  —  — 
Residual tranches & surplus debentures
173,142  188,760  —  102,003  71,139  —  — 
Cash, cash equivalents &
   short-term investments
162,188  162,242  162,188  —  —  —  — 
Derivatives 3,547  3,547  —  3,547  —  —  — 
Separate account assets 3,033,301  3,033,301  2,811,809  221,154  338  —  — 
Total financial instruments $ 10,181,963   $ 10,986,276   $ 2,973,997   $ 4,820,615   $ 2,387,351   $   $  

As of December 31, 2023, the Company had no investments where it is not practicable to estimate fair value.


48


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)

(in thousands except where noted in millions)

Below is a listing of the aggregate fair value for all financial instruments as of December 31, 2022 and the level within the fair value hierarchy:

Aggregate
Fair Value
Admitted
Assets
Level 1 Level 2 Level 3
NAV
Not
Practicable
(Carrying
Value)
Financial Instruments:
Bonds $ 6,589,768  $ 7,545,870  $ —  $ 4,745,506  $ 1,844,262  $ —  $ — 
Preferred stock 48,712  50,783  —  33,888  14,824  —  — 
Common stock 27,213  27,213  —  —  27,213  —  — 
Mortgage loans 477,499  535,875  —  13,660  463,839  —  — 
Residual tranches & surplus debentures
175,734  187,228  —  89,392  86,342  —  — 
Cash, cash equivalents &
   short-term investments
147,710  148,609  88,326  8,205  51,179  —  — 
Contract loans 6,165  6,538  —  —  6,165  —  — 
Other invested assets 19,070  24,477  —  16,053  3,017  —  — 
Derivatives (57,801) —  —  (57,801) —  —  — 
Separate account assets 2,922,878  2,922,878  2,654,450  250,874  8,663  8,891  — 
Total financial instruments $ 10,356,948   $ 11,449,471   $ 2,742,776   $ 5,099,777   $ 2,505,504   $ 8,891   $  

As of December 31, 2022, the Company had no investments where it is not practicable to estimate fair value.

For the years ended December 31, 2023 and 2022, Level 3 bonds were primarily private placement debt securities priced using the Company’s internal discounted cash flow model. Market spreads used in the model were unobservable. Nearly all of these securities were in the Industrial and Miscellaneous category.


14.    Surplus Notes

NNY’s 7.15% surplus notes are due December 15, 2034 and were originally issued with a face value of $175.0 million. During September 2012, the Company retired $48.3 million face value of these surplus notes, after receiving prior approval from the Department. Interest payments also require the prior approval of the Department and may be made only out of surplus funds that the Department determines to be available for such payments under New York insurance law. The 7.15% surplus notes were issued December 15, 2004 and interest on the notes is scheduled to be paid on June 15 and December 15 of each year, commencing June 15, 2005. Interest payments for these notes for 2023 and 2022 each totaled $9.1 million. The 7.15% surplus notes may be redeemed at the option of NNY at any time at the “make-whole” redemption price set forth in the offering circular. New York insurance law provides that the notes are not part of the legal liabilities of NNY. The 7.15% notes were issued pursuant to Rule 144A under the Securities Act of 1933. NLA, an affiliate, holds $2.2 million of these notes.

Below are the details on the outstanding surplus notes (amounts in millions):

Item # Date
Issued
Interest
Rate
Original
Issue Amount
of Note
Note Holder
a Related
Party (Y/N)
Carrying
Value of
Notes
Prior Year
Carrying
Value of
Notes
Current Year
Unapproved
Interest
and/or
Principal
1000 12/15/2004 7.15% $ 175.0  N $ 126.4  $ 126.4  $ — 
Total $ 175.0  $ 126.4  $ 126.4  $  


49


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Item # Current
Year
Interest
Expense
Recognized
Life-to-Date
Interest
Expense
Recognized
Current
Year
Interest
Offset
Percentage
Current
Year
Principal
Paid
Life-to-Date
Principal
Paid
Date of
Maturity
1000 $ 9.1  $ 189.8  N/A $ —  $ 48.3  12/15/2034
Total $ 9.1  $ 189.8  $   $ 48.3 

Item # Are
Surplus Note
payments
contractually
linked
(Y/N)
Surplus Note
payments
subject to
administrative
offsetting
provisions
(Y/N)
Were
Surplus Note
proceeds used
to purchase
an asset
directly from
the holder of
the surplus
(Y/N)
Is Asset
Issuer a
Related
Party
(Y/N)
Types of
Assets
Principal
Amount of
Assets
Received
Upon
Issuance
Book/Adjusted
Carrying
Value of
Assets
Is Liquidity
Source a
Related
Party to
the Issuer
(Y/N)
1000 N N N N Cash $ 173.9  $ 173.9  N
Total $ 173.9  $ 173.9 

The impact of any restatement due to prior quasi-reorganizations is a follows:

Change in
Surplus
Change in
Gross
Paid-in and
Contributed
Surplus
2016 $ —  $ (896.9)


15.    Commitments and Contingencies

Litigation and regulatory matters

The Company is regularly involved in litigation and arbitration, both as a defendant and as a plaintiff. The litigation and arbitration naming the Company as a defendant ordinarily involves the Company’s businesses and operations. In certain of these matters, the plaintiffs are seeking large and/or indeterminate amounts, including punitive or exemplary damages.

The Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations related to the Company’s products and practices. It is the Company’s practice to cooperate fully in these matters.

It is not feasible to predict or determine the ultimate outcome of all litigation, arbitration or regulatory proceedings or to provide reasonable ranges of potential losses. It is believed that the outcome of the Company’s litigation, arbitration, and regulatory matters are not likely, either individually or in the aggregate, to have a material adverse effect on the financial condition of the Company beyond the amounts already reported in these financial statements. However, given the large or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, arbitration and regulatory investigations, it is possible that an adverse outcome in certain matters could, from time to time, have a material adverse effect on the results of operations or cash flows in particular annual periods.


50


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
Litigation related to lapsed California policies

On October 27, 2022, a putative class action captioned Velez v. Foresters Life Insurance and Annuity Company (“FLIAC”) was filed in the Superior Court of the State of California, Los Angeles County. On December 9, 2022, the Company timely removed the case to the United States District Court for the Central District of California, 2:22-cv-08932. The litigation alleges that FLIAC, which was merged into the Company effective July 8, 2020, improperly lapsed life insurance policies issued in California without fully complying with California Insurance Code Sections 10113.71 and 10113.72. The litigation makes substantially the same allegations made in litigation filed against FLIAC prior to the merger with the Company in which class certification was subsequently denied. Discovery in the Velez case is underway. The Company disputes the allegations in the Velez complaint and intends a vigorous defense.


16.    Other Commitments

As part of its normal investment activities, the Company enters into agreements to fund limited partnerships that make debt and equity investments. As of December 31, 2023, the Company had unfunded commitments of $104.9 million.

In addition, the Company enters into agreements to purchase private placement investments. At December 31, 2023, the Company had open commitments of $6.8 million.


17.    Information about Financial Instruments with Off-Balance Sheet Risk

The Company, at December 31, 2023 and 2022, held the following financial instruments with off-balance sheet risk:

Assets* Liabilities*
2023 2022 2023 2022
Swaps $ 900,000  $ 311,199  $ 18,423  $ — 
Total $ 900,000   $ 311,199   $ 18,423   $  
———————
* Notional amount

The Company uses derivative instruments including interest rate swaps. A more detailed description of these instruments is provided in Footnote 2 - “Summary of Significant Accounting Policies.”

The Company is not exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments, as the interest rate swaps are fully collateralized. The credit exposure of interest rate swaps is represented by the fair value (market value) of contracts with a positive fair value (market value) at the reporting date.

Because exchange-traded interest rate swaps are affected through a regulated exchange and positions are marked to market on a daily basis, the Company has no exposure to credit-related losses in the event of nonperformance by counterparties to such financial instruments.

The Company is required to put up collateral for any interest rate swap contracts that are entered. The amount of collateral that is required is determined by the exchange on which it is traded. The Company currently puts up cash to satisfy this collateral requirement. As of December 31, 2023 and 2022, the Company posted $61.0 million and $70.7 million of collateral, respectively.


51


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Notes to Statutory Financial Statements
(continued)
(in thousands except where noted in millions)
The current credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date. Credit risk is managed by entering into transactions with creditworthy counterparties and obtaining collateral as required. The Company also attempts to minimize its exposure to credit risk through the use of various credit monitoring techniques. Approximately 100% of the net credit exposure to the Company from derivative contracts is with investment-grade counterparties.


18.    Appropriated Surplus

Surplus includes amounts available for contingencies, some of which are required by state regulatory authorities. The contingency amounts as of December 31, 2023 and 2022 were $2.5 million.


19.    The Merger

On July 1, 2023, NNY completed its acquisition of DLNY for a purchase price of $188.5 million after receipt of insurance regulatory approval by the NYDFS. Effective July 5, 2023, DLNY merged with and into NNY pursuant to a merger agreement with NNY as the surviving entity. In accordance with SSAP No. 68, the acquisition was treated as a statutory merger. The Company’s shares remained as the outstanding shares of the merged company. No new shares were issued by the Company, and the common capital stock of DLNY was canceled under the agreement.

Pre-merger unaudited separate company revenue, net income, and other surplus adjustments for the six months ended June 30, 2023 (the date of the last quarterly filings for NNY and DLNY) were as follows (in millions):

NNY
DLNY
Revenue $ 333.9  $ 29.6 
Net income (loss) $ (62.2) $ 14.7 
Other surplus adjustments $ (12.7) $ (5.1)

For 2023, the merger adjustments line includes $9.6 million as a reduction to capital and surplus related to DLNY’s net income and other surplus changes.


20.    Reconciliation to the Annual Statement

In the 2023 Annual Statement, the Company classified the acquisition of DLNY (which was subsequently merged into NNY) in the Statements of Cash Flows as cash used for financing and miscellaneous sources. In the audited Statements of Cash Flows, the acquisition is presented in the Statements of Cash Flows as cash used for investments. The amount reclassified was $188.5 million.


21.    Subsequent Events

The Company evaluated events subsequent to December 31, 2023 and through April 1, 2024, the date of issuance of these financial statements. There were no events occurring subsequent to the end of the year that merited recognition or disclosure in these financial statements.




52


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Supplemental Schedule
Summary of Investments - Other than Investments in Related Parties
December 31, 2023
(in thousands)
Amortized
Cost
Fair
Value
Amount shown
in the
balance sheet
Fixed maturities:
Bonds:
U.S. government and government agencies and authorities
$ 240,740  $ 167,630  $ 240,740 
States, municipalities and political subdivisions
34,814  32,445  34,814 
Foreign governments
102,769  88,184  102,769 
All other corporate bonds [1]
6,369,477  5,733,993  6,369,232 
Redeemable preferred stock
50,074  48,236  49,028 
Total fixed maturities
6,797,874  6,070,488  6,796,583 
Equity securities:
Common stock:
Industrial, miscellaneous and all other
27,054  38,368  38,368 
Total equity securities
27,054  38,368  38,368 
Mortgage loans
515,829  468,850  517,609 
Real estate, at depreciated cost
27,446  XXX 27,446 
Contract loans
2,496,443  XXX 2,496,443 
Other invested assets [2]
345,204  330,051  343,759 
Cash and short-term investments
162,242  162,242  162,242 
Receivables for securities
5,820  XXX 5,820 
Total cash and invested assets
$ 130,77,912   $ 10,388,270  
———————
[1] Amortized cost and fair value amounts exclude $245,867 and $230,265, respectively, of related-party bonds.
[2] Difference between amortized cost and amount on balance sheet relates to $1,446 of non-admitted other invested assets.























See accompanying independent auditors’ report.

53


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Supplemental Schedule
Summary of Investments - Other than Investments in Related Parties
December 31, 2022 (continued)
(in thousands)

Amortized
Cost
Fair
Value
Amount shown
in the
balance sheet
Fixed maturities:
Bonds:
U.S. government and government agencies and authorities
$ 241,993  $ 167,756  $ 241,993 
States, municipalities and political subdivisions
35,874  33,000  35,874 
Foreign governments
105,654  89,956  105,654 
All other corporate bonds [1]
6,862,349  6,051,886  6,896,641 
Redeemable preferred stock
53,429  48,710  50,783 
Total fixed maturities
7,299,299  6,391,308  7,330,945 
Equity securities:
Common stock:
Industrial, miscellaneous and all other
16,796  27,213  27,213 
Total equity securities
16,796  27,213  27,213 
Mortgage loans
535,875  476,770  535,875 
Real estate, at depreciated cost
27,148  XXX 27,148 
Contract loans
2,482,361  XXX 2,482,361 
Other invested assets [2]
451,686  440,192  447,577 
Cash and short-term investments
148,608  148,601  148,609 
Receivables for securities
3,163  XXX 3,163 
Derivative collateral 70,474  XXX 70,474 
Total cash and invested assets
$ 11,035,410   $ 11,073,365  
———————
[1] Amortized cost and fair value amounts exclude $300,525 and $247,170, respectively, of related-party bonds.
[2] Difference between amortized cost and amount on balance sheet relates to $4,109 of non-admitted other invested assets.






















See accompanying independent auditors’ report.

54


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Supplementary Insurance Information
For the years ended December 31, 2023, 2022 and 2021    
(in thousands)

As of December 31, For the years ended December 31,
Future policy
benefits,
losses and
claims
Other
policy claims
and benefits
payable
Premium
and annuity
considerations
Net
investment
income
Benefits,
claims and
losses
Other
operating
expenses
2023:
Insurance Segment $ 10,077,924  $ 198,925  $ 343,202  $ 578,124  $ 610,520  $ 114,009 
2022:
Insurance Segment $ 10,328,341  $ 116,175  305,818  $ 621,969  $ 570,358  $ 117,475 
2021:
Insurance Segment $ 10,649,570  $ 184,763  $ 309,570  $ 718,275  $ 573,672  $ 151,395 






































See accompanying independent auditors’ report.

55


Nassau Life Insurance Company
(a wholly owned subsidiary of The Nassau Companies of New York)
Supplementary Schedule - Reinsurance
For the years ended December 31, 2023, 2022 and 2021    
(in thousands)
Gross
amount
Reinsurance
ceded
Reinsurance
assumed
Net
amount
Percentage of
assumed to net
Life insurance in force:
2023 $ 29,778,130  $ 12,733,268  $ 3,002,453  $ 20,047,315  15%
2022 32,184,980  14,055,740  3,036,110  21,165,350  14%
2021 35,008,124  15,350,674  3,033,651  22,691,101  13%
Life insurance premiums:
2023 $ 417,539  $ 114,018  $ 39,681  $ 343,202  12%
2022 390,010  117,322  33,130  305,818  11%
2021 402,797  128,354  35,127  309,570  11%







































See accompanying independent auditors’ report.

56